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ABSTRACT 
The olfactory epithelium (OE) is one of the few tissues to undergo constitutive 
neurogenesis throughout the mammalian lifespan. It contains multiple cell types including 
olfactory sensory neurons (OSNs) that are replaced by two populations of basal stem 
cells – frequently dividing globose basal cells (GBCs), and quiescent horizontal basal 
cells (HBCs). Strikingly, the mechanisms that control stem cell activation and proliferation, 
during normal OE homeostasis and in response to injury remain largely unexplored. My 
data indicate that HBCs possess primary cilia, cellular organelles that regulate the activity 
of multiple signaling pathways, including Hedgehog (HH) signaling. The HH pathway is 
required for the formation, survival, and activity of stem/progenitor cell populations in 
several adult tissues, making it an attractive candidate for HBC regulation. The goals of 
this dissertation are: 1) to investigate the role of primary cilia in HBC-driven olfactory 
neurogenesis and 2) to explore the contribution of HH signaling to HBC function. 
My data indicate that HBC-specific deletion of the ciliary gene Ift88 effectively 
abrogates primary cilia. Interestingly, the loss of HBC cilia did not affect HBC cell numbers 
or maintenance of the adult OE, but dramatically impaired the regeneration of OSNs 
following injury. Furthermore, the loss of cilia during development resulted in region-
specific decreases in neurogenesis, implicating HBCs in in OE establishment. These 
results demonstrate a novel role for primary cilia in olfactory neurogenesis and suggest a 
role for primary cilia in HBC activation, proliferation, and differentiation.
xi 
 
My data also demonstrate that HH pathway components are expressed in the adult 
OE. Specifically, the HH transcription factors, Gli2 and Gli3 are selectively expressed in 
HBCs, implicating HH signaling in the control of HBC function. Constitutive Gli2 activation 
in HBCs resulted in hyperproliferation and loss of neuronal cells, and also impaired OE 
regeneration following injury. Surprisingly, constitutive Gli2 repression in HBCs did not 
alter OE maintenance, but did impair injury-induced OE regeneration. These results 
suggest a novel role for HH signaling, and specifically Gli2, in HBC regulation during OE 
homeostasis and regeneration. Overall, this work defines novel roles for primary cilia and 
HH signaling in HBC-mediated regulation of the mammalian OE. 
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CHAPTER I: 
Introduction 
1.1 Abstract 
An appreciation of olfaction, or the sense of smell, and its importance across 
species dates back to ancient civilizations. This appreciation has grown with recent 
advances in technology and olfactory research. The sense of smell relies on olfactory 
sensory neurons (OSNs) in the olfactory epithelium (OE) that project compartmentalized 
organelles, called cilia into the nasal cavity. Cilia contain various odorant receptors to 
which odorants bind and propagate a signal to the central nervous system (CNS), where 
the sense of smell is perceived. OSNs are unique neurons in that they both directly 
contact the external environment and the brain. While this direct contact allows OSNs to 
detect odors, it also makes them susceptible to environmental toxins leading to cell death. 
Upon their death, OSNs are replenished by basal stem cells in the OE leading to 
constitutive regeneration and neurogenesis. However, several forms of olfactory 
dysfunction can arise from various perturbations of OSNs, including disruption of olfactory 
cilia, cell death, or odorant signal transduction pathways. Some olfactory disturbances 
are treatable but more severe dysfunctions lack therapeutic remedies. In order to develop 
novel treatments for olfactory dysfunction, understanding the mechanisms of OE 
maintenance and uncovering additional etiologies of olfactory dysfunction are imperative. 
Many questions concerning the maintenance of the OE remain unanswered, including the 
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precise mechanisms and signaling pathways necessary for the cell division, cell fate, and 
cell differentiation of the basal stem cells. Various signaling pathways, including the cilia-
dependent Hedgehog (HH) pathway, play important roles in adult stem cell function. In 
this chapter, I review: 1) the olfactory system itself, 2) the role of cilia in olfactory function, 
and 3) the role of cilia-dependent HH signaling as a potential novel regulator of olfactory 
maintenance and regeneration. 
 
1.2 Olfaction: An Evolutionarily Conserved Sense 
1.2.1 Importance and Mechanism of Smell 
Olfaction, or the sense of smell, is an evolutionarily and historically important 
function. The importance of smell ranges across species and extends to prehistoric times. 
In early medicine, odor and taste were used often as a diagnosis of disease and for 
animals and prehistoric humans, olfaction was and remains important for survival in 
obtaining food, finding a mate, and avoiding predators (Doty, 2015). From ancient 
civilization to present-day, smell has been a large part of the quality of life of humans 
through the use of fragrances in religious rites and celebrations, as well as for skin care 
and food (Doty, 2015). In mammals, olfaction has been linked to behaviors related to 
alarm, feeding, mating, predator-prey relationships, social status appraisal, and species 
recognition through the social and emotional associations of certain smells (Doty, 2015). 
A major advance has been the discovery that the loss of smell is the first, or among the 
first, sign of common neurodegenerative diseases like Alzheimer’s disease and 
Parkinson’s disease (Doty, 2003a; Smutzer et al., 2003; Doty, 2015), making olfactory 
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testing an important early indicator of some neurodegenerative disorders. Olfaction has 
varying uses and levels of importance across species and this is due in part to the 
evolution of smell.  
Evolution of Smell 
Olfaction began in an aquatic environment in which fish detected water-soluble 
odorants and evolved to incorporate both water-soluble and volatile odorants in four-
limbed animals due to their dual environments on land and in water (Hoover, 2010). 
Eventually mammals evolved, and unlike other non-mammal vertebrates, used an organ, 
the nose, to detect volatile odors. Within the nose are nasal turbinates that help push 
odorants within the inhaled air into the olfactory epithelium (OE) via the orthonasal route 
(Shepherd, 2004). In humans, odorants also reach the OE via the retronasal route from 
the back of the oral cavity through the nasopharynx, allowing for smell perception of foods 
and liquids (Shepherd, 2004). Further evolution of humans was characterized by the 
increasing importance of other senses, like vision, due to the adoption of an erect posture 
which moved the nose away from the ground and closer to the face, allowing for the eyes 
to have more depth perception (Sarafoleanu et al., 2009). Although other senses have 
become important for humans, the sense of smell has not become irrelevant, but its 
importance has become associated with aspects that diverge from other mammals.  
The basic organization of the olfactory system of humans and mice is similar with 
only some differences in its structure, making experimental information about the function 
of the mouse olfactory system applicable to humans (Harkema et al., 2012). A schematic 
of the mouse olfactory turbinates and resulting coronal sections can be seen in Fig. 1-1. 
From rodents to humans, there is a reduction in the proportion of functional odorant 
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receptor (OR) genes to total OR genes. In mammals, volatile odors are detected via ORs 
found in specialized primary cilia (small organelles important for cell function) that project 
from olfactory sensory neurons (OSNs) in the OE. While mice have approximately 1,300 
– 1,500 OR genes with 1,100 that are functional (Young et al., 2002; Zhang and Firestein, 
2002), humans only have 350 functional OR genes of the approximate 1,000 in the 
genome (Glusman et al., 2001). However, this reduction in humans is compensated by 
the larger capacity of human brain processing via the integration of various areas of 
olfactory perception in the brain (Sarafoleanu et al., 2009). This combination of odor 
detection in the main olfactory system and odor perception in the cerebrum is the basis 
for olfactory transduction. 
Olfactory Transduction 
The main olfactory system detects odorants in the nasal cavity via OSNs and the 
resulting information is sent to various regions of the CNS. OSNs are bipolar neurons with 
a single dendrite that projects to the surface of the OE and ends in a structure called the 
dendritic knob. Basal bodies within the dendritic knob project cilia towards the nasal cavity 
into mucous of the OE. The human OE contains approximately 50 million OSNs with 8-
20 cilia (Sarafoleanu et al., 2009) compared to 6-10 million OSNs in the mouse OE 
(Firestein, 2001). In most mammals and humans, lengths of OSN cilia are approximately 
50µm, while in non-mammalian vertebrates such as frogs, they can be as long as 200µm 
(Menco and Morrison, 2003). These cilia are enriched in ORs and other signaling 
components that mediate the initial transduction events in the cell (Firestein, 2001). The 
family of ORs was initially identified as a large multigene family of olfactory-specific G 
protein-coupled receptors (GPCRs) in the rat (Buck and Axel, 1991). They exhibit 
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extensive sequence diversity within their transmembrane domains (the presumed ligand 
binding sites), allowing for the detection of a wide range of chemicals in the environment 
(DeMaria and Ngai, 2010). In addition to the ORs, a second family of receptors called 
trace amine-associated receptor (TAAR) family are also expressed in a unique subset of 
OSNs and are thought to recognize volatile amines (Liberles and Buck, 2006). The 
receptors within the multitude of OSN cilia increase the sensory surface area of the OE, 
priming the olfactory system for signal detection.  
The signaling cascade for the sense of smell starts with the binding of an odorant 
to its receptor (Fig. 1-2A). Only volatile materials that are soluble in the mucous and that 
interact with specific OSNs produce odors (Turin and Yoshii, 2003). Odorant molecules 
pass through the nasal cavity, dissolve in the mucous and bind to their corresponding 
olfactory receptors. Upon odorant binding, the activated OR couples through the G-
protein, Gαolf, which is a Gαs isoform enriched in OSNs (Belluscio et al., 1998). Activated 
Gαolf then activates type III adenylyl cyclase (ACIII) (Wong et al., 2000), which catalyzes 
the production of cyclic AMP (cAMP) (Fig. 1-2A). The increase in intracellular cAMP 
opens a cyclic nucleotide-gated (CNG) channel (Brunet et al., 1996), leading to an influx 
of sodium and calcium ions, and depolarization of the neuron (Fig. 1-2A). The initial 
depolarization is further amplified by the subsequent activation of calcium-activated 
chloride channels and, due to the low concentration of extracellular Cl- in the mucus, the 
efflux of Cl- from the cell (Stephan et al., 2009) (Fig. 1-2A). The odor-induced 
depolarization in the olfactory cilia spreads throughout the neuron, resulting in the 
opening of voltage-sensitive ion channels in the sensory neuron’s axon hillock, the firing 
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of action potentials, and the release of neurotransmitter at the synaptic terminal (DeMaria 
and Ngai, 2010). 
At the other end of OSNs, a single, unbranched axon projects to the olfactory bulb 
(OB), a structure in the forebrain that serves as the first relay of olfactory information. The 
axons of OSNs in the periphery together comprise the olfactory nerve (the first cranial 
nerve). Once the axons reach the OB, they form synapses with the dendrites of projection 
neurons within discrete structures known as glomeruli (DeMaria and Ngai, 2010) (Fig. 1-
2B). Each OSN in the OE expresses just one allele of a single OR (Chess et al., 1994; 
Serizawa et al., 2003) – known as the “one receptor, one neuron” rule (DeMaria and Ngai, 
2010). Although OSNs expressing a given OR are distributed broadly throughout the OE, 
their axons converge to specific glomeruli in the OB in a spatially invariant pattern 
(Ressler et al., 1993; Vassar et al., 1993; Ressler et al., 1994; Vassar et al., 1994; 
Mombaerts et al., 1996). The projection neurons of the OB, the mitral and tufted cells, 
extend their axons to the olfactory cortex which is comprised of several anatomically 
distinct areas including the piriform cortex, olfactory tubercle, anterior olfactory nucleus, 
and specific parts of the amygdala and entorhinal cortex (Zou et al., 2001) (Fig. 1-2C). 
Communication with the limbic system allows for interplay between smell and various 
processes like taste, memory and behavior.  
1.2.2 Development and Anatomy of the Olfactory Periphery 
The sensory organs of the vertebrate head derive from the sensory placodes and 
the cranial neural crest (NC) during embryogenesis. Placodes are discrete areas of 
thickened non-neural epithelium that give rise to the paired sensory organs including the 
olfactory system (Katoh et al., 2011). The olfactory organ has been shown to arise from 
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a combination of the olfactory placode and cranial NC cells (Katoh et al., 2011). The role 
of the olfactory placode in olfactory development was first experimentally demonstrated 
in amphibians when obstruction of the olfactory placode disrupted the development of the 
OB (Burr, 1916). The importance of NC cells in the development of the olfactory system 
was demonstrated in rats with a mutation in the Pax6 gene in which impaired migration 
of midbrain crest cells into the frontonasal mass led to the loss of the nasal placode 
(Osumi-Yamashita et al., 1997). Olfactory progenitors are believed to arise from the 
placode (Chuah et al., 2003) but some studies have revealed they might also arise from 
the NC (Katoh et al., 2011). 
During development, neural stem cells are important for early neurogenesis and 
morphogenesis of the OE (Gokoffski et al., 2010). Apical and basal progenitors divide 
and differentiate into various cells resulting in a pseudostratified epithelium of five basic 
cell types (Chuah et al., 2003; Murdoch and Roskams, 2007). These cell types are 
morphologically and biochemically distinguishable. From the apical surface down, 
sustentacular (SUS) cells, mature and immature olfactory sensory neurons (OSNs), 
Bowman’s gland (BG) duct cells, globose basal cells (GBCs), and horizontal basal cells 
(HBCs) make up the OE (Fig. 1-3). In addition to the five basic cell types, microvillar cells 
(MVCs) have also been observed in the OE (Moran et al., 1982; Morrison and Costanzo, 
1990; Miller et al., 1995). In human and other mammalian embryos, there is a dramatic 
increase in mitosis in the OE immediately before the first emergence of olfactory axons 
at stage 13 (28 days) (Chuah et al., 2003). At this stage in development, mitosis in the 
OE is similar to the cell division observed in the developing neural tube (Chuah et al., 
2003). The epithelial cells undergo interkinetic nuclear migration (Sauer, 1937) as G1- 
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and S-phases take place in deeper parts of the epithelium, and the cells migrate 
superficially to complete mitosis at the apical epithelial surface (homologous to the 
ventricular surface of the neural tube) (Smart, 1971; Chuah et al., 2003). Later in 
development, once the basal cell layer is established, a shift of mitotic activity occurs to 
the base of the OE (Smart, 1971; Chuah et al., 2003). The precise relationship between 
the apical and basal progenitor populations has not been clarified but neurons are being 
generated even at times when mitoses are concentrated apically (Chuah et al., 2003).  
The most detailed studies on the development of the various cell types in the OE 
have been done in rodents. In mice, the OE begins to form at embryonic day 10 (E10), 
which is shortly after the placode begins to invaginate (Cuschieri and Bannister, 1975; 
Cau et al., 2000; Murdoch and Roskams, 2007). Within the olfactory placode, the order 
and progression of pro-neural genes that regulate olfactory neurogenesis have been 
revealed by genetic analysis of basic helix-loop-helix (bHLH) family proteins which are 
expressed in GBCs (Guillemot et al., 1993; Cau et al., 1997; Cau et al., 2002). This 
genetic analysis has led to the current model in which a pool of rapidly proliferating transit 
amplifying cells expressing Ascl1 (formerly Mash1) give rise to Ngn1- and NeuroD-
positive immediate neuronal precursors (Duggan et al., 2008). While maturing GBCs that 
migrate from the apical surface clearly contribute to organogenesis (Cau et al., 2002), the 
precise role of HBCs is unclear. Small numbers of p63-expressing cells, which are 
thought to be HBC precursors, first appear at E14, after the emergence of all other cell 
types (Packard et al., 2011b). HBCs settle to the basal lamina, begin to express Keratin5 
(K5), and become dormant between ~E16 and P10 (Packard et al., 2011b). Due to their 
late emergence, HBCs are not believed to participate in the establishment of the OE. 
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However, evidence from a lineage-trace mouse model suggests that upon their 
establishment in the OE at postnatal day 10 (P10), HBCs do participate in neurogenesis 
to a lesser extent (Iwai et al., 2008).  
The first cells to differentiate are neurons and slightly later, there is a major 
transition in the appearance of the epithelium, which coincides with the shift of mitotic 
activity from the apical epithelium to the basal region (Chuah et al., 2003). At this time, 
the various cell types become morphologically distinct (Chuah et al., 2003). The OE is 
separated from the lamina propria (LP), the underlying region, by a basement membrane 
called the basal lamina (Fig. 1-3A). The developing LP contains olfactory ensheathing 
cell (OEC) precursors and immature OECs which ensheath OSN axons (Murdoch and 
Roskams, 2007). The postnatal LP contains axon bundles, OECs, connective tissue, 
blood vessels, and Bowman’s glands (Murdoch and Roskams, 2007). The highly 
vascularized LP is supplied by the ethmoidal artery which is distinct from sphenopalatine 
supply of the respiratory mucosa (Ding and Xie, 2015a). The resulting high perfusion rates 
in nasal tissue allow for rapid absorption and systemic distribution of substances that 
penetrate the OE, however, this high perfusion can also allow for toxins in the 
bloodstream to come in contact with xenobiotic-metabolizing enzymes in the olfactory 
mucosa (Ding and Xie, 2015b).  
OSNs 
OSNs make up 80-85% of the epithelial cells and are densest in the posterior 
dorsal part of the OE (Menco and Morrison, 2003). They are comprised of mature and 
immature sensory neurons. Mature OSNs are identified by their expression of olfactory 
marker protein (OMP) (Danciger et al., 1989), and just below and blending in with the 
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basal cells are the immature OSNs identified by the expression of GAP43 (Verhaagen et 
al., 1989) and β-tubulin type III (Roskams et al., 1998). 
SUS cells 
The supporting cells of the OE, SUS cells, make up 12-15% of the epithelial cells 
and span the apical olfactory epithelium tapering basally where they attach by foot-like 
processes known as endfeet to the basal lamina (Menco and Morrison, 2003) and make 
contacts with basal stem cells (Joiner et al., 2015). They are identified by a number of 
antigens including SUS1 (Hempstead and Morgan, 1983) and SUS4 (Goldstein and 
Schwob, 1996), as well as more defined markers like keratin 18, E-cadherin (Packard et 
al., 2011a), and transcription factors like Sox2 and Pax6 (Guo et al., 2010; Packard et al., 
2011b). SUS cells are covered with microvilli that extend into the mucus and intermingle 
with olfactory cilia (Menco and Morrison, 2003). They are phagocytic and like CNS glia, 
provide structural support (Dennis et al., 2015). The SUS cells make multiple contacts 
with the OSNs and may release materials in and/or absorb material from the mucus 
(Menco and Morrison, 2003). They express high levels of enzymes known to participate 
in metabolic modification of toxicants, suggesting a glia-like protective role of the neuronal 
environment (Dennis et al., 2015). Some of these enzymes that SUS cells express include 
several cytochrome P450 isoforms (Ling et al., 2004) and glutathione S-transferase 
(GST) (Weech et al., 2003; Whitby-Logan et al., 2004). 
The Notch receptor, a component of the Notch pathway that is involved in a variety 
of cell fate decisions during development, is expressed in adult glia (Rodriguez et al., 
2008) and in the OE, while Notch1 is known to be expressed in basal cells, Notch2 
(Carson et al., 2006; Rodriguez et al., 2008) and Notch3 (Rodriguez et al., 2008), are 
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expressed in SUS cells. Studies have suggested that maintained expression of Notch 
receptors may be required to permanently establish fate in a differentiated cell type and 
that transient activation of the Notch pathway is sufficient to promote gliogenesis 
(Morrison et al., 2000; Tanigaki et al., 2001). One study investigated the role of Notch in 
SUS cells and found that the loss of Notch2 leads to a decrease in expression of P450s 
and GST, as well as GST activity, that is accompanied by neurodegeneration of OSNs 
(Rodriguez et al., 2008). These findings support the idea of SUS cells having a 
neuroprotective role in the OE and show that Notch is important for this role.      
BG cells 
Like SUS cells, BG cells, are involved in metabolism of xenobiotic compounds 
(Ding and Dahl, 2003). The acinar and duct cells of BGs contain many xenobiotic-
metabolizing enzymes but their localization is species dependent (Ding and Xie, 2015a). 
BGs found in the LP are responsible for the mucous secretion at the epithelial surface 
and the glands along with their duct complex, which enters the OE, allows for the olfactory 
cilia to be embedded in mucous (Menco and Morrison, 2003).  
MVCs 
 There is approximately one MVC per SUS cell in the OE, making up about 1% of 
the olfactory epithelial cells (Miller et al., 1995). They have neuron-like morphology and 
are observed in the apical part of the OE (Dennis et al., 2015). Although their function 
and cell-lineage is unknown, there have been several studies that attempt to address the 
identity and role of MVCs in the OE. Multiple types of MVCs have been observed in the 
OE, including 1) microvillous OSNs with an axon projecting to the OB (Moran et al., 1982) 
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displaying a morphology similar to that of the microvillous sensory neurons found in the 
vomeronasal organ that express transient receptor channel C2 (TRP C2) (Liman et al., 
1999) and 2) microvillous non-OSNs that lack a basal process or axon (Carr et al., 1991). 
Within the non-neuronal microvillous cell populations, a subset express the TRP M5 
channel (Lin et al., 2007; Hansen and Finger, 2008) or phospholipase C beta-2 (PLCβ2), 
TRP C6 and the type 3 inositol triphosphate receptor (IP3R3) (Elsaesser et al., 2005). A 
study that looked at the TRP5-expressing MVCs found that these cells also express 
choline acetyltransferase and are able to synthesize and potentially release Ach which 
modulates activities of OSNs and SUS cells (Ogura et al., 2011). Additionally, a study 
that focused on IP3R3-expressing MVCs found that these cells make contacts with nerve 
fibers and a subset are responsive to ATP, substance P and some odorants (Hegg et al., 
2010). However, they do not possess neuronal or glial markers and do not project 
processes to the OB (Hegg et al., 2010). These findings suggest that IP3R3 MVCs might 
be a type of solitary chemosensory cell which respond to odorants at concentrations 
classified as irritants and may transfer sensory information via the nerve fibers (Hegg et 
al., 2010). These cells were also found to be a possible regulatory link between 
degenerating OSNs and olfactory stem cells (Jia and Hegg, 2012). Additional studies 
need to be performed to reveal the true classification and roles of MVCs. 
GBCs and HBCs 
The GBCs and HBCs are the stem/progenitor cell populations of the OE and make 
up approximately 5% of the epithelial cells. GBCs are a heterogeneous population of 
actively cycling cells (Jang et al., 2014), while HBCs are a relatively homogeneous 
population of quiescent cells (Holbrook et al., 1995; Carter et al., 2004). HBCs resemble 
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the basal cells of the adjacent respiratory epithelium and envelop the olfactory axons as 
they exit the OE (Mackay-Sim, 2003). They are identified by their expression of a variety 
of antigens including keratins 5 and 14 and ICAM-1 (Holbrook et al., 1995). GBCs are 
round cells located more superficially than HBCs that are not seen in the respiratory 
epithelium (Goldstein and Schwob, 1996). A type of GBC that is located above the HBC 
layer but extends a slender process to contact the basal lamina has been interpreted as 
an intermediate form between HBCs and GBCs (Graziadei and Graziadei, 1979; Holbrook 
et al., 1995). The functions of HBCs and GBCs will be addressed in greater detail in the 
next section of this chapter. Together, these cells are important for the olfactory system 
to properly function. 
1.2.3 Olfactory Dysfunction 
 Olfactory disorders arise from various disturbances, having a large impact on one’s 
quality of life. They can be classified as (i) anosmia (absence of smell), (ii) partial anosmia 
(ability to perceive some odorants), (iii) hyposmia (decreased sensitivity to odorants), (iv) 
hyperosmia (abnormally acute olfactory function), (v) dysosmia (distorted smell 
perception), (vi) phantosmia (sensation in absence of odor stimulus) and (vii) 
presbyosmia (absence of smell due to aging) (Murphy et al., 2003). These impairments 
can occur from (i) nasal passage obstruction, (ii) damage to the OE and/or (iii) damage 
to the central nervous system (Murphy et al., 2003).  
There are numerous reported etiologies for olfactory disturbance including various 
drugs, endocrine or metabolic disorders, industrial debris, viral and bacterial infections, 
lesions of the nose or airway blockage, neoplasms, neurological disorders, nutritional or 
metabolic imbalances, psychiatric disorders, and pulmonary diseases (Murphy et al., 
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2003). Additionally, a normal decline in olfactory function due to aging afflicts 
approximately 25% of the population over 65 years old and this estimation is largely 
underrepresented (Murphy et al., 2002). If sensory information cannot be properly 
detected in the OE, transduced in the OB, or processed in the cerebrum, olfactory 
disturbances will occur. 
Disturbance to OSNs  
Impairments to the OE are often associated with a loss of OSNs. Due to the contact 
of OSNs with damaging agents in the inhaled air, the olfactory system is vulnerable to 
insult. There are some defense mechanisms that the system employs in order to 
counteract this vulnerability. These mechanisms include 1) the detection of irritants by the 
nerve endings of the trigeminal nerve to trigger a flight response and change in breathing 
rate and/or pattern to minimize the entry of the irritant into the airways (Hastings and 
Miller, 2003) and 2) the metabolism of these xenobiotics through the presence of phase I 
and phase II enzymes – cytochrome P450s, glutathione, and related enzymes (Reed, 
1993). However, these protective systems can fail and result in olfactory deficits after 
some toxic exposures (Hastings and Miller, 2003). Exposure to various compounds at 
certain concentrations can affect the histology and function of specific cells in the OE (for 
review, see ref. Hastings and Miller, 2003). Additionally, there is a net loss of OSNs over 
time due to the fact that the capacity to match OSN death with regeneration is 
compromised as a function of age (Conley et al., 2003). This compromise can be 
attributed to the dramatic decrease in basal stem cell proliferation with age, with olfactory 
cell proliferation decreasing ~10 to 15 times after birth during the first 3 months of life 
(Legrier et al., 2001; Ducray et al., 2002). Upper respiratory infections can also lead to 
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loss of OSNs, a decrease in OSN cilia, and respiratory infiltration (Murphy et al., 2003), 
which ultimately lead to olfactory dysfunction.  
Disturbance to Signaling Machinery  
Disturbances to smell can also be associated with dysfunction in the signaling 
machinery of OSNs. Channelopathies, a class of disorders that are associated with 
mutations in genes that encode ion channel subunits or regulatory proteins (Kass, 2005) 
are associated with olfactory disturbances. Mice that lack the potassium channel, Kv1.3, 
were shown to be “super-smellers” with increased discrimination of odor molecules and 
increased odor threshold (Fadool et al., 2004; Biju et al., 2008). This phenotype is most 
likely associated with the altered axonal targeting of OSNs exhibited in Kv1.3-null mice 
(Biju et al., 2008). Additionally, the loss of the sodium channel, Nav1.7, in mice led to a 
decrease in odor-guided behaviors, odor discrimination, and innate avoidance towards 
predator odor (Weiss et al., 2011). The OSNs in these Nav1.7-nulll mice still evoke action 
potentials but fail to initiate synaptic signaling to the projection neurons in the OB (Weiss 
et al., 2011). A more recent manifestation of diseases related to olfactory dysfunction is 
the group of disorders associated with a dysfunction in cilia, termed ciliopathies, which 
will be discussed in greater detail later in this chapter. 
Blockage and Disturbance to the CNS 
Nasal and sinus disease as well as intranasal and intracranial tumors can obstruct 
the nasal cavity leading to blockage of airflow or disturbance to the CNS resulting in a 
loss of olfaction (Murphy et al., 2003). Also, some viruses can infiltrate the CNS and 
influence central structures independent of peripheral damage (Baker and Genter, 2003). 
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Psychiatric disorders such as schizophrenia and chronic hallucinatory psychoses are 
associated with altered olfactory function affecting the CNS (Smutzer et al., 2003). Head 
trauma can cause olfactory dysfunction and the likelihood of anosmia is dependent on 
the severity of the injury (Costanzo et al., 2003). Traumatic olfactory dysfunction may be 
caused by: 1) sinonasal contusions or fractures without direct damage to the olfactory 
apparatus, 2) tearing or shearing of olfactory nerve filaments, or 3) contusion or 
hemorrhage within the olfactory-related brain regions (Costanzo et al., 2003).  
Current Therapies 
 Meaningful treatments are available for some, but not all, patients with an olfactory 
disturbance. The prognosis for patients suffering from long-standing total loss of smell 
due to upper respiratory illness or head trauma is poor. There are, however, several 
treatments and surgical procedures to help the improvement of smell, but the prognosis 
for recovery seems to be better for patients with less severe olfactory dysfunction (Murphy 
et al., 2003). For loss of smell due to obstruction of the airway, surgery and steroid therapy 
can reduce the obstruction and improve the sense of smell (Murphy et al., 2003). 
However, there is no current treatment for congenital olfactory dysfunction or loss of smell 
due to malformations of the olfactory bulbs and stalks (Murphy et al., 2003). In general, 
olfactory dysfunction due to sensorineural causes such as upper respiratory illness or 
head trauma is difficult to treat. Prognosis for recovery appears to be better for patients 
with less severe hyposmia than for those with anosmia, which may reflect the less 
extensive damage into the basal layer of the epithelia and possibly less fibrosis around 
the cribriform plate through which the olfactory nerves pass (Murphy et al., 2003). The 
use of basal stem and progenitor cells as a viable therapeutic strategy has been proposed 
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but is still in very early stages of investigation (Krolewski et al., 2011). Furthermore, a 
more complete understanding of olfactory stem cell function could aid in the development 
of future therapies.  
 
1.3 Adult Neurogenesis 
1.3.1 Distinct Areas of Adult Neurogenesis 
Stem cells have varying potencies and capabilities ranging from totipotent stem 
cells that can give rise to a full organism, to pluripotent stem cells that can give rise to 
every cell of the organism except the trophoblasts of the placenta, to multipotent stem 
cells that are believed to give rise to only cells of the organ from which they are derived 
(Gage, 2000). Neurogenesis occurs from the self-renewal and differentiation of neural 
stem cells (NSCs), which can give rise to cells other than themselves through asymmetric 
cell division (Gage, 2000). NSCs exist in the developing and adult nervous system of all 
mammalian organisms, however, areas of continuous adult neurogenesis have been 
identified in the olfactory epithelium (OE), the subventricular zone (SVZ) of the lateral 
ventricle, and the subgranular zone (SGZ) of the hippocampus (Altman and Das, 1965; 
Gage, 2000; Alvarez-Buylla and Garcia-Verdugo, 2002; Lie et al., 2004).  
In the adult OB, neural stem cells in the SVZ, a layer of dividing cells located along 
the lateral wall of the lateral ventricles, proliferate and give rise to neuroblasts which then 
migrate in the rostral migratory pathway and differentiate into granule and periglomerular 
neurons (Doetsch, 2003; Lie et al., 2004). There are four main cell types in the SVZ; 
neuroblasts, astrocytes, immature precursors, and ependymal cells (Doetsch et al., 
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1997). The dominant cell in the rodent SVZ is the dual-functioning astrocyte which can 
serve as both a neural stem cell (NSC) and a supporting cell that interacts with other 
astrocytes to promote neurogenesis (Lim and Alvarez-Buylla, 1999). 
In the adult hippocampus, neural progenitors located in the SGZ, a germinal layer 
in the hippocampus located between the granule cell layer and hilus of the dentate gyrus, 
proliferate and give rise to dentate gyrus granular neurons (Doetsch, 2003; Lie et al., 
2004). Foci within the SGZ contain astrocytes, which extend basal processes under the 
blades of the dentate gyrus and an apical process into the granule cell layer and dividing 
immature Type D cells, which express markers for neuronal differentiation, newly 
generated neurons, and endothelial cells (Palmer et al., 2000; Seri et al., 2001). As in the 
SVZ, SGZ astrocytes are the primary precursors of neurons and divide to generate 
granule neurons via Type D cells (Seri et al., 2001).  
Various studies suggest that factors and mechanisms that regulate proliferation, 
migration, differentiation, and cell survival during development are reactivated in the 
injured adult environment, allowing for tissue repair and neuroplasticity (Lie et al., 2004). 
Transplantation studies suggest that adult neural stem/progenitor cells from different 
regions are not fate-restricted by intrinsic programs but by extrinsic cues derived from the 
local environment (Lie et al., 2004). The adult olfactory system is an example of 
extraordinary plasticity in its ability to respond to injury through the replacement of 
neurons by olfactory stem cells (Joel, 2003). 
1.3.2 Constitutive Neurogenesis in the Olfactory Periphery 
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Early evidence that OSNs could regenerate after damage was seen in primates in 
1960 (Schultz, 1960). Studies have shown that the type of repair seems to correlate to 
the degree or extent of initial damage (Mackay-Sim, 2003). The discovery of the co-
existence of mitotic cells, immature sensory cells, mature sensory cells, and dying cells 
suggested that sensory cells are continually replaced (reviewed in Mackay-Sim, 2003). 
This hypothesis was further supported by other investigators proving that the OE is a 
system of renewal and regeneration (Graziadei and Graziadei, 1979; Graziadei and Monti 
Graziadei, 1983). This survival process allows olfactory function to continue throughout 
the lifetime of an organism. In the mouse, this neurogenesis occurs during three phases: 
embryonic establishment (E10-P0), postnatal expansion (P1-P30), and postnatal 
maintenance (P30-death) (Murdoch and Roskams, 2007).  
GBCs and HBCs 
The precise mechanisms controlling regeneration and homeostasis in the OE are 
unclear; however, there are several proposed models. Regeneration and neurogenesis 
is thought to occur through the differentiation of GBCs, HBCs, or a combination of both 
(Graziadei and Graziadei, 1979; Calof and Chikaraishi, 1989; Leung et al., 2007; Iwai et 
al., 2008; Jang et al., 2014), but there still remains controversy over which cell type is the 
true stem cell population. GBCs are neurogenic and bi-potential since they can produce 
both OSNs and SUS cells (Murdoch and Roskams, 2007). Several studies show that 
GBCs are neuronal precursors that exist as a heterogeneous population, 
compartmentalized by their expression of distinct transcription factors. In the GBC lineage 
cascade, Ascl1 (Mash1) expression lies upstream of Neurogenin1 (Ngn1) which lies 
upstream of, but also overlaps with, NeuroD1 expression (Cau et al., 1997; Manglapus et 
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al., 2004; Packard et al., 2011a; Krolewski et al., 2013). NeuroD1 is eventually switched 
off prior to the onset of postmitotic differentiation, and low levels of NeuroD1 are 
sometimes found in immature OSNs (Packard et al., 2011a). HBCs are multipotent 
progenitors with a more quiescent “stem-cell” like behavior (Murdoch and Roskams, 
2007). The transcription factor, p63, was found to be a regulator of HBC dormancy and 
activation and is highly expressed in the basal cell layer of skin and other stratified 
epithelia (Packard et al., 2011b). Additionally, the basal cell cytokeratins K5/K14 which 
mediate adhesion to the basal lamina and in the OE are distinctly expressed in HBCs 
(Holbrook et al., 1995) and are among the genes directly regulated by p63 (Packard et 
al., 2011a). When p63 is downregulated, HBCs are thought to be activated (Packard et 
al., 2011a) and can differentiate into GBCs (Leung et al., 2007), suggesting that they are 
GBC precursors and replenish the GBC population upon damage. 
Other Possible Stem Cells 
 In addition to the basal cells of the OE, the human olfactory mucosa contains a 
stem cell known as an “ectomesenchymal” stem cell with properties of mesenchymal and 
neural stem cells (Delorme et al., 2010). It is grown in vitro from whole mucosa which 
includes cells of the OE and LP and has the capability of differentiating into neurons, 
astrocytes, oligodendrocytes, and non-neural cell types such as cardiac and skeletal 
muscle, chondrocytes, osteocytes, liver cells, and fat cells (Murrell et al., 2005; Murrell et 
al., 2008; Delorme et al., 2010; Wetzig et al., 2011). It is possible that the 
ectomesenchymal stem cell in the adult olfactory mucosa is derived from the 
ectomesenchymal stem cell that migrates out from the cranial neural crest during 
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embryogenesis which give rise to multiple neural and non-neural tissues of the head 
(Mackay-Sim et al., 2015). 
Lesion Models 
In order to study the restoration of the OE, transgenic mouse models are used to 
study the lineage of cells as they divide and differentiate into various cell types in the OE. 
Particularly, the use of Cre-Lox fate mapping to track genetic lineage of gene expression 
with lesion models of the OE has uncovered some insight to this restoration (Murdoch 
and Roskams, 2007). The main lesion models used include a surgical bulbectomy and a 
chemical/pharmacological lesion.  
A bulbectomy is the removal of the OB, which in rodents induces a retrograde wave 
of apoptosis in OSNs within 24-36 hours of lesion (Cowan and Roskams, 2004). This 
apoptosis stimulates mitosis in local progenitors and OSNs are generated from adult OE-
residing progenitors, with a rapid increase in the number of immature OSNs by 10 days 
and a return of mature OSNs by 3 weeks (Verhaagen et al., 1990). This lesion model 
limits axon-retargeting and allows the analysis of OSN regeneration only (Schwob et al., 
1992). A chemical/pharmacological lesion leaves the OB available for retargeting, but 
destroys multiple cell types. Tritonx100, ZnSO4, MeBr gas and the thyroid drug 
methimazole are effective in inducing widespread OE cell loss and stimulating 
regeneration of multiple lineages (Harding et al., 1978; Schwob et al., 1995; Bergman 
and Brittebo, 1999). If damage is too severe, regeneration can be incomplete or 
respiratory epithelium can replace the OE (Jang et al., 2003) (Xie et al., 2010). After MeBr 
treatment, proliferation initially occurs at 1-2 days, peaks at 1 week and continues for up 
to 4 weeks with the OE almost fully restored by 6 weeks (Murdoch and Roskams, 2007). 
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Methimazole (MMI) is currently used over the more toxic MeBr and works by binding to 
SUS and BG cells, causing OE destruction via the formation of toxic metabolites mediated 
by P450s (Brittebo, 1995; Bergman et al., 2002), depleting the GBCs and sparing the 
HBCs in the mouse OE (Brittebo, 1995; Packard et al., 2011b).  
Evidence from these lesion models so far has shown that GBCs frequently divide 
and, during neuronal-specific lesions, are the lead contributor to replacing OSNs through 
differentiation (Caggiano et al., 1994; Huard et al., 1998) (Fig. 1-4A-B). However, 
evidence has also shown that when there is a severe lesion that results in the death of 
not only OSNs, but SUS cells and often GBCs, HBCs, which are the more quiescent cell 
population, become proliferative and differentiate into multiple cell types to regenerate the 
OE (Carter et al., 2004; Leung et al., 2007; Iwai et al., 2008) (Fig. 1-4A, C). Within 18 
hours of unilateral MeBr exposure, p63 levels in HBCs are reduced in the lesioned side 
of the OE compared to unlesioned side and during the next day, some HBCs proliferate 
and lose all detectable p63 expression while retaining keratins 5 and 14 and ICAM-1 
expression (Schnittke et al., 2015). These data suggest that p63 prevents the activation 
and multipotency of HBCs. During olfactory neurogenesis, GBCs go through the following 
stages, 1) multipotent stem cells (Chen et al., 2004), 2) multipotent progenitors that can 
generate multiple epithelial cells in response to injury (Huard et al., 1998) and express, 
3) transit amplifying cells which are committed to neurons (Guillemot et al., 1993), and 4) 
immediate neuronal precursors which undergo a final division and differentiate into 
neurons (Calof and Chikaraishi, 1989; Cau et al., 1997). Following injury, residual GBCs 
express Sox2 and Pax6 (Guo et al., 2010), when the cells are considered to be 
multipotent stem cells, and then go on to express Ascl1 (formerly known as Mash1), as 
23 
 
they become transit amplifying cells, then Neurog1 and NeuroD1 as followed by 
differentiation of post-mitotic daughter cells into immature OSNs (Cau et al., 1997; 
Manglapus et al., 2004).  While some of the transcription factors that are turned off or on 
during the division and differentiation of HBCs and GBCs are known, the molecular 
regulation of these cells, including proliferation in response to injury and cell fate 
determination during differentiation, remains largely unexplored (Doty, 2003b; Manglapus 
et al., 2004). 
1.3.3 Regulation of Olfactory Neurogenesis 
Various regulatory factors are thought to regulate neurogenesis of the OE including 
positive regulator factors that sense a need for more OSNs and stimulate mitosis and 
differentiation and a reduction in negative feedback from mature OSNs to inhibit additional 
OSN production (reviewed in Murdoch and Roskams, 2007; Mackay-Sim et al., 2015). 
Positive regulators include the leukemia inhibitory factor (LIF), a mitogen that contributes 
to proliferation in embryonic and postnatal OE in vitro and in vivo, the fibroblast growth 
factor (FGF), transforming growth receptor α (TGFα), and epidermal growth factor (EGF), 
which binds to and signals through the EGF receptor, EGFR), and are most prominently 
expressed in HBCs and SUS cells (reviewed in Murdoch and Roskams, 2007). Factors 
that negatively regulate OSN genes include TGF-β superfamily of growth factors made 
up of TGF-β, activins, and BMPs (Murdoch and Roskams, 2007). These proteins are 
highly conserved and play active roles during differentiation and development of variety 
of tissues and signal via a serine-threonine kinase receptor complex (reviewed in 
Murdoch and Roskams, 2007). Additionally, increased BMP signaling can inhibit 
neurogenesis and was found to induce respiratory epithelial character at the expense of 
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sensory epithelial character during development (Maier et al., 2010). ATP and the peptide 
NPY were also shown to play a role in basal cell proliferation via SUS cells (Jia and Hegg, 
2010). 
The Notch and Wnt signaling pathways have also been proposed to play important 
roles in the neurogenesis of the OE. The Notch signaling pathway regulates cell 
proliferation, cell fate, differentiation, and cell death (Kopan, 2012). Notch is a cell-surface 
receptor that transduces short-range signals by interacting with transmembrane ligands 
(Kopan, 2012). In the olfactory system, Notch signaling is thought to play a key regulatory 
role in GBC differentiation (Manglapus et al., 2004). It is known to stimulate expression 
of Hes1 and Hes5, proteins seen in the GBCs of recovering olfactory epithelium, and 
Notch is expressed by some GBCs (Manglapus et al., 2004). The Wnt signaling pathway 
plays critical roles during embryonic development and in the regeneration of adult tissues 
and regulates cell fate determination, motility, polarity, and stem cell renewal (reviewed 
in Komiya and Habas, 2008; Rodriguez-Gil and Greer, 2008; Clevers and Nusse, 2012). 
Wnt proteins are secreted glycoproteins that bind to the extracellular domain of the 
Frizzled receptor to initiate signaling (Komiya and Habas, 2008). The pathway exists as 
a canonical pathway which is β-catenin-dependent and a non-canonical pathway which 
is β-catenin-independent (Komiya and Habas, 2008). Wnt signaling is important in adult 
stem cells of the intestine, skin and hematopoietic system (Grigoryan et al., 2008). In the 
OE, Wnt signaling was found to augment GBC proliferation and prevent transit amplifying 
neuronal progenitor cells from further differentiation into mature OSNs (Chen et al., 2014). 
Additionally, Wnt proteins were seen in the OECs in the LP and in adult glomeruli 
indicating a role in axonal guidance (Rodriguez-Gil and Greer, 2008). Although there have 
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been advances in olfactory research, there are still many unanswered questions, 
including the precise signaling involved in neurogenesis. 
 
1.4 Cilia: Important Signaling Antennas 
1.4.1 Motile and Primary Cilia 
Cilia are specialized cellular compartments or organelles found in most 
mammalian cell types with varying important roles. Many unicellular organisms and some 
specialized vertebrate cells contain multiple, motile cilia which beat in a coordinated and 
polarized manner for locomotion, feeding, sensation, or to drive directional fluid flow 
across tissues (Brooks and Wallingford, 2014). In vertebrates, including humans, most 
cells possess or are capable of generating single, non-motile primary cilia, which serve 
as critical regulators of signal transduction during development and homeostasis (Brooks 
and Wallingford, 2014).  
The primary cilium, which was first named by Sergei Sorokin (Sorokin, 1968) is a 
single, non-motile organelle that projects from the cell surface of most mammalian cell 
types during growth arrest (Satir et al., 2010). Primary cilia act as communication 
scaffolds to coordinate signaling pathways that are critical in embryonic and postnatal 
development as well as in adult tissue homeostasis (Pedersen et al., 2008). Signaling in 
cilia mediate key cellular processes including cell migration, differentiation, and/or re-
entry into the cell cycle, specification of the plane of cell division, and apoptosis. Cilia 
respond to mechanical stimulation (bending of the cilium) and chemosensation (detection 
of a specific ligand, growth factor, hormone, or morphogen) (Satir et al., 2010).  
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Development and Maintenance of Cilia  
The assembly of primary cilia is tightly coupled to the cell cycle. It occurs from the 
distal end of the mother centriole as cells enter growth arrest and then sheds shortly 
before cells enter mitosis (Quarmby and Parker, 2005; Plotnikova et al., 2009). During 
interphase of the cell cycle, a modified centriole migrates to the plasma membrane and 
attaches to a Golgi-derived vesicle forming the basal body which templates the nucleation 
of the axoneme, the structural core of the cilium (Sorokin, 1968). The basal body is 
composed of 9 sets of microtubules and serves as the microtubule organizing center 
(MTOC) from which axonemal tubules project (Burton, 1992). These specialized 
structures result in various functions in the different cell types. Most motile cilia have an 
additional central microtubule pair resulting in a 9+2 configuration while primary cilia are 
usually immotile and lack a central pair resulting in a 9+0 configuration with the exception 
of primary motile cilia present on the embryonic node (Singla and Reiter, 2006). In 
contrast to those of motile 9+2 cilia, the axonemes of non-motile primary cilia lack key 
elements involved in ciliary motility, including the central pair of microtubules and the 
outer and inner dynein arms that power microtubule sliding to produce motility (Satir and 
Christensen, 2007).  
Assembly of the axoneme is mediated by intraflagellar transport (IFT) (Pedersen 
et al., 2008). IFT was first described in the alga Chlamydomonas reinhardtii (Kozminski 
et al., 1993) and is essential for the construction and maintenance of cilia in all species 
(Singla and Reiter, 2006; Pedersen et al., 2008). Its basic mechanisms are widely 
conserved not only between cilia types but also often between species (Sung and Leroux, 
2013). Since cilia lack the necessary components for protein synthesis, structural 
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components of the cilium and cargo must be synthesized in the cell and carried into cilia 
through the IFT system (McEwen et al., 2008). IFT is a bidirectional motility system 
localized between the outer doublet microtubules and the ciliary membrane by which 
particles are moved into and out of the cilium by molecular motors (Rosenbaum and 
Witman, 2002): 1) a kinesin motor responsible for anterograde transport toward the distal 
plus end of the cilium, and 2) a dynein motor that mediates retrograde transport of cargo 
out of the cilium and back into the cell (Hirokawa et al., 1998) (Fig. 1-5). Motors associate 
with 2 distinct complexes of IFT proteins: complexes A and B, which comprise a set of 
highly conserved proteins (Cole et al., 1998; Cole, 2003) (Fig. 1-5). Besides IFT complex 
proteins, there are a number of other proteins involved in cilia establishment, 
maintenance, and particle entry and movement. The BBSome (Loktev et al., 2008; 
Scheidecker et al., 2014) is a group of eight conserved proteins affected in human Bardet-
Beidl syndrome (BBS) (Zaghloul and Katsanis, 2009), a pleiotropic disorder characterized 
by obesity, polydactyly, retinal dystrophy, and cystic kidneys. It is proposed to interact 
with IFT complexes and participate in particle entry and movement (Liew et al., 2014; 
Williams et al., 2014). When some of these ciliary proteins are defective, they are a major 
cause of human diseases and developmental disorders known as ciliopathies (Veland et 
al., 2009). 
Growing Roles of Cilia and Disease 
Defects in cilia function lead to various human diseases, termed ciliopathies, which 
are a diverse class of congenital diseases with 23 recognized syndromes caused by 
mutations in at least 89 different genes (van Reeuwijk et al., 2011). These diseases are 
highly pleiotropic and the degree of penetrance can vary between patients (McIntyre et 
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al., 2013). Various impairments can occur including blindness, hearing loss, altered 
nociception, and anosmia as well as renal and liver cysts, airway distress, and 
hydrocephaly (reviewed in van Reeuwijk et al., 2011) 
Evidence that dysfunction of non-motile cilia play a role in human disease was first 
considered after the orthologous protein of human polycystin-1 (PC1), which is mutated 
in autosomal dominant polycystic kidney disease (ADPKD) type 1, was shown to be 
expressed in ciliated neurons of C. elegans (Barr and Sternberg, 1999). Proteins of 
mutated genes in cystic kidney diseases were later found to localize to primary cilia, 
including the IFT protein IFT88/Polaris (Pazour et al., 2002b). The significance of primary 
cilia in signaling became clear upon examination of a hypomorphic mutant mouse, 
Tg737orpkRpW, which is deficient in the homolog of IFT88 (Lehman et al., 2008). The mouse 
was developed as a model for human autosomal recessive polycystic kidney disease 
(ARPKD) because they eventually developed polycystic kidneys. It was found that upon 
development of ARPKD in these mice, like other models of the disease, PC1, PC2 and 
the transient receptor potential (TRP) Ca2+ channel protein complex were mislocalized or 
absent from primary cilia (Pazour et al., 2002a; Yoder et al., 2002). These mice were also 
later found to be anosmic (McIntyre et al., 2012). Another complex of recessive cystic 
kidney diseases is nephronophthisis (NPHP) which results from defects in the genes that 
encode for Nephrocystin (Nphp) 1-9 (reviewed in Veland et al., 2009). Other ciliopathies 
include Joubert syndrome in which mutations in ARL13B were found in patients 
(Cantagrel et al., 2008) and Meckel syndrome, in which mutations in NPHP were found 
(Craige et al., 2010). 
Cilia and Olfactory Dysfunction 
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Olfactory dysfunction due to ciliary defects can occur by 2 separate mechanisms: 
1) a complete loss of olfactory cilia and 2) a defect in protein trafficking leading to a loss 
in olfactory signaling (McEwen et al., 2008). The first documented case of a human patient 
with anosmia presumably due to ciliary defects was in 1975 in which the patient had OSNs 
devoid of cilia (Douek et al., 1975). Since then, olfactory deficits were shown to occur in 
2 different pleiotropic diseases, BBS and Leber Congenital Amaurosis (LCA). There have 
been observations that patients with BBS are frequently unable to smell (reviewed in 
Fliegauf et al., 2007). Mice that lack BBS1 or BBS4 have a severely reduced olfactory 
ciliated border and defects in the highly specialized ciliated dendritic knobs (Kulaga et al., 
2004). Additionally mice that lack BBS8 also show decreased olfactory function (Tadenev 
et al., 2011). LCA is a congenital retinal dystrophy and can occur due to mutations in 
several proteins of varying function, including mutations in the centrosomal/basal body 
protein CEP290 (reviewed in McEwen et al., 2008). Mutations in CEP290 resulted in 
severely impaired olfactory function despite a self-described normal sense of smell which 
was due to mislocalization of G-proteins rendering the signaling pathway nonfunctional 
(McEwen et al., 2007). 
1.4.2 Cilia in Adult Neurogenesis and Tissue Homeostasis: Implications in Signaling 
Pathways 
 
Recent research has shown a growing role for cilia in stem cell proliferation and 
differentiation. Primary cilia are required for the formation of adult neural stem cells in the 
hippocampal denate gyrus during development, and also play an essential role in the 
initiation of mesenchymal stem cell differentiation (Tummala et al., 2010; Amador-Arjona 
et al., 2011). There is also evidence that human embryonic stem cells (hESCs) possess 
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primary cilia, which contain important components of the HH pathway (Kiprilov et al., 
2008). Quiescent stem cells in the subventricular zone (SVZ) and the subgranular zone 
(SGZ) of the denate gyrus were shown to arise in late embryonic stages and respond to 
SHH during their differentiation into various cell types (Ahn and Joyner, 2005). 
Additionally, primary cilia were found to be required for proper proliferation and 
neurogenesis in a specific subregion of the postnatal ventricular-SVZ as well as for proper 
HH signaling (Tong et al., 2014).  
In regards to differentiation, cilia play important roles in various signaling pathways 
essential for proper cell differentiation during development and adult homeostasis. These 
pathways include Platelet-Derived Growth Factor (PDGF), Sonic Hedgehog (SHH) and 
Wnt (reviewed in Gerdes et al., 2009), which is important in adult stem cells of the 
intestine, skin and hematopoietic system (Grigoryan et al., 2008). In the adult skin, a loss 
of IFT88 from basal cells resulted in proliferation of cells in the interfollicular epidermis 
but not the follicle, and an overall abnormal differentiation in skin homeostasis (Croyle et 
al., 2011). Conversely, in the hippocampus, when cilia were removed postnatally from 
neural stem cells (NSCs) via genetic deletion of the IFT gene, Ift20, the number of neural 
stem cells (NSCs) remained the same in mutants compared to controls with an overall 
reduction in proliferation in the SVZ and a reduction in neurogenesis (Amador-Arjona et 
al., 2011). In the adult kidney of mice, loss of the kinesin motor, Kif3a, resulted in cyst 
formation and increased proliferation following an injury (Sharma et al., 2013).  
Mice with defective IFT proteins and mutations in BBS genes exhibit phenotypes 
resembling those observed in mutants of the non-canonical Wnt pathway (reviewed in 
Goetz and Anderson, 2010), which is also known as the polar cell polarity (PCP) 
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pathway (Klein and Mlodzik, 2005). The primary cilium was proposed to act as a switch 
between canonical and non-canonical Wnt signaling pathways but the connection 
between cilia and Wnt signaling is controversial (Corbit et al., 2008; Huang and Schier, 
2009). The PCP pathway is a conserved signaling pathway for coordinated polarization 
of cells within the plane of an epithelial cell layer (reviewed in Hildebrandt et al., 2011). 
Core planar cell polarity proteins are sorted asymmetrically along the polarization axis 
and the protein IFT88/Polaris is required for establishing epithelial planar cell polarity 
(Jones et al., 2008). Proper positioning of ciliary basal bodies and the formation of 
polarized cellular structures are disrupted in mice with mutant ciliary proteins (reviewed 
in Hildebrandt et al., 2011). The HH pathway, which will be discussed in greater detail in 
the next section of this chapter, has been implicated in the maintenance of 
stem/progenitor cells in many adult tissues (reviewed in Dessaud et al., 2008; Balbuena 
et al., 2011; Petrova and Joyner, 2014). Further investigation of these signaling 
pathways in the OE could answer many open questions pertaining to the regulatory 
signaling that occurs during neurogenesis and restoration of the OE. 
 
1.5 The Hedgehog (HH) Signaling Pathway 
1.5.1 Canonical HH Signaling Mechanisms 
The Hedgehog (HH) signaling pathway is critical for normal embryonic 
development and plays important roles in adult tissue maintenance. HH was first 
discovered in a genetic screen aimed to understand the body segmentation of Drosophila 
(Nusslein-Volhard and Wieschaus, 1980), in which mutant embryos developed were 
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phenotypically reminiscient of a Hedgehog animal, due to the lack of segment boundaries. 
The core components of the HH pathway were also initially identified in Drosophila 
(Nakano et al., 1989; Alcedo et al., 1996) and are conserved in vertebrates (Echelard et 
al., 1993; Krauss et al., 1993; Riddle et al., 1993; Goodrich et al., 1996). The HH ligand 
is first synthesized as a 45kDa precursor that undergoes autocatalytic cleavage to 
generate a 19kDa processed form that is modified by the covalent attachment of a 
cholesterol molecule to the C-terminus  (Porter et al., 1996) and addition of palmitate, a 
saturated fatty acid, (Chamoun et al., 2001) to the N-terminus in order to attain its final 
secreted form. In Drosophila and in mammals, the protein, Dispatched, is specifically 
required for the controlled release of the modified HH ligand (Burke et al., 1999). When 
HH is secreted, it acts in a concentration- and time-dependent manner to initiate various 
cell responses such as cell survival, proliferation, and cell fate specification and 
differentiation.  
HH signal transduction is initiated at the plasma membrane of HH-responsive cells 
where it interacts with its 12 transmembrane protein receptor, Patched (Ptc in Drosophila; 
Ptch1 in vertebrates) (Chen and Struhl, 1996; Marigo et al., 1996; Stone et al., 1996) 
which is facilitated by the Ihog/Cdo family of co-receptors (McLellan et al., 2006; Tenzen 
et al., 2006; Yao et al., 2006). The binding of HH to Patched sequesters HH by 
internalizing the Patched/HH complex and targeting it to lysosomes for degradation 
(Gallet and Therond, 2005). This event also increases the expression and activation of 
Smoothened (Smo) (Chen and Struhl, 1996; Denef et al., 2000; Ingham et al., 2000) via 
a conformational change (Fan et al., 2012) which results in the downstream signaling 
cascade that functions to regulate the HH transcription factors.  
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In mammals, there are three paralogues of HH genes (Echelard et al., 1993): Sonic 
HH (SHH, the most broadly expressed and best studied HH molecule), Indian HH (IHH, 
primarily involved in bone differentiation) and Desert HH (DHH, involved in gonad 
differentiation). Two major differences between HH signaling in Drosophila and 
vertebrates include: 1) while there is a single ancestral gene encoding the transcription 
factor, Ci, in Drosophila, three genes comprise this family (Gli1, Gli2, and Gli3) in 
vertebrates, and 2) the requirement in vertebrates for intraflagellar transport (IFT), which 
is necessary for the establishment and maintenance of cilia. The first indication of a 
potential role for cilia in mammalian HH signaling emerged from genetic screens in the 
mouse which identified mutations in IFT genes that produced patterning defects similar 
to those of mutations in genes encoding HH pathway components (Huangfu et al., 2003). 
Both PTCH1 and SMO can localize to primary cilia in a mutually exclusive way, where 
the binding of HH ligand to PTCH1 allows SMO to move into the cilium where it 
accumulates and promotes pathway activation through the HH transcription factors 
(Rohatgi et al., 2007) (Fig. 1-6). The transcription factors then undergo various processing 
events to either inhibit or activate the pathway (Fig. 1-6). 
1.5.2 GLI Processing in HH Signaling 
The GLI family of transcription factors mediates most vertebrate HH signaling and 
it is proposed that cilia are required for the differential regulation of these transcription 
factors (Caspary et al., 2007). GLI proteins localize to primary cilia and require intact IFT 
for proper processing and function (Haycraft et al., 2005; Liu et al., 2005). Disruption of 
the HH pathway results in aberrant cell growth, differentiation and migration with a tissue 
homeostatic imbalance leading to severe disorders (Mimeault and Batra, 2010). When 
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the IFT protein, IFT88, and cilia are disrupted, SMO translocation and GLI processing is 
perturbed, resulting in HH-specific phenotypes (Huangfu et al., 2003; Haycraft et al., 
2005; Goetz and Anderson, 2010). 
HH signaling results in a change in the balance between the activator and 
repressor forms of the Ci and GLI proteins by regulating their post-translational proteolytic 
processing (Fig. 1-7). All GLI and Ci proteins have a Zn-finger DNA-binding domain 
(Kinzler et al., 1988) and a C-terminal activation domain, while only Ci, GLI2 and GLI3 
contain an N-terminal repressor domain (Sasaki et al., 1999; Briscoe and Therond, 2013) 
(Fig. 1-7). GLI1 has diverged evolutionarily, lacking a transcriptional repressor domain 
(Park et al., 2000). The post-translational regulation of Ci and GLI proteins is similar, 
however, each GLI protein has a unique role.  
In Drosophila, in the absence of HH ligand, the C-terminal domain of Ci undergoes 
sequential phosphorylation on multiple sites, first by PKA and then by glycogen synthase 
kinase 3β (GSK3β) and different members of the casein kinase I (CKI) family (reviewed 
in Hui and Angers, 2011). These events lead to the recruitment of an E3 ubiquitin ligase 
complex (Jia et al., 2005; Smelkinson and Kalderon, 2006) and ubiquitylation of specific 
residues targets the modified protein to the proteasome, where the C-terminal 
transactivation domain is removed by partial degradation (Briscoe and Therond, 2013). 
The remaining protein, which comprises the N-terminal repressor domain and DNA-
binding domains, translocates to the nucleus, binds genomic target sites and represses 
transcription. In the presence of HH ligand, activation of SMO inhibits the phosphorylation 
and partial proteolytic processing of Ci, allowing full length Ci to act as a transcriptional 
activator. 
35 
 
In vertebrates, in the absence of HH ligand, GLI proteins are retained in the 
cytoplasm by the kinesin-4 protein, KIF7, and suppressor of fused, SUFU, to limit 
transcriptional activation (Kogerman et al., 1999; Merchant et al., 2004). Like Ci, GLI2 
and GLI3 require PKA and an E3 ubiquitin ligase for processing to a transcriptional 
repressor, but GLI1 functions solely as a transcriptional activator (Hooper and Scott, 
2005). Mouse mutant studies suggest that GLI2 is chiefly responsible for the activator 
function in response to HH signaling, and GLI3 is responsible for the repressor activity 
(Matise et al., 1998; Litingtung and Chiang, 2000; Wang et al., 2000a; Pan et al., 2006). 
However, there are instances when GLI2 acts as a repressor (Pan et al., 2006) and GLI3 
acts as an activator as seen in the developing somite (Buttitta et al., 2003). Additionally, 
GLI3 has been shown to act as an activator in spinal cord patterning (Bai et al., 2004). 
Gli1, but not Gli3 is transcriptionally activated by SHH signaling which creates a positive-
regulatory feedback loop (Lee et al., 1997). In mammals, GL1 seems to have only a minor 
role in amplifying the transcriptional response (Park et al., 2000). It is believed that GLI2 
and GLI3 are the primary transducers of HH signaling and GLI1 plays a secondary role 
since its expression is transcriptionally regulated by GLI2 and GLI3 (Bai et al., 2004) and 
Gli1-/- mice are viable (Park et al., 2000).  
1.5.3 HH Signaling in Adult Neurogenesis and Tissue Homeostasis 
HH acts as a long-range morphogen to control cell patterning and differentiation in 
several embryonic tissues (Jiang and Hui, 2008). In addition to its role in normal 
embryonic development, HH also plays important roles in adult tissue homeostasis. In the 
adult, HH continues to signal to and regulate several populations of stem and progenitor 
cells within various organs, including the brain (Lai et al., 2003; Machold et al., 2003; Ahn 
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and Joyner, 2005; Ihrie et al., 2011), skin, prostate, and bladder and others (reviewed in 
Petrova and Joyner, 2014). It is also required for the maintenance of stem cells in a range 
of tissues, from the hair follicle to the haematopoetic system, and is involved in the injury-
dependent regeneration of many organs, including the exocrine pancreas, prostate, and 
bladder (Beachy et al., 2004; Shin et al., 2011; Lim et al., 2014).  
Neural Stem Cells 
 As mentioned in Section 1.3, in the adult mammalian brain, new neurons are 
generated from transit-amplifying cells (TACs) that are derived from quiescent and self-
renewing neural stem cells (NSCs) located in the SVZ of the lateral ventricles and the 
SGZ of the hippocampal dentate gyrus (DG). In vivo evidence that SHH is required for 
the establishment of stem and progenitor cells in the SVZ and SGZ has come from 
conditional genetic loss-of-function studies. When HH genes or cilia are abrogated 
midgestation, there is a severe depletion of progenitors in the olfactory bulb and DG, 
suggesting that HH signaling is required for the initial establishment of NSCs (Balordi and 
Fishell, 2007a; Han et al., 2008). HH signaling has also been shown to be required for 
the continuous maintenance of neurogenesis in the SVZ and SGZ. Studies using small 
molecules showed that SHH gain or loss of function increases or inhibits proliferation 
respectively in neurogenic regions and neural stem/progenitor cells (reviewed in Petrova 
and Joyner, 2014). Inhibition of the pathway by removal of SMO in the majority of adult 
SVZ NSCs results in reduced neurogenesis (Balordi and Fishell, 2007b; Petrova et al., 
2013) while over-activation of the pathway by deletion of Ptch1 promoted NSC self-
renewal at the expense of transit amplifying progenitors and neuron production (Ferent 
et al., 2014). This reduction in neurogenesis was linked to a shift in NSC division from 
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asymmetric to symmetric potentially through the induction of NOTCH signaling (Ferent et 
al., 2014). 
Hair and skin 
 There are multiple populations of lineage-restricted stem cells in the adult 
mammalian skin (reviewed in Solanas and Benitah, 2013). Like the adult brain, SHH is 
the main HH ligand present in postnatal skin (Petrova and Joyner, 2014). Mitotically active 
cells in the epithelial basal layer of the skin constantly produce new interfollicular skin 
cells (Petrova and Joyner, 2014). During the expansion (anagen) phase of the hair cycle, 
Shh expression is seen in the epithelial cells of the lower end of the hair follicle while the 
downstream effectors Gli1 and Ptch1 are more broadly expressed (Oro and Higgins, 
2003). During the resting (telogen) phase when old hairs degenerate and die, Gli2 and 
Gli3 are broadly expressed in both the follicle and in the surrounding dermis (Petrova and 
Joyner, 2014), while Gli1 and Ptch1 expression is restricted to two distinct epithelial stem 
cell domains in the upper bulge and the lower bulge (Brownell et al., 2011). Inhibition of 
SHH with the antibody 5E1 in mice blocks the anagen progression and hair re-growth, 
suggesting that SHH is required for the regenerative function of adult stem cells (Wang 
et al., 2000b). Conversely, exogenous expression of SHH via adenoviral infection triggers 
the onset of the anagen phase in resting hair follicles and stimulates hair growth (Sato et 
al., 1999). Additionally, removal of Shh in the hair germ causes defects in proliferation 
throughout the hair follicle while genetic abrogation of Smo or Gli2 alone in the stem cells 
reduced their proliferative abilities but did not affect anagen progression, suggesting that 
SHH is required to maintain the function of hair follicle stem cells but not of the progenitor 
cells in which it is expressed (Hsu et al., 2014).  
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 Additionally, SHH signaling gain of function mutations are found in human basal 
cell carcinoma (BCC) (Hahn et al., 1996; Johnson et al., 1996; Reifenberger et al., 1998). 
Overexpression of Gli1 and to a lesser extent, Gli2 are common features of BCC 
(Dahmane et al., 1997; Grachtchouk et al., 2000; Oro and Higgins, 2003; Hutchin et al., 
2005). SMO gain of function or PTCH1 loss of function mutations also give rise to BCC-
like lesions when induced either in the mouse interfollicular epidermis or in hair follicle 
stem cells that move into the interfollicular skin following injury (reviewed in Petrova and 
Joyner, 2014), suggesting these stem cells can function as tumor-initiating cells for BCC.   
Teeth 
 Rodent incisors continue to grow throughout the life of the animal and require 
constant repair via stem and progenitor cells that produce amelioblasts to renew the 
incisor epithelium (reviewed in Petrova and Joyner, 2014). During the growth of the adult 
rodent incisor, SHH signals to parental Gli1-expressing amelioblast stem cells (Seidel et 
al., 2010). Inhibition of SHH signaling leads to a decrease in amelioblast production and 
tooth growth but does not deplete the GLI1+ stem cell population (Seidel et al., 2010), 
suggesting that SHH signaling is not required for stem cell survival but instead for 
maintaining the ability of stem cells to expand the amelioblast population. Although 
human teeth do not grow continuously, a multipotent stem cell population within the 
connective tissue surrounding the tooth was shown to express SHH, GLI1, and PTCH1 
(Martinez et al., 2011). 
Bone 
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 Indian hedgehog (IHH) is one of the main regulators of chondrocyte proliferation 
and osteoblast differentiation during development (reviewed in Petrova and Joyner, 
2014). Throughout adulthood, HH signaling continues to contribute to maintenance of the 
bone as administration of the SMO inhibitor, cyclopamine, to adult mice resulted in 
decreased bone mass and conversely, Ptch1+/- mutant mice exhibit a high bone mass 
density and Ptch1+/- cultured cells showed osteoblast differentiation associated with a loss 
of GLI3 repressor generation (Ohba et al., 2008). 
Respiratory and gastrointestinal 
 Localized upregulation of HH signaling occurs in response to an injury in the adult 
lung airways (Petrova and Joyner, 2014). Initially, in the normal adult mouse lung, only a 
few fibroblasts around the airway express Gli1; however, upon lung fibrosis or airway 
injury, HH signaling is upregulated as seen by an increase in stromal GLI1+ cells (Watkins 
et al., 2003; Liu et al., 2013b). Additionally, overexpression of Shh in the normal adult 
mouse airway epithelium can induce cell proliferation and lung tissue modifications similar 
to those seen in injury (Krause et al., 2010). 
 Shh and Ihh are continuously detected throughout the adult gastrointestinal tract 
of both humans and rodents where it signals to the Gli-expressing mesenchyme 
(reviewed in Petrova and Joyner, 2014). In the stomach of the adult mouse, HH signaling 
inhibits proliferation (van den Brink et al., 2001) and stimulates the differentiation (van 
den Brink et al., 2002) of the gastric epithelium. Additionally, the loss of IHH in the 
intestinal epithelium of the mouse results in a wound healing response in which there is 
epithelial proliferation and an ultimate loss of smooth muscle and villi (van Dop et al., 
2010; Zacharias et al., 2011). When isolated mesenchyme from the intestine was treated 
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with SHH or IHH ligand, smooth muscle precursors decreased in number and smooth 
muscle cells increased in number (Zacharias et al., 2011), suggesting that HH signaling 
is important for smooth muscle differentiation. Overall, these studies propose that HH 
signaling in the intestine of the adult mouse regulates tissue homeostasis in a 
concentration-dependent manner.  
Taste 
 The adult fungiform taste papilla is comprised of specialized cell types that reside 
in a stratified squamous tongue epithelium. This sensory organ contains taste buds, 
papilla epithelium, and lateral walls that extend into underlying connective tissue to 
surround a core of lamina propria cells. The taste buds continue to differentiate and turn 
over postnatally throughout the life span (Beidler and Smallman, 1965; Farbman, 1980). 
A few studies have suggested that SHH signaling is involved in the maintenance and 
differentiation of taste cells. SHH ligand is produced by taste bud cells for paracrine 
signaling to HH-responsive cells in the basal epithelial layer, perigemmal cells, and 
stromal cells of the papilla and was found that these Shh-responding cells contribute to 
the maintenance of not only filiform and fungiform papillae, but also taste buds (reviewed 
in Liu et al., 2013a). Additionally, constitutive activation of GLI2 in the tongue epithelium 
led to a rapid loss of fungiform papillae and taste buds (Liu et al., 2013a), while ectopic 
expression of SHH induced the formation of taste buds in regions not capable of 
generating taste buds (Castillo et al., 2014). It was also shown that pharmacological 
blockade of the HH pathway with the SMO inhibitor, LDE-225, disrupted taste organs 
including the fungiform papillae and taste buds, and electrophysiological responses to all 
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taste qualities in mice (Kumari et al., 2015), suggesting that HH signaling is a principal 
regulator of papilla and taste bud maintenance and taste sensation. 
Olfactory Periphery 
 HH signaling in the olfactory periphery has been limited to a few studies in 
Drosophila and rats and remains largely unexplored. In Drosophila, HH signaling was 
found to play a role in OSN axon targeting that is dependent on Smo and Ihog, a co-
receptor for HH ligands (Chou et al., 2010). Differential HH activity in peripheral sensory 
organ precursors in larva and early pupa creates OSN populations with different levels of 
Ptc: low-Ptc class and high Ptc class. Genetic knockdown and overexpression 
experiments showed that removing HH from the periphery results in loss of Ptc 
expression in high-Ptc OSNs which releases Smo inhibition and causes axon 
mistargeting similar to loss of Ptc, while brain-derived Hh is required for low-Ptc classes 
(Chou et al., 2010). Additionally, a recent study suggested a novel cilia-dependent role 
for Hh signaling in Drosophila that occurs in the cilia of OSNs, however, there was no 
evidence for the role of Hh in the OSNs (Kuzhandaivel et al., 2014). One study 
investigating HH signaling in the mammalian olfactory periphery found that: 1) Shh mRNA 
is expressed in mitral and tufted cells of the olfactory bulb and 2) cultured OSNs, when 
exposed to SHH protein, exhibit an increase in axonal branching (Gong et al., 2009), 
suggesting a role for HH signaling in axon branching of mammalian OSNs. This same 
study showed transcripts of several HH pathway components not only in the olfactory 
bulb, but also in the olfactory periphery, suggesting a potential role for HH signaling the 
adult mammalian olfactory periphery.  
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1.6 Conclusions 
Olfaction is an important part of our everyday life and has evolved to have a large 
influence on our taste, memory, and behavior. Odorant detection occurs in the olfactory 
epithelium (OE) which is comprised of various cell types including olfactory sensory 
neurons (OSNs), which are necessary for the detection of smell, and the stem/progenitor 
cell populations, globose basal cells (GBCs) and horizontal basal cells (HBCs) (for review, 
see ref. Murdoch and Roskams, 2007). OSNs are unique in that they both directly contact 
the external environment and the brain (Doty, 2008), which exposes them and other cells 
in the OE to insults from toxins, bacteria, and viruses leading to cell death (Duggan and 
Ngai, 2007). It is known that GBCs and HBCs participate in the restoration of the OE 
following injury and tissue homeostasis injury (Barber, 1982; Costanzo, 1991; Iwai et al., 
2008). However, olfactory dysfunction can still arise from a variety of etiologies. 
Treatment for more severe cases remains under investigation.  
While the cell types involved in the maintenance and regeneration of the OE are 
known, the signaling pathways that control their activation and proliferation during normal 
homeostasis, and in response to injury remain largely unexplored. Various signaling 
factors and pathways have been investigated in the olfactory system including the 
involvement of Wnt and Notch signaling in the proliferation of GBCs (Cau et al., 2002; 
Manglapus et al., 2004; Wang et al., 2011; Krolewski et al., 2012; Chen et al., 2014). 
However, there has been no clear answer to which factors and pathways are directly 
involved in the regulation (cell division, differentiation, and fate determination) of the 
stem/progenitor cells, specifically HBCs. The central focus of this dissertation is to 
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investigate specific factors involved in regulating the activity of HBCs and their 
contribution to neurogenesis in the OE following an injury.  
Cilia have become greatly associated with stem cells in the regulation of their 
dormancy, proliferation, and differentiation as well as proper adult neurogenesis 
(reviewed in Irigoin and Badano, 2011).  In Chapter II, I provide evidence of primary cilia 
on HBCs and indicate that OSNs are not the only ciliated cell type in the OE. I use an 
HBC-specific inducible system to delete cilia specifically from HBCs in order to assess 
the effects that a loss of HBC cilia have on OE development, homeostasis, and recovery 
following an injury. Disruption of cilia in systems in which cilia are important for cell 
proliferation and differentiation alters the activity of signaling pathways that utilize cilia, 
such as the HH pathway (Kumamoto et al., 2012; Tong et al., 2014). The HH pathway is 
not only important for the development of various tissues and organs, but also for the 
formation, survival, and function of stem and progenitor cell populations in several adult 
tissues (reviewed in Petrova and Joyner, 2014). It is an attractive candidate for regulation 
of HBCs due to its dependence on cilia in tissue maintenance (Croyle et al., 2011). 
Although HH signaling has been investigated in the SVZ and olfactory bulb (Balordi and 
Fishell, 2007a), and in OSN axon branching and targeting (Gong et al., 2009), it is virtually 
unexplored in the mammalian OE. In Chapter III, I use lacZ reporter mice to determine 
expression profiles of HH components in the OE. Additionally, I utilize an HBC-specific 
inducible system to target specific components of the HH pathway in order to assess the 
effects that HH signaling has on OE homeostasis and regeneration following an injury.  
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1.7 Figures 
 
Figure 1-1. Rodent olfactory system. Schematic of the rodent olfactory system adapted 
from Adam C. Puche. A, Sagittal view of the mouse head depicts olfactory turbinates I-
IV, olfactory bulb, and accessory olfactory bulb. B, Resulting coronal sections from 
hypothetical cuts 1-4. Roman numerals represent endoturbinates and numbers represent 
ectoturbinates.    
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Figure 1-2. Olfactory transduction pathway. Schematic of the olfactory transduction 
pathway. A, All olfactory signaling machinery is found in the cilia of olfactory sensory 
neurons (OSNs). Upon an odorant binding to its corresponding olfactory receptor (OR), 
the G-protein, Gαolf, is activated resulting in the activation of adenylyl cyclase II (ACIII) 
and production of cyclic AMP (cAMP). This increase in cAMP opens cyclic nucleotide-
gated (CNG) channels leading to an influx of sodium (Na+) and calcium (Ca2+) ions and 
depolarization of OSNs. This depolarization is further amplified by activation of calcium-
activated chloride (Cl-) channels. B, OSNs project axons to corresponding structures in 
the olfactory bulb (OB) known as glomeruli, where they form synapses with dendrites of 
mitral and tufted cells. C, These projection neurons extend their axons to the olfactory 
cortex which is comprised of several areas including the piriform cortex, olfactory tubercle, 
anterior olfactory nucleus, and specific parts of the amygdala and entorhinal cortex.  
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Figure 1-3. Cell composition of the olfactory epithelium. A, Immunofluorescent image 
of the mouse OE in grayscale showing the cilia layer of the OE within the nasal cavity and 
the separation of the OE from the lamina propria (LP) by the basement membrane. B, 
Schematic illustration depicting the various cell types in the OE and LP. Microvillar and 
SUS cells project microvilli into the nasal cavity, while mature OSNs project cilia. 
Immature OSNs do not possess cilia but like mature OSN, extend axons into the LP that 
traverse to the olfactory bulb. Globose basal cells are comprised of a heterogeneous 
population of cells that can be grouped into two main types of cells due to their expression 
of distinct transcription factors: immediate neuronal progenitors, transit-amplifying 
precursors committed to producing neurons, and multi-potent precursors that can 
produce non-neuronal cells. They lie just below immature OSNs and above horizontal 
basal cells which lie just against the basement membrane. Olfactory ensheathing cells 
are found in the lamina propria. NC = nasal cavity, OE = olfactory epithelium, and LP = 
lamina propria. 
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Figure 1-4. Differentiation pathways of olfactory basal stem cells. Schematic 
illustration depicting various cell types of the OE and the differentiation pathways of basal 
stem cells at varying levels of injury to the OE. A, Cell types of the normal, unlesioned 
OE. B, During a neuronal-specific lesion, as seen with olfactory bulbectomy models, 
GBCs are the lead contributor to replacing OSNs through differentiation. C, However, in 
more severe lesion models such as ablation with MeBr or the anti-thyroid drug, 
methimazole (MMI), in which SUS cells, BG cells, and GBCs are also depleted, HBCs 
replenish neuronal cells (neuronal precursor GBCs) and non-neuronal cells (multipotent 
GBCs, SUS cells, and BG cells) of the OE through differentiation. GBCs are believed to 
differentiate into non-neuronal cells (SUS cells and BG cells) from a sub-population of 
multipotent cells and neuronal cells (neuronal precursor GBCs and OSNs) from a sub-
population of transit-amplifying GBCs. OE = olfactory epithelium.  
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Figure 1-5. Cilia machinery and trafficking. Schematic illustration showing the cilium 
and its trafficking components adapted from (Hildebrandt et al., 2011). Centrioles form 
basal bodies, comprised of 9 sets of microtubules, from which the axoneme extends. 
Intraflagellar transport (IFT) proteins mediate the assembly and maintenance of the cilium 
by associating with kinesin motors to bring cargo into the cilium for anterograde transport 
and associating with dynein motors to bring cargo out of the cilium for retrograde 
transport. Kinesin motors associate with 2 distinct complexes of IFT proteins: complex A 
for anterograde trafficking and complex B for retrograde trafficking. 
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Figure 1-6. Canonical Hedgehog pathway. Schematic illustration depicting the 
canonical Hedgehog (HH) pathway in mammalians. A, In the absence of HH ligand, the 
transmembrane receptor Patched1 (PTCH1), inhibits the transmembrane protein 
Smoothened (SMO), resulting in the transcriptional repression of HH target genes by GLI 
transcription factor. B, In the presence of HH ligands, which bind to PTCH1, de-repressed 
SMO, which traffics into cilia, allows for the activation of GLI transcription factors and HH 
target genes.  
 
 
Figure 1-7. GLI processing in the Hedgehog pathway. Schematic illustration showing 
the processing of GLIs into activators and repressors. A, All GLI proteins have a DNA-
binding domain and C-terminal activation domain while GLI1 has diverged evolutionarily 
to lack a transcriptional repressor domain. In the presence of HH ligand, activation of 
SMO inhibits the proteolytic processing of GLI2 or in certain circumstances, GLI3, 
allowing the full length protein to act as a transcriptional activator. B, In the absence of 
HH ligand, GLI3 and to a lesser degree, GLI2, are processed as a transcriptional 
repressor upon proteolytic cleavage of the C-terminal activation domain. N = N-terminus, 
C = C-terminus, and HH = hedgehog.  
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CHAPTER II: 
Primary Cilia on Horizontal Basal Cells Regulate Regeneration of the Olfactory 
Epithelium 
2.1 Abstract 
The olfactory epithelium (OE) is one of the few tissues to undergo constitutive 
neurogenesis throughout the mammalian lifespan. It is comprised of multiple cell types 
including olfactory sensory neurons (OSNs) that are readily replaced by two populations 
of basal stem cells, frequently dividing globose basal cells (GBCs) and quiescent 
horizontal basal cells (HBCs). However, the precise mechanisms by which these cells 
mediate OE regeneration are unclear. Here, we show for the first time that the HBC 
subpopulation of basal stem cells uniquely possess primary cilia that are aligned in an 
apical orientation in direct apposition to sustentacular cell endfeet. The positioning of 
these cilia suggests that they function in the detection of growth signals and/or 
differentiation cues. To test this idea, we generated an inducible, cell-type specific Ift88 
knockout mouse line (K5rtTA;tetOCre;Ift88fl/fl) to disrupt cilia formation and maintenance 
specifically in HBCs. Surprisingly, the loss of HBC cilia did not affect the maintenance of 
the adult OE but dramatically impaired the regeneration of OSNs following lesion. 
Furthermore, the loss of cilia during development resulted in a region-specific decrease 
in neurogenesis, implicating HBCs in the establishment of the OE. Together, these
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results suggest a novel role for primary cilia in HBC activation, proliferation, and 
differentiation. 
 
2.2 Introduction 
 Neurogenesis occurs from the self-renewal and differentiation of neural stem cells 
(Gage, 2000). While prevalent during development, neural stem cells are also found in 
the adult nervous system, in the olfactory epithelium (OE), subventricular zone (SVZ) of 
the lateral ventricle, and the subgranular zone (SGZ) of the hippocampus (Gage, 2000; 
Alvarez-Buylla and Garcia-Verdugo, 2002; Lie et al., 2004). Factors and mechanisms that 
regulate proliferation, migration, differentiation, and cell survival during development can 
be active in the adult nervous system, allowing for tissue repair and neuroplasticity 
(reviewed by Lie et al., 2004). Unlike most sensory systems, the OE is able to reconstitute 
both neuronal and non-neuronal populations following injury and neuronal death via the 
action of resident populations of olfactory stem cells (Graziadei and Graziadei, 1979; 
Calof and Chikaraishi, 1989; Edge and Chen, 2008). Olfactory sensory neurons (OSNs) 
are unique in that they both directly contact the external environment and the brain. While 
this direct contact allows OSNs to detect odors, it also exposes the OE to insults from 
toxins, bacteria, and viruses leading to cell death. Therefore, the capacity for 
neurogenesis and replacement of OSNs is critical for maintaining this important sensory 
system. 
 The OE is composed of OSNs, supporting sustentacular (SUS) cells, Bowman’s 
gland (BG) duct cells, and two groups of basally located stems cells, globose basal cells 
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(GBCs), and horizontal basal cells (HBCs). GBCs and HBCs are considered progenitor 
or stem cells of the OE, capable of promoting regeneration and neurogenesis both for 
tissue homeostasis and in response to injury (Barber, 1982; Costanzo, 1991; Leung et 
al., 2007). GBCs are a heterogeneous population of actively cycling cells comprised of 
immediate neuronal progenitors and transit-amplifying precursors committed to producing 
neurons as well as multi-potent precursors that can produce non-neuronal cells (Jang et 
al., 2014). HBCs are a homogeneous population of multi-potent, quiescent cells (Holbrook 
et al., 1995; Carter et al., 2004; Iwai et al., 2008). Following the selective death of olfactory 
neurons, as occurs in response to an olfactory bulbectomy, GBCs replace OSNs through 
differentiation, while HBCs remain quiescent (Caggiano et al., 1994; Huard et al., 1998; 
Leung et al., 2007). In severe lesion models such as exposure to methyl bromide or 
ablation with methimazole (MMI), in which SUS cells and GBCs are affected, HBCs 
contribute to the regeneration of the OE (Leung et al., 2007; Iwai et al., 2008). While the 
cell types involved are known, the precise mechanisms controlling regeneration and 
homeostasis are unclear. Importantly, the molecular regulation of olfactory basal stem 
cells, including their activation and proliferation in response to injury and cell fate 
determination during differentiation, remains largely unknown. 
  Primary cilia have important roles in cell proliferation, differentiation, and regulation 
of the cell cycle (reviewed by Irigoin and Badano, 2011). There is growing evidence that 
primary cilia regulate neurogenesis and/or proper differentiation of adult stem cells into 
amplifying progenitor cells or glial cells in the SVZ and hippocampus (Amador-Arjona et 
al., 2011; Kumamoto et al., 2012; Tong et al., 2014). Consequently, when cilia are 
disrupted in these systems, cilia-dependent signaling pathways such as Wnt and SHH 
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are also disrupted (Kumamoto et al., 2012; Tong et al., 2014). These findings 
demonstrate the important role cilia play in signaling pathways essential for proper cell 
differentiation during development and adult homeostasis. 
Here, we show that HBCs possess primary cilia, suggesting a potential mechanism 
for the molecular regulation of olfactory basal stem cells in the OE. In mice with a HBC-
specific cilia deletion, the OE showed limited regeneration following lesion, with a 
significant reduction of mature OSNs. Additionally, when HBC cilia were removed early 
in development, specific regions of the OE were found to have a significant reduction in 
OSNs. These data identify HBC cilia as a previously unrecognized signaling structure in 
the OE, provide mechanistic insight into the regulation of HBCs during olfactory 
regeneration, and indicate a potential role for HBCs in OE development.  
 
2.3 Results  
Olfactory stem cells possess primary cilia.  
ARL13B is a small Ras GTPase that regulates ciliogenesis and cilia function 
(Cantagrel et al., 2008; Higginbotham et al., 2013; Kasahara et al., 2014; Bangs et al., 
2015). While immunostaining the OE of wild-type mice for endogenous ARL13B, we 
made a fortuitous discovery of what appeared to be cilia projecting from cells located just 
above the lamina propria (Fig. 2-1). To determine if these primary cilia were on a specific 
olfactory cell type we immunolabeled the OE for the basal body marker gamma (γ) tubulin 
and the nuclear transcription factor p63, which labels HBCs (Packard et al., 2011). The 
staining revealed ARL13B+ cilia projecting from basal bodies located within HBCs (Fig. 
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2-1A-B). To confirm the presence of cilia using a transgenic marker, we analyzed the OE 
of mice expressing an ARL13B-GFP fusion protein (Arl13b-EGFPtg) (Delling et al., 2013) 
labeled with a second HBC marker, Keratin5 (K5) (Holbrook et al., 1995). Similar to the 
endogenous staining, ARL13B:GFP also labels cilia structures projecting from HBCs (Fig. 
2-1C). To further characterize HBC cilia, we stained the OE for additional ciliary markers. 
Adenylyl cyclase III (AC3) is a canonical marker of cilia projecting from OSNs, but also 
labels cilia present on other cell types including primary neurons and astrocytes (Bishop 
et al., 2007; Guadiana et al., 2013; Higginbotham et al., 2013). AC3 co-localizes with 
endogenous ARL13B (Fig. 2-1D) in wildtype mice, as well as ARL13B:GFP (Fig. 2-1E) in 
transgenic mice. The AC3+ cilia are also associated with p63 labeled HBCs similar to 
ARL13B (Fig. 2-1F). Finally, we used a second transgenic mouse, EGFP-Cetn2, as an 
additional label for basal bodies (Higginbotham et al., 2004; Bangs et al., 2015). Staining 
tissue with AC3 antibodies revealed AC3+ projections associated with EGFP-CETN2 
labeled basal bodies (Fig. 2-1G). Together, these data suggest that HBCs possess 
primary cilia and indicate that OSNs are not the only ciliated cell type in the OE.  
In the OE, apically located SUS cells possess basal projections, known as endfeet, 
that juxtapose olfactory basal cells en route to contact with the basal lamina (Doyle et al., 
2001). The purpose of these connections has yet to be elucidated; however, it has been 
proposed that this is a site for communication between basal cells and SUS cells (Jia and 
Hegg, 2010). In our analysis, we observed that the majority of HBC cilia project from the 
top of the HBCs towards the SUS cell endfeet. To determine if HBC cilia are associated 
with SUS cell endfeet, analysis of p63+ HBCs and SUS cells immunolabeled with 
Keratin18 (K18) (Holbrook et al., 2011) was carried out in Arl13b-EGFPtg mice. As seen 
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in a representative image, cilia projecting from HBCs are in apposition to the endfeet (Fig. 
2-1H). To improve the resolution of a single SUS cell endfoot, we analyzed the OE of 
mice intranasally injected with an adenovirus expressing GFP, in which a small subset of 
SUS cells are transduced (for methods, see ref. McIntyre et al., 2012). Using this 
approach, we observed that the ARL13B+ cilium projects into the interstitial space 
between the HBC and SUS cell (Fig. 2-1I). These data suggest the potential for cilia to 
act as an antenna for communication between basal cells and SUS cells perhaps in a 
manner analogous to the immunological synapse (Bromley et al., 2001; Finetti et al., 
2011). 
Cilia are present on distinct subpopulations of olfactory stem cells.  
Given the close proximity of GBCs and HBCs at the base of the OE, we assessed 
whether GBCs also possess primary cilia. We identified a novel pan-GBC marker to 
distinguish between HBC and GBC subpopulations. SEC8 is one of eight subunits in the 
exocyst complex that was initially discovered in the secretory pathway of yeast S. 
cerevisae and proposed to contribute to various mechanisms, including protein synthesis 
and vesicle trafficking (Wang et al., 2004). Antibody staining for SEC8 in the OE 
specifically labels a large population of GBCs overlapping with previous identified makers 
of GBC subpopulations (Fig. 2-2A). Immunostaining with antibodies to either MASH1 
(also known as ASCL1) (Manglapus et al., 2004), a basic helix-loop-helix transcription 
factor that is required in the early stages of olfactory neuron lineage (Cau et al., 1997) or, 
LSD1 (lysine-specific demethylase 1), a chromatin modifying complex protein (Krolewski 
et al., 2013) in conjunction with SEC8 confirmed that SEC8 is indeed a pan-GBC marker. 
All MASH1+ or LSD1+ cells appear to co-express SEC8 (Fig. 2-2A). Approximately 41% 
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of SEC8+ cells were MASH1+, while approximately 90% of SEC8+ cells were also LSD1+ 
(Fig. 2-2A, C; N=4). Labeling of the OE with ARL13B and SEC8 antibodies revealed that 
very few (<5%) SEC8+ GBCs possess cilia, while >70% of K5+ HBCs possess cilia (Fig. 
2-2B, D; N=6). These data show that HBCs are the predominant ciliated olfactory basal 
stem cells and suggest a specific role for cilia in this subpopulation of neural progenitors.   
Conditional deletion of IFT machinery results in the specific loss of cilia on HBCs. 
To study the cell autonomous function of cilia in HBCs, we used a floxed allele for 
a gene essential for intraflagellar transport (Ift88) and an inducible Cre driver specific to 
HBCs in the OE (see methods). IFT88 is a critical component of the bi-directional 
intraflagellar transport (IFT) system (Singla and Reiter, 2006; Pedersen and Rosenbaum, 
2008) and conditional knockout of Ift88 ablates cilia from specific cell types (Croyle et al., 
2011; Sharma et al., 2013). Mice in which HBC cilia were ablated (K5rtTA;TetOCre;Ift88fl/fl 
and K5rtTA;TetOCre;Ift88fl/Δ) are hereafter referred to as iHBC-IFT88 mice, while 
phenotypically wildtype mice (K5rtTA;TetOCre;Ift88fl/wt) are hereafter referred to as 
control mice. 
Control and iHBC-IFT88 mice were administered a doxycycline-containing (dox) 
diet to activate Cre expression (Gunther et al., 2002; Grachtchouk et al., 2011) at 
postnatal day 28 (P28), when the OE is mature (Murdoch and Roskams, 2007). One week 
post dox administration, ~90% of HBCs in mice with both TetO-Cre and K5rtTA alleles 
show Cre expression (Fig. 2-3A). Cre expression was not detected in HBCs of mice that 
lacked the TetOCre allele (Fig. 2-3B). More importantly, iHBC-IFT88 mice show a 
significant loss (88.5%) of ciliated HBCs after 4 weeks of dox (Fig. 2-3C-D, N=5). 
Interestingly, loss of cilia does not result in a change in the number of HBCs (Fig. 2-3E, 
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N=5). Immunostaining with the mature OSN marker, olfactory marker protein (OMP), and 
acetylated α-tubulin (Acet-Tub) revealed no changes in OSN composition (Fig. 2-3F). An 
increase in cilia loss on HBCs (95.6%) was detected after 8 weeks of dox administration 
(Fig. 2-4A-B), with no effect on the number of HBCs (Fig. 2-4C), GBCs (Fig. 2-4D-E) and 
OSNs (Fig. 2-4F-G) (Control mice N=2, iHBCIFT88 mice N=4). These data demonstrate 
that genetic ablation of Ift88 efficiently removes cilia from HBCs, without altering HBC 
quiescence or the normal maintenance of the OE. 
Loss of cilia in HBCs results in improper regeneration of the olfactory epithelium 
following injury.  
 
HBCs are believed to be a quiescent population of cells unless activated by severe 
injury to participate in OE regeneration (Leung et al., 2007). Methimazole (MMI) is an 
olfactory toxicant whose metabolites induce cell death of OSNs, SUS cells, and GBCs 
but spares HBCs in the mouse OE (Brittebo, 1995; Packard et al., 2011). Four weeks 
after dox administration, iHBC-IFT88 and control mice were given an intraperitoneal 
injection of MMI (75 mg/kg) to chemically lesion the OE, and analyzed at 8 weeks post-
recovery (Genter et al., 1995; Bergman and Brittebo, 1999). The presence of cilia on 
HBCs remained significantly reduced in iHBC-IFT88 mice after recovery (Fig. 2-5A, C; 
N=5 for both groups), while no difference in the number of HBCs was observed between 
iHBC-IFT88 and control mice, as indicated by the number of K5+ cells (Fig. 2-5A, D; N=5 
for both groups). Surprisingly, there was a significant reduction in the number of SEC8+ 
GBCs in iHBC-IFT88 mice compared to controls (Fig. 2-5B, E; N=5 for both groups). In 
addition, the number of OMP+ mature OSNs was reduced by approximately 75% in iHBC-
IFT88 mice (Fig. 2-5F, G; N=5 for both groups). Consequently, the thickness of the OE 
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was also reduced by approximately 50% (Fig. 2-5H; N=5 for both groups). Interestingly, 
no change in the number of cleaved caspase-3+ cells was observed between control and 
iHBC-IFT88 mice 8 weeks post-recovery, suggesting that the reduction of mature OSNs 
and thickness of the OE was not due to increased cell death (Fig. 2-5I, J; N=5 for both 
groups).  
While the regeneration of neurons was not completely eliminated, the OSNs that 
returned possess acetylated α-tubulin labeled cilia (Fig. 2-5F). Since IFT88 is required for 
OSN cilia (McIntyre et al., 2012), the presence of ciliated OSNs in the regenerated OE 
suggests that these OSNs were derived from progenitors other than HBCs lacking IFT88. 
In our iHBC-IFT88 mice that were administered dox for 4 weeks, approximately 12% of 
HBCs still possessed cilia (see results above). Based on our MMI lesion paradigm, it is 
therefore possible that this remaining 12% of ciliated HBCs, in which IFT88 is present, 
contributed to regeneration of the OE. However, another possible explanation is that 
these OSNs were derived from residual GBCs and not from HBCs lacking IFT88. This 
notion is consistent with MMI lesion, which can leave residual GBCs (Xie et al., 2013). 
Nonetheless, such significant reduction of OSNs should coincide with a decline in 
synaptic input into the olfactory bulb (OB), which can be measured by the expression of 
tyrosine hydroxylase (TH) in the dopaminergic interneurons of the OB (Baker et al., 1993; 
Baker et al., 1999). Following recovery there was a significant reduction in the intensity 
of TH in the bulb of iHBC-IFT88 mice compared to control mice (Fig. 2-5K-L; N=4 for both 
groups) and the glomerular perimeter was significantly reduced. Together, these data 
indicate that without cilia, HBCs are unable to contribute to the regeneration of the OE, 
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potentially due to disrupted HBC proliferation, resulting in impaired OSN recovery and 
olfactory function. 
 In order to link the observed effects to cilia function, and not off-target effects of 
IFT88 loss (Robert et al., 2007), we repeated these experiments using a cell-specific 
knockout of Arl13b (Caspary et al., 2007; Larkins et al., 2011). ARL13B is specifically 
localized to the cilia membrane and is required for proper ciliogenesis (Caspary et al., 
2007). Moreover, mutations in Arl13b, lead to loss of cilia phenotypes as well as HH-
related phenotypes due to the disruption in the localization and ciliary targeting of HH 
pathway components (Caspary et al., 2007; Duldulao et al., 2009; Larkins et al., 2011). 
K5rtTA;TetOCre;Arl13bfl/fl mice (referred to hereafter as iHBC-ARL13B mice) and  
K5rtTA;TetOCre;Arl13bfl/wt mice (referred to hereafter as control mice) underwent the 
same MMI lesion paradigm as stated above. After 8 weeks of recovery, ARL13B+ HBC 
cilia were observed in control mice but not in iHBC-ARL13B mice (Fig. 2-6A). Similar to 
results observed in iHBC-IFT88 mice, the number of HBCs did not differ between control 
and iHBC-ARL13B mice (Fig. 2-6B; N=3 for both groups). Additionally, there was a 
significant reduction (~ 30%) in the number of SEC8+ GBCs (Fig. 2-6C-D; N=3 for both 
groups) as well an approximate 75% reduction in the number of OMP+ mature OSNs 
(Fig. 2-6E-F; N=3 for both groups) in iHBC-ARL13B mice compared to controls. 
Interestingly, the apical surface of the OE of iHBC-ARL13B mice had reduced Acet-Tub 
labeled OSN cilia. Together, these results not only recapitulate those observed in the 
iHBC-IFT88 mice but also suggest that Arl13b is required for HBC cilia function and 
regeneration of the OE. 
Depletion of HBC cilia results in the impaired development of the OE.  
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In mice, the OE begins to form at embryonic day 10 (E10) (Murdoch and Roskams, 
2007). Small numbers of p63-expressing cells first appear at E14, after the emergence of 
all other cell types (Packard et al., 2011). Therefore, HBCs are not believed to participate 
in the establishment of the OE. HBCs settle to the basal lamina, begin to express K5, and 
become dormant between ~E16 and P10 (Packard et al., 2011). In order to exploit this 
late development, iHBC-IFT88 mice were administered dox starting at E16 for 4.5-5 
weeks to ablate cilia during OE maturation. At P28, iHBC-IFT88 mice had a near complete 
loss of cilia on HBCs across all regions of the OE compared to control mice (Fig. 2-7A-B; 
N=5 for both groups), with no difference in the total number of HBCs (Fig. 2-7A, C; N=5 
for both groups). Interestingly, the dorsal lateral region associated with ectoturbinates 2 
and 2’, exhibited a significantly reduced number of OMP+ mature OSNs in iHBC-IFT88 
mice (Fig. 2-8A-H). While other regions of the OE also exhibit a reduction in the number 
of mature OSNs, this reduction was variable along the anterior-posterior axis of the OE 
and most pronounced near the midpoint of the anterior-posterior axis. Quantitation of 
OMP+ neurons in the posterior OE revealed a reduction in mature OSNs in the dorsal 
medial and dorsal lateral regions but not the ventral medial and ventral lateral OE (Fig. 2-
8E, I; N=5 for both groups). These data show that cilia on HBCs are important for proper 
neurogenesis during development of the OE, providing evidence that HBCs participate in 
the establishment of this tissue that was thought to be limited to GBCs (Treloar et al., 
2010).  
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2.4 Discussion  
 Within the olfactory system, it is well known that cilia from individual OSNs create 
a large receptive field in which an OSN can be activated by an odorant (for review, see 
DeMaria and Ngai, 2010). Until now it was widely believed that neurons were the sole 
ciliated cell type in the OE. Here, we show for the first time that primary cilia exist on a 
reserve population of olfactory basal stem cells, the HBCs. Furthermore, utilizing the 
genetic deletion of two cilia-specific genes in HBCs, we demonstrate that primary cilia are 
critical for activation of the regenerative capacity of HBCs following chemical lesion.  
While Ift88 plays a critical role in ciliogenesis and maintenance, it has also been 
implicated in G1-S transition in ciliated cells (Robert et al., 2007). However in other studies 
targeted deletion of Kif3a, a kinesin motor important for cilia function, shows similar 
phenotypic effects observed with loss of Ift88 suggesting a common mechanism of action 
through the cilium (Berbari et al., 2009; Wong et al., 2009). In our study we have validated 
the results observed with deletion of Ift88 by the targeted removal of Arl13b. The loss of 
Arl13b has previously been demonstrated to affect neural development, and mutations in 
Arl13b underlie human ciliopathies (Caspary et al., 2007; Cantagrel et al., 2008; 
Higginbotham et al., 2012; Zhang et al., 2013). As IFT88 and ARL13B serve different 
roles in cilia function, the similar phenotypes observed in two different mutant lines 
supports the conclusion that the loss in regenerative capacity of HBCs is due to 
dysfunctional primary cilia.  
HBCs are long-lived quiescent progenitors that are activated only after extensive 
lesion of the OE in which SUS cells and GBCs are depleted (Leung et al., 2007). The 
mechanism by which HBCs become activated remains unknown; however, SUS cell 
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endfeet have been previously shown to terminate on HBCs (Holbrook et al., 1995). Given 
that the present findings demonstrate an anatomical localization of the HBC cilia relative 
to SUS cell endfeet, we propose a model in which HBC cilia act to sense cues from the 
SUS cells regarding the health of the OE. We propose that this communication occurs at 
the interface between SUS cell endfeet and HBC cilia (Fig. 2-9A). This paradigm may be 
analogous to the immunological synapse that forms between a T cell and an antigen-
presenting cell functioning to orchestrate signals that drive T cell activation (for review, 
see Bromley et al., 2001). Following injury to the OE, signaling is conceivably altered 
between SUS cells and HBCs resulting in activation of the quiescent HBCs (Fig. 2-9B). 
Without cilia, HBCs are unlikely to detect signals necessary for proliferation and/or 
differentiation (Fig. 2-9C). Additional support for a SUS/HBC connection in regenerating 
the OE comes from different lesion models. In OSN-specific lesions, where SUS and GBC 
cell death is spared, HBCs remain quiescent, and the GBCs are the leading contributor 
to regeneration (Leung et al., 2007; Makino et al., 2009). However, when lesions result in 
SUS and GBC cell death, HBCs become active and contribute to regeneration (Leung et 
al., 2007; Jia et al., 2010). These findings suggest that death of SUS cells stimulates 
HBCs to proliferate and contribute to regeneration. However, an alternative explanation 
that cannot be ruled out based on current lesion models is whether signaling occurs 
between GBCs and HBCs, and how such signaling may contribute to HBC proliferation 
and OE regeneration. Interestingly, negative feedback signaling is known to occur in the 
OE, as is observed between neuronal and stem/progenitor cells, in order to control self-
replication and differentiation of the stem progenitor cell population (Beites et al., 2005; 
Gokoffski et al., 2010). It is therefore plausible that such feedback signaling may occur 
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between GBCs and HBCs via HBC cilia, and that this signaling is lost when lesion results 
in GBC cell death. In either case, whether the injury results in the release of a stimulatory 
signal, or the loss of a tonic inhibitory cue between HBCs and other cell types remains to 
be determined.  
Quiescent adult stem cells typically forgo cell cycle decisions in order to respond 
to transient environment signals sensed through the cilia (Plotnikova et al., 2009). These 
signals include the Notch, Wnt, and HH pathways, each of which is strongly linked to 
neurogenesis in the brain (Kumamoto et al., 2012; Tong et al., 2014). The Wnt pathway 
has been previously implicated in OE proliferation and neurogenesis during development 
and regeneration (Wang et al., 2011; Chen et al., 2014). In contrast, Notch signaling 
appears to participate in development of supporting cells but not neurons in the OE 
(Manglapus et al., 2004; Krolewski et al., 2012). Currently, there is no evidence for the 
role of the HH pathway in OE development. However, canonical HH signaling is strongly 
linked to cilia in numerous other systems (for review, see Goetz and Anderson, 2010). 
Numerous HH pathway components dynamically localize to cilia, while disruption of cilia 
results in aberrant HH signal transduction and impaired morphogenesis in specific organ 
systems (for review, see Berbari et al., 2009). 
While the signaling pathways may be shared, the phenotypic effects of cilia loss 
differ between ciliated cell types including various stem cells. In the adult skin, loss of cilia 
on basal cells resulted in the proliferation of cells in the interfollicular epidermis with 
subsequent perturbation of epidermal homeostasis (Croyle et al., 2011). In contrast, the 
conditional ablation of primary cilia postnatally from neural stem cells (NSCs) in the 
hippocampus led to a reduction in amplifying progenitor cells without altering the number 
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of quiescent NSCs (Amador-Arjona et al., 2011). In addition, primary cilia in the 
cerebellum are required for expansion of the neural progenitor pool (Chizhikov et al., 
2007). Similarly, a recent report suggested that localized ablation of cilia in NSCs in the 
ventricular–subventricular zone (V-SVZ) decreases neurogenesis only in the ventral V-
SVZ (Tong et al., 2014). These data in NSCs are similar to what we observed with a loss 
of cilia from HBCs in the OE– no change in the number of HBCs, but a reduction in the 
neurogenesis of the OE. Together, these data suggest the convergence of a common 
cilia ablation phenotype between neural stem cells as opposed to epidermis.  
During development, NSCs are important for early neurogenesis and 
morphogenesis of the OE (Gokoffski et al., 2010). While maturing GBCs that migrate from 
the apical surface clearly contribute to organogenesis (Cau et al., 2002), the precise role 
of HBCs is unclear. Evidence from a lineage-trace mouse model suggests that upon their 
establishment in the OE at P10, HBCs do participate in neurogenesis (Iwai et al., 2008). 
Our data supports the notion of HBC-driven neurogenesis in early postnatal development 
of the OE and suggests that cilia on HBCs are required for normal OE development. 
Interestingly, the loss of OSNs observed in the developing OE was regional whereas in 
the recovering OE it was global. We speculate that these differences can be attributed to 
the temporal and spatial release of morphogens during development that are 
synchronized after severe injury to the OE (Vedin et al., 2009). Nevertheless, our data 
demonstrate a clear role for HBCs and their cilia in the developing OE. 
 Our finding of cilia on HBCs and their importance in neurogenesis reveals a 
potential novel mechanism for the etiology of olfactory dysfunction. It is now well 
recognized that anosmia is a clinical manifestation of ciliopathies, a growing class of 
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pleiotropic genetic disorders, traditionally associated with the loss of cilia on OSNs. 
However, the ability to maintain a functional olfactory system throughout life depends on 
the presence of a stem cell population. While the OE undergoes constant neurogenesis, 
there is a net loss of neurons over time due to reduced stem cell function (Ducray et al., 
2002; Conley et al., 2003). Changes that alter cilia function on HBCs could hasten this 
decline and contribute to age related olfactory loss. Moreover, ciliopathy patients may 
show increased susceptibility to chemical insult to the OE. Work here suggests that 
impaired neurogenesis may be a new unforeseen mechanism for olfactory dysfunction in 
congenital anosmias.   
 
2.5 Materials and Methods  
Mouse strains and Genotyping. All mice were maintained on a mixed genetic 
background. Transgenic Arl13b-EGFPtg mice were provided by David Clapham (Harvard 
University). EGFP-Cetn2 mice were obtained from The Jackson laboratory (stock number 
008234) (Higginbotham et al., 2004). Conditional deletion of Ift88 from olfactory HBCs 
was achieved by the use of a doxycycline-inducible Cre mouse model. This model utilized 
mice carrying three alleles: (a) a K5-promoter driving expression of the reverse 
tetracycline transactivator (rtTA) (K5rtTA) (Diamond et al., 2000), (b) a tetracycline 
Operator (TetO) to permit expression of Cre (TetOCre) (Mucenski et al., 2003), and (c) a 
floxed Ift88fl/Δ to ablate cilia (the Δ allele has exons 4-6 deleted from Ift88) (Haycraft et al., 
2007). K5rtTA and TetOCre mice were provided by Dr. Andrzej Dlugosz (University of 
Michigan, Ann Arbor, MI).  Ift88fl/Δ mice were provided by Dr. Bradley Yoder (University 
of Alabama at Birmingham, Birmingham, AL). Removal of Arl13b from olfactory horizontal 
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basal cells was achieved using a similar strategy with a floxed Arl13b (exon 2) mouse 
provided by Dr. Tamara Caspary (Emory University). All mice of either sex were housed 
and maintained according to the University of Michigan and University of Florida 
institutional guidelines. All protocols for mouse experimentation were approved by the 
University of Michigan and the University of Florida Committee(s) on the Use and Care 
of Animals. Genotyping was performed using primers and PCR parameters from 
previously published work referenced above.  
Doxycycline Transgene Induction and olfactory epithelium lesion. Mice were fed 
doxycycline chow (200 mg/kg doxycycline, Bio-Serv) and water (200µg/ml doxycycline, 
5% sucrose, Fisher) starting at either embryonic day 16 (E16) or postnatal day 28 (P28) 
and remained on doxycycline diet until the time of euthanasia. Based on an approximate 
daily food intake of 4 g/mouse and water intake of 6ml/mouse (Bachmanov et al., 2002), 
mice consumed approximately 2 mg doxycycline / day (0.8 mg in chow and 1.2 mg in 
water). P28 doxycycline treated K5rtTA;TetOCre;Ift88fl/fl mice or 
K5rtTA;TetOCre;Arl13bfl/fl mice and control littermates received an intraperitoneal 
injection of Methimazole (2-Mercapto-1-methylimidazole, Sigma) (75 mg/kg in sterilized 
1xPBS) four weeks after the start of doxycycline diet. Mice were euthanized 8 weeks after 
methimazole treatment. 
Tissue Collection and Preparation. Mice were anesthetized with 30% Fluriso 
(Isoflurane, VetOne), transcardially perfused with 4% paraformaldehyde (PFA), 
decapitated, and their heads fixed in 4% PFA for 12-16 hours at 4°C. Tissue was then 
decalcified in 0.5M EDTA (Fisher)/1xPBS overnight at 4°C, cryoprotected in 10% (1hr), 
20% (1hr), and 30% sucrose/1xPBS overnight at 4°C, and frozen in OCT compound 
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(Tissue Tek). 10-12μm of the olfactory epithelium and olfactory bulb were collected on a 
Leica CM1860 cryostat.  
Immunohistochemistry. For all immunofluorescence, antigen retrieval was used. 
For antigen retrieval, tissue sections were rinsed in 1xPBS to remove OCT then incubated 
in Citrate buffer (pH 6.0) for 30min at 90°C, cooled for 20min at RT, then washed with 
distilled water for 5min. Sections were blocked with 2% donkey or goat serum, 1% BSA 
in 1xPBS and incubated overnight in primary antibody. Antibodies were used at the 
following dilutions: mIgG2a anti-p63 (BioCare Medical, 1:200); mIgG2a anti-ARL13B 
(Neuromab, 1:500); rabbit anti-ARL13B (Proteintech, 1:500); mIgG1 anti-gamma tubulin 
(Sigma, 1:500); rabbit anti-K5 (Covance, 1:2500); chicken anti-GFP (Abcam, 1:500); 
rabbit anti-K18 (Abcam, 1:500); mIgG1 anti-MASH1 (BD Pharmingen, 1:100); mIgG2b 
anti-SEC8 (BD Transduction Laboratory, 1:500); rabbit anti-LSD1 (Abcam, 1:500); goat 
anti-OMP (Wako Chemicals, 1:1000); mouse anti-Cre (Millipore, 1:500); mouse anti-α 
acetylated tubulin (Sigma, 1:1000); rabbit anti-AC3 (EnCor Biotechnology, 1:2000), and 
rabbit anti-TH (Millipore, 1:500). Sections were washed in 1xPBS three times for 5min 
each at room temperature and then incubated with Alexa Fluor-conjugated secondary 
antibodies (1:1000) for 1hr at room temperature. Tissue sections were then incubated 
with DAPI (Invitrogen, 5mg/ml) for 5 min, washed two times with 1xPBS, and then sealed 
with cover slips mounted with ProLong Gold (Invitrogen). 
For detection of Cre, tissue sections were rinsed in 1xPBS to remove OCT, 
puddled with citrate buffer, and steamed for 10min in a glass jar in a hot water bath. 
Sections were blocked with 2% donkey or goat serum/5% dry non-fat milk/4% BSA/1% 
TTX100 in 1xPBS and incubated overnight in primary antibody. For detection of GFP, 
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tissue sections were rinsed in 1xPBS to remove OCT, puddled with citrate buffer, and 
steamed for 10min in a glass jar in a hot water bath. Sections were blocked with 2% 
donkey or goat serum/0.3% TTX100 in 1xPBS and incubated overnight in primary 
antibody. For triple staining with MASH1, SEC8, and LSD1 or OMP and Acet-Tub, mouse 
antibodies or OMP were incubated together overnight and LSD1 or Acet-Tub, 
respectively, were incubated for 1hr the following day. 
Image processing and quantification. Images were captured using a Nikon A1R 
confocal microscope. ImageJ software was used to measure the length of the OE (in µm) 
in each image, to count specific cell types with the cell counter plugin, and to measure 
the TH intensity. In order to quantify cell types, 10-15 images were taken from the dorsal 
medial, dorsal lateral, ventral medial, and ventral lateral regions, across 3-4 sections of 
the OE. Cell counts were averaged and converted to number of cells/mm of OE. 
Quantitation was performed for N= 3-6 mice in all control, iHBC-IFT88, and iHBC-Arl13b 
groups, unless otherwise stated. Reported N-values represent the number of mice 
examined. Measurements of TH intensity were quantified for all glomeruli in each of 3-4 
sections of the OB in 4 iHBC-IFT88 and 4 control mice using Image J software. A blind 
experimental paradigm was utilized to eliminate bias during image processing and 
quantification.  
Statistics. Statistical significance was determined using an unpaired t test with 
GraphPad Prism software. Data are presented as mean ± SEM with two-tailed P values 
less than 0.05 considered significant. 
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2.7 Figures 
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Figure 2-1. HBCs possess primary cilia. Immunofluorescence staining was performed 
on tissue from the olfactory epithelium of 3-6 week old wildtype, Arl13b-EGFPtg, and 
Centrin2-EGFPtg mice. A, P63-labeled HBCs possess ARL13B-labeled cilia (inset - 
magnified image). Scale bars = 10µm. B, Cilia extend from gamma (γ) tubulin-labeled 
basal bodies (arrows). Low magnification view (left) and high magnification view (right) of 
ciliated HBC. Scale bars = 5µm. C, In Arl13b-EGFPtg mice, K5-labeled HBCs possess 
GFP+ cilia (inset – magnified image). Scale bars = 10µm. D, HBC cilia labeled with 
canonical cilia markers Adenylate cyclase III (AC3) and ARL13B. E, In Arl13b-EGFPtg 
mice, AC3 labels GFP+ cilia. F, P63-labeled HBCs possess AC3-labeled cilia. G, In 
Centrin2-EGFPtg mice, GFP expressing basal bodies possess AC3+ cilia. H, In Arl13b-
EGFPtg mice, GFP+ cilia (arrows) project from p63-labeled HBCs into the interstitial space 
between HBCs and K18-labeled SUS cell endfeet (inset - magnified image. Scale bars = 
5µm. I, In wildtype mice intranasally infected with adenovirus containing GFP, K5-labeled 
HBCs possess ARL13B-labeled cilia (see arrow) that project into the interstitial space 
between an HBC and GFP+ endfoot of a SUS cell (see inset for higher magnified image). 
Scale bar = 10µm. N=10 total mice for all immunostaining. Dashed lines = basement 
membrane. HBCs = horizontal basal cells, GFP = green fluorescent protein, K5 = Keratin 
5, K18 = Keratin 18, and SUS cells = sustentacular cells. 
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Figure 2-2. HBCs are the predominantly ciliated olfactory basal stem cell. 
Immunofluorescence staining was performed in the olfactory epithelium of wildtype mice. 
A, The canonical GBC marker, MASH1, co-localizes with a subset of SEC8+ GBCs, while, 
LSD1, co-localizes with a larger subset of SEC8+ GBCs. B, Few SEC8-labeled GBCs 
possess ARL13B-labeled cilia (see arrows) compared to K5-labeled HBCs (inset – 
magnified image). Scale bars = 10µm. Dashed line = basement membrane. † Occasional 
migrating GBC. C, Quantified data of SEC8+ cells that are either MASH1+ (N=4) or 
LSD1+ (N=4), and D, the percentage of HBCs (N=6) and GBCs (N=6) that possess cilia. 
****P<0.0001 by Student t test. Data shown are means ± SEM. HBCs = horizontal basal 
cells, GBCs = globose basal cells, and K5 = Keratin 5. 
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Figure 2-3.  Cell-specific deletion of Ift88 in HBCs results in the loss of HBC cilia 
with no effects on OSN cilia. Control and iHBC-IFT88 mutant mice (referred to as iHBC-
IFT88) were administered a doxycycline (dox) diet at postnatal day 28 (P28) for 1 or 4 
weeks and immunofluorescence staining of the olfactory epithelium was performed. After 
1 week of dox, A, Cre is present in K5-labeled HBCs of mice with K5rtTA and TetOCre 
alleles but B, Cre is absent in mice lacking the TetOCre allele. After 4 weeks of dox, C, 
in control mice but not iHBC-IFT88 mice, K5-labeled HBCs possess Arl13b-labeled cilia 
(see arrows). See inset for higher magnified image. D, E Quantified data show the 
percentage of HBCs that are ciliated in control mice is significantly reduced by ~88.5% in 
iHBC-IFT88 mice with no significant difference in the number of HBCs per mm of OE in 
control and iHBC-IFT88 mice after 4 weeks of dox. F, Acetylated α tubulin (Acet-Tub)-
labeled cilia are still present in OMP-labeled mature OSNs (see short arrows). Scale bars 
= 10µm. Dashed lines = basement membrane. N=5 for both groups. ****P<0.0001, n.s. = 
not significant by Student t test. Data shown are means ± SEM. IFT88 = intraflagellar 
transport 88, HBCs = horizontal basal cells, cells, OSNs = olfactory sensory neurons, Cre 
= Cre Recombinase, K5 = Keratin 5, and OMP = olfactory marker protein. 
95 
 
 
Figure 2-4. Loss of HBC cilia has no homeostatic effects on the cell composition of 
the olfactory epithelium (OE). Control and iHBC-IFT88 mice were administered a 
doxycycline diet at postnatal day 28 (P28) for 8 weeks. A, In control mice, but not iHBC-
IFT88 mice, K5-labeled HBCs possess ARL13B-labeled cilia (see arrows) (inset – 
magnified image). B, C, Quantified data show a significant loss of ciliated HBCs in iHBC-
IFT88 mice with no change in the number of HBCs per mm of OE. D, SEC8-labeled GBCs 
in the OE of control and iHBC-IFT88 mice. E, Quantified data show no significant 
difference in the number of GBCs per mm of OE in both groups. F, OMP-labeled mature 
OSNs in control and iHBC-IFT88 mice. G, Quantified data show no significant difference 
in the number of mature OSNs per mm of OE between both groups. Scale bars = 10µm. 
Dashed lines = basement membrane. N=2 for control mice and N=4 for iHBC-IFT88 mice. 
****P<0.0001, n.s. = not significant by Student t test. Data shown are means ± SEM. HBC 
= horizontal basal cells, IFT88 = intraflagellar transport 88, K5 = Keratin 5, GBCs = 
globose basal cells, OMP = olfactory marker protein, and OSNs = olfactory sensory 
neurons. 
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Figure 2-5. Loss of HBC cilia results in the improper regeneration of the olfactory 
epithelium (OE) and loss of tyrosine hydroxylase (TH) expression in the olfactory 
bulb (OB). Control and iHBC-IFT88 mice were administered a doxycycline (dox) diet at 
postnatal day 28 (P28) for 4 weeks and then given an intraperitoneal injection of 75mg/kg 
of Methimazole to ablate the OE. Following 8 weeks of recovery, immunofluorescence 
staining was performed. A, In the OE of control mice but not iHBC-IFT88 mice, K5-labeled 
HBCs possess ARL13B-labeled cilia. B, SEC8-labeled GBCs in the OE of control and 
iHBC-IFT88 mice. C-D, Quantified data show the percentage of HBCs that are ciliated in 
control mice is significantly reduced in iHBC-IFT88 mice with no difference in the number 
of HBCs per mm of OE between both groups. E, Quantified data show a significant 
reduction in the number of GBCs per mm of OE. F, OMP-labeled mature OSNs and 
acetylated α tubulin (Acet-Tub)-labeled cilia in the OE of control and iHBC-IFT88 mice. 
G, Quantified data show a significant reduction in the number of mature OSNs per mm of 
OE, and H, a significantly thinner OE in iHBC-IFT88 mice. I - J, No difference in the 
number of cleaved caspase-3 labeled apoptotic cells was observed in the OE of control 
and iHBC-IFT88 mice. K, TH expression within glomeruli (dotted circles) in the OBs of 
control and iHBC-IFT88 mice. L, Quantified data show that the intensity of TH measured 
in arbitrary units is significantly reduced in the OBs of iHBC-IFT88 mice. Scale bars = 
10µm. Dashed lines = basement membrane. N=4 for both groups. *P<0.05, ****P<0.0001, 
n.s. = not significant by Student t test. Data shown are means ± SEM. HBCs = horizontal 
basal cells, IFT88 = intraflagellar transport 88, K5 = Keratin 5, GBCs = globose basal 
cells, OMP = olfactory marker protein, and OSNs = olfactory sensory neurons. 
 
 
 
 
 
 
 
 
 
 
98 
 
 
Figure 2-6. Loss of Arl13b in HBCs results in the improper regeneration of the 
olfactory epithelium (OE). Control and iHBC-ARL13B mice were administered a 
doxycycline diet at postnatal day 28 for 4 weeks to induce deletion of Arl13b. Mice were 
then given an intraperitoneal injection of 75mg/kg of methimazole to ablate the OE and 
allowed 8 weeks of recovery. A, K5-labeled HBCs in the OE of iHBC-ARL13B mice do 
not possess ARL13B-labeled cilia. B, The percentage of HBCs per mm of OE in both 
control and iHBC-ARL13B mice. C, SEC8-labeled GBCs in the OE of control and iHBC-
ARL13B mice. D, Quantified data show a significant reduction in the number of GBCs per 
mm of OE. E, OMP-labeled mature OSNs and acetylated α tubulin (Acet-Tub)-labeled 
cilia in the OE of control and iHBC-ARL13B mice. F, Quantified data show a significant 
reduction in the number of mature OSNs per mm of OE. Scale bars = 10µm. Dashed lines 
= basement membrane. N=3 for both groups. *P<0.05, ***P<0.001, n.s. = not significant 
by Student t test. Data shown are means ± SEM. HBCs = horizontal basal cells, ARL13B 
= ADP-ribosylation factor-like protein 13b, K5 = Keratin 5, GBCs = globose basal cells, 
OMP = olfactory marker protein, and mOSNs = mature olfactory sensory neurons. 
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Figure 2-7. Conditional deletion of Ift88 in HBCs during development of the 
olfactory epithelium (OE) results in the loss of HBC cilia with no effects on the 
number of HBCs. Control and iHBC-IFT88 null mice were treated with doxycycline at 
embryonic day 16 (E16) for 4.5-5 weeks and analyzed at postnatal day 28 (P28) with 
immunofluorescence staining of the OE. A, In control mice, but not iHBC-IFT88 null mice, 
K5-labeled HBCs possess ARL13B-labeled cilia (see arrows) (inset - magnified image). 
Scale bars = 10µm. Dashed lines = basement membrane. Quantified data show B, the 
percentage of HBCs that are ciliated in control mice is significantly reduced in iHBC-IFT88 
null mice across all regions and C, the number of HBCs per mm of OE is similar across 
all regions in both groups. N=3 for both groups. **P<0.01, ***P<0.001, n.s. = not 
significant by Student t test. Data shown are means ± SEM. HBCs = horizontal basal 
cells, IFT88 = intraflagellar transport 88, K5 = Keratin 5, DM = dorsal medial, DL = dorsal 
lateral, VM = ventral medial, and VL = ventral lateral. 
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Figure 2-8. Loss of HBC cilia results in the impaired development of regions in the 
olfactory epithelium (OE). Control and iHBC-IFT88 mice were treated with doxycycline 
at embryonic day 16 (E16) for 4.5-5 weeks and analyzed at postnatal day 28 (P28) with 
immunofluorescence staining of the OE. A-F, OMP-labeled mature OSNs in anterior to 
posterior sections of control and iHBC-IFT88 mice. Scale bars = 200µm. G, Illustration 
depicting the location of sections A-F in a sagittal view of the mouse olfactory organ. H, 
Magnified view of boxed region in D with OMP-labeled mature OSNs and acetylated α 
tubulin (Acet-Tub)-labeled cilia in the OE of control and iHBC-IFT88 mice. Scale bars = 
50µm. I, Quantified data show the number of mature OSNs per mm of OE in iHBC-IFT88 
mice is significantly reduced specifically in dorsal lateral and medial regions of the OE but 
not in ventral regions. N=5 for both groups. *P<0.05 by Student t test. Data shown are 
means ± SEM. HBCs = horizontal basal cells, IFT88 = intraflagellar transport 88, OMP = 
olfactory marker protein, OSNs = olfactory sensory neurons, DM = dorsal medial, DL = 
dorsal lateral, VM = ventral medial, and VL = ventral lateral. 
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Figure 2-9. Model of HBC cilia-dependent neurogenesis during restoration and 
development of the olfactory epithelium (OE). A, Illustration shows that the SUS 
endfoot may release some signal factor that is received and transduced by HBC cilia. B, 
Following an injury, when HBCs possess cilia, SUS cells alert HBCs to the lesion resulting 
in their activation and production of additional GBCs, which contribute to regeneration of 
OSNs. C, Without cilia, HBCs no longer detect a signal from SUS cells, resulting in limited 
recovery from residual GBCs and a thinner OE. HBCs = horizontal basal cells, SUS cells 
= sustentacular cells, GBCs = globose basal cells and OSNs = olfactory sensory neurons. 
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CHAPTER III: 
Role of Hedgehog Signaling in the Adult Mammalian Olfactory Epithelium 
3.1 Abstract 
The olfactory epithelium (OE) is a pseudostratified tissue composed of various cell 
types including olfactory sensory neurons (OSNs) that are readily replaced by two 
populations of basal stem cells, frequently dividing globose basal cells (GBCs) and 
quiescent horizontal basal cells (HBCs). This continuous replacement of OSNs makes 
the OE one of the few tissues to undergo constitutive neurogenesis throughout the 
mammalian lifespan. Although the cell types involved in the maintenance and 
regeneration of the OE are known, the signaling pathways that control their activation and 
proliferation during normal homeostasis, and in response to injury remain largely 
unexplored. Previous data indicate that HBCs possess primary cilia (Joiner and Green, 
et. al., submitted), cellular organelles that regulate the activity of multiple signaling 
pathways, including the Hedgehog (HH) signaling pathway. The HH pathway is implicated 
in stem and progenitor cell function in several adult tissues, making it an attractive 
candidate for the regulation of HBCs. Here, I show that various components of the HH 
pathway are expressed in cells of the OE. Specifically, I found that the HH transcription 
factors, GLI2 and GLI3 are expressed in HBCs, suggesting that HH signaling is involved 
in regulation of HBCs. To test this hypothesis, I utilized two inducible, cell-type specific 
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mouse models (Fig. 3-1): 1) a constitutively active form of Gli2 (K5-rtTA;TetO-Gli2ΔN) 
and 2) a dominant negative repressive form of Gli2 (K5-rtTA;TetO-Gli2ΔC4) to disrupt HH 
signaling specifically in HBCs. The constitutive activation of Gli2 in HBCs resulted in their 
hyperproliferation and consequential loss of neuronal cells and also impaired 
regeneration of the OE following lesion. Interestingly, the repressive form of Gli2 in HBCs 
did not affect the maintenance of the adult OE but led to a decrease in regeneration 
following an injury. Together, these results suggest a novel role for HH and more 
specifically, Gli2, in HBC regulation and HBC-driven neurogenesis.
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3.2 Introduction 
The olfactory epithelium (OE) is a tissue of regeneration and constitutive 
neurogenesis (Graziadei and Graziadei, 1979; Graziadei and Monti Graziadei, 1983; 
Calof and Chikaraishi, 1989). Olfactory sensory neurons (OSNs) within the OE act as a 
direct link between the CNS and the external environment (Doty, 2008), causing them 
and other cells to be susceptible to various injuries resulting from inhalation of toxicants 
or metabolism of drugs (Hastings and Miller, 2003; Murphy et al., 2003). Fortuitously, two 
groups of presumed stem cells: globose basal cells (GBCs) and horizontal basal cells 
(HBCs) (Murdoch and Roskams, 2007) are able to replenish the OSNs and other non-
neuronal cells in the OE. In vitro studies and fate-mapping studies in rodents have shown 
the varying differentiation pathways of HBCs and GBCs under specific conditions. 
Although in defined conditions HBCs can generate multiple differentiated neuronal and 
glial progeny in vitro (Carter et al., 2004), GBCs were initially thought to be the main 
contributor to regeneration of the OE (Treloar et al., 2010). However, in more recent fate-
mapping studies, in which GBCs are depleted from a severe injury to the OE, HBCs were 
shown to be multipotent stem cells that can regenerate neuronal and non-neuronal cells 
(Leung et al., 2007; Iwai et al., 2008).  
 HBCs and GBCs have distinct characteristics and expression profiles. HBCs lie in 
a monolayer against the basement membrane of the OE. They are a quiescent, 
homogeneous population of cells (Holbrook et al., 1995; Carter et al., 2004; Leung et al., 
2007) that were recently found to possess primary cilia that were necessary for proper 
regeneration of the OE following a severe injury (Joiner et al., 2015). GBCs are a 
heterogeneous population of cells situated just above HBCs and below immature OSNs 
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(Packard et al., 2011a; Krolewski et al., 2013). Among the GBCs are transit-amplifying 
progenitor cells and committed neuronal precursors (Jang et al., 2014). During 
neurogenesis in the OE, a subset of GBCs that are Ascl1+ (Mash1+) transit amplifying 
cells primarily give rise to Neurogenin1+ (Ngn1+) and NeuroD1+ immediate neuronal 
precursors (Duggan et al., 2008; Krolewski et al., 2013), and a recent study suggests that 
a subpopulation of GBCs are also multipotent progenitors that likely give rise to non-
neuronal cells (Jang et al., 2014).  
Various growth factors and pathways have been reported to play a role in the 
proliferation and differentiation of basal stem cells (reviewed in Murdoch and Roskams, 
2007). In particular, Notch (Manglapus et al., 2004; Krolewski et al., 2012) and Wnt (Chen 
et al., 2014) are suggested to play a role in the differentiation of GBCs; however, these 
studies did not use direct in vivo models to perturb specific components of the pathways. 
The recent finding of cilia on HBCs and its role in regeneration of the OE reveals new 
potential signaling pathways that could be involved in the regulation of HBCs and 
neurogenesis in the OE.  
 Primary cilia are cellular organelles that regulate the activity of multiple signaling 
pathways, including the HH signaling pathway (for review, see ref. Nozawa et al., 2013). 
In other tissues, primary cilia have important roles in cell proliferation and cell 
differentiation (for review, see ref. Irigoin and Badano, 2011). The HH pathway is not only 
important for the development of various tissues and organs but also for the formation, 
survival, and function of stem and progenitor cell populations in several adult tissues 
(reviewed in Petrova and Joyner, 2014). Additionally, there is growing evidence that adult 
stem cells utilize cilia for adult neurogenesis (Amador-Arjona et al., 2011; Kumamoto et 
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al., 2012; Tong et al., 2014). In particular, disruption of cilia in these systems alters the 
activity of signaling pathways that utilize cilia, such as HH (Kumamoto et al., 2012; Tong 
et al., 2014). Canonical HH signaling occurs through a signal transduction cascade 
mediated by the GPCR-like protein smoothened (SMO) following ligand binding to the 
canonical HH receptor patched 1 (PTCH1), resulting in modulation of the downstream 
GLI transcription factors (Chen and Struhl, 1996; Ingham et al., 2000; Fan et al., 2012). 
In the absence of ligand, PTCH1 suppresses SMO activity, allowing for GLI3, and to a 
lesser extent GLI2, to be processed into transcriptional repressors; following HH binding 
to PTCH1, SMO enters the cilium and promotes the processing of GLI2 into a 
transcriptional activator and the degradation of GLI3 (for review, see ref. Petrova and 
Joyner, 2014). Due to its utilization of cilia and the fact that cilia regulate HBC-driven 
neurogenesis in the OE, the HH pathway is an attractive candidate for the regulation of 
HBCs. However, the HH pathway remains largely unexplored in the mammalian OE 
(Chou et al., 2010). Interestingly, a study reported that the HH target gene, Pax6 (Briscoe 
et al., 2000), is expressed in HBCs and is essential for the differentiation of HBCs into 
neuronal cells during regeneration following an MMI-induced injury to the OE (Suzuki et 
al., 2015), suggesting a potential role for HH signaling in OE maintenance. 
Here, I show that components of the HH pathway are expressed in distinct cell 
populations in the OE, suggesting a potential role for the pathway in olfactory tissue 
maintenance. Specifically, HBCs express the transcription factors GLI2, and GLI3, 
suggesting a role for the HH pathway in the molecular regulation of olfactory basal stem 
cells in the OE. Following expression of a constitutively active form of GLI2 (GLI2∆N) (Fig. 
3-1) in HBCs of mice, HBCs become hyperproliferative with an upregulation of the GBC 
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marker, SEC8, and a consequential loss of neuronal cells. Additionally, there is 
incomplete regeneration of the OE following an injury. Conversely, HBC-specific 
expression of a dominant-negative GLI2 repressor (GLI2∆C4) (Fig. 3-1) does not change 
the cell types of the OE during normal tissue homeostasis; however, there is a reduction 
in regeneration and neurogenesis following an injury. These data identify expression of 
HH pathway components in specific cells of the OE, implicating a previously unrecognized 
pathway (HH) in the regulation of OE homeostasis. Additionally, these data provide 
mechanistic insight into the regulation of HBCs during olfactory regeneration, and indicate 
a potential role for HH signaling in the differentiation of HBCs during neurogenesis.  
 
3.3 Results 
HH components are found in cells of the olfactory periphery. 
The HH pathway is an attractive candidate for the regulation of HBCs due to its 
dependence on primary cilia in tissue maintenance (Croyle et al., 2011). However, in the 
mammalian olfactory epithelium (OE), a potential role for the HH pathway remains largely 
unexplored (Gong et al., 2009). To investigate if components of the HH pathway were 
present in the OE, I analyzed the heads of lacZ reporter mice with an X-Gal stain to read 
out expression of the specific transcript of interest (Fig. 3-2). Tissue from these mice was 
incubated with an X-Gal substrate that is cleaved by β-Galactosidase, producing a blue 
precipitate that indicates lacZ expression. Compared to control tissue in which no color is 
present (Fig. 3-2A-C’’’), sagittal views of the whole mouse head indicate that most core 
HH pathway components are found throughout various regions of the brain, including the 
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cerebellum (Fig. 3-2D, G, J, M). Interestingly, Gli1, a general readout of HH activity (Lee 
et al., 1997) is not expressed in the olfactory bulb (OB) (Fig. 3-2E) and only faintly 
detected in the olfactory turbinates (bony structures that are comprised of OE) specifically 
in the stroma (Fig. 3-2F’-F’’’). Gli2, the common transcriptional activator of the HH 
pathway (Matise et al., 1998; Pan et al., 2006), is expressed in the dorsal part of the OB 
(Fig. 3-2H) and throughout all olfactory turbinates in more ventral and anterior areas (Fig. 
3-2I’-I’’’). The major transcriptional repressor of the HH pathway, Gli3 (Litingtung and 
Chiang, 2000; Wang et al., 2000), is not detected in the OB (similar to Gli1; Fig. 3-2K) but 
is detected in the OE more faintly, but in a similar pattern to Gli2 (Fig. 3-2L’-L’’’). 
Conversely, the HH receptor, Ptch1, which, like Gli1, is a direct target of the pathway and 
reads out HH pathway activity (Agren et al., 2004), is expressed throughout the OB (Fig. 
3-2N) and in more dorsal and posterior areas of the olfactory turbinates (Fig. 3-2O’-O’’’). 
The expression profiles of these HH pathway components are unusual, especially 
because Gli1 and Ptch1, which are typically expressed together, do not appear to have 
the same expression profile in the olfactory turbinates. Interestingly, the expression profile 
of Gli2 is typical of the profile of a repressor of the pathway in which the profile is in 
opposition to the expression profile of Ptch1 (Goodrich et al., 1996; Marigo and Tabin, 
1996; Ruiz i Altaba, 1998). These data demonstrate that HH components are expressed 
not only in the CNS, but also in the olfactory periphery.           
To analyze the expression profile of the HH components more closely, coronal 
sections of the lacZ reporter mice were obtained and incubated with X-Gal substrate (Fig. 
3-3). Again, no color developed in control tissue (Fig. 3-3A-D). Similar to the whole mount 
images (Fig.3-2), Gli1 is not expressed in the OE, but instead in cells within the underlying 
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Lamina Propria (LP) (Fig. 3-3E-H). Gli2 is expressed in basal cells of the OE (Fig. 3-3I-L) 
and, in some areas, detected in apical cells that appear to be SUS cells (Fig. 3-3L). 
Similarly, Gli3 is also expressed in basal cells (Fig. 3-3M-P) and a subset of SUS cells (3-
3N, P), but with less intensity and uniformity than Gli2. In contrast, Ptch1 is strongly 
expressed in a region-specific and “patchy” pattern in apical cells that appear to be OSNs, 
and possibly at a lower intensity in basal cells (Fig. 3-3Q-T). Together, these results 
corroborate the whole mount images in Figure 3-2, and also suggest that HH pathway 
components are expressed in distinct cell types within the mammalian OE. 
HH pathway components are present in distinct cell populations of the olfactory 
epithelium. 
 
In order to confirm the cell types in the OE that express specific HH pathway 
components, I performed a sequential X-Gal and immunofluorescence stain on tissue 
from Gli2lacZ/+, Gli3lacZ/+, and Ptch1lacZ/+ mice. Following incubation with the X-Gal 
substrate, I immunolabeled the OE with either the recently identified marker of GBCs, 
SEC8 (Joiner and Green, et. al., submitted), and the HBC marker, Keratin 5 (K5) 
(Holbrook et al., 1995), or the immature OSN marker, growth-associated protein 43 (GAP-
43) (McIntyre et al., 2010) and the mature OSN marker, olfactory marker protein (OMP) 
(McIntyre et al., 2010). Dual staining revealed that Gli2 is expressed in all K5+ cells but 
excluded from SEC8+ cells (Fig. 3-4A), while Gli3 is present in a subset of K5+ cells but 
not in SEC8+ cells (Fig. 3-4B). Additionally, I found that Ptch1 is expressed in OMP+ cells 
but not in GAP-43+ cells or in more basally located cells (Fig. 3-4C). Ptch1 expression 
was thought to be present at a lower intensity in immature OSNs and basal cells based 
on X-Gal staining in sections of the OE (Fig 3-3Q-T), however, it is possible that this low 
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signal was not resolved in the dual staining. Nonetheless, these data suggest that Gli2 
and Gli3 are expressed selectively in HBCs of the OE, while Ptch1 is expressed in a 
region-specific manner in mature OSNs.  
Constitutively active Gli2 in HBCs results in proliferative HBCs. 
GLI2 contains both transcriptional activation and repression domains and 
therefore, full-length GLI2 is a weak transcriptional activator (Sasaki et al., 1999). Deletion 
of the N-terminal repression domain results in Gli2 protein that functions as a strong 
transcriptional activator (Gli2ΔN) in cultured cells and mimics overactive SHH signaling 
in transgenic mice (Sasaki et al., 1999). In order to investigate the role of GLI2 as a 
transcriptional activator in HBCs, I analyzed K5-rtTA;TetO-Gli2ΔN mice (Grachtchouk et 
al., 2011) which utilize a doxycycline (dox)-regulated mouse model (Gunther et al., 2002). 
These mice carry two alleles: 1) a promoter specific dox-inducible strain (K5-rtTA) 
(Diamond et al., 2000) and 2) an effector strain (tetO-Gli2ΔN) (Grachtchouk et al., 2011). 
The K5 promoter drives expression of the reverse tetracycline transactivator (rtTA) and 
binding of doxy to rtTA allows for binding to the tetracycline operator (tetO) and 
expression of Gli2ΔN specifically in HBCs in the OE.  
 K5-rtTA;TetO-Gli2ΔN mice (referred to hereafter as iHBC-Gli2ΔN mice) and 
control littermates (referred to hereafter as control mice) were initially administered a dox 
diet to activate Gli2ΔN expression in HBCs after P28, when the OE is mature (Murdoch 
and Roskams, 2007). Mice were treated with dox for 24 hours, 3 days, 5 days, 7 days, or 
10 days. Antibody staining for the HBC markers, p63 and K5, revealed that, compared to 
control mice (Fig. 3-5AI), which exhibit a typical monolayer of HBCs (Holbrook et al., 
1995), there is initially no difference in the appearance and number of HBCs in iHBC-
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Gli2ΔN mice after 24 hours (Fig. 3-5AII, B) and 3 days (Fig. 3-5AIII, B). However, following 
5 days of dox treatment, HBCs undergo a change in morphology as they become more 
round and GBC-like in appearance (Fig. 3-5AIV). By 7 and 10 days, the population of 
HBCs has expanded and are no longer a monolayer of cells (Fig. 3-5AV-AVI). This 
change in appearance following 5 days of dox is reflected in the doubling, and eventual 
tripling by 10 days, of the number of HBCs (Fig. 3-5B). Consequently, the increase in the 
number of HBCs, results in an increase in thickness of the HBC layer (Fig. 3-5C). These 
data suggest that constitutively active GLI2 causes a switch of the HBCs from a dormant 
state to an active state. When the transcription factor, p63, is downregulated, HBCs are 
believed to be activated and differentiate into other cell types (Packard et al., 2011a). 
However, the additional HBCs seen in iHBC-Gli2ΔN mice still express p63 (Fig. 3-5AV-
AVI). 
 In order to determine the proliferative state of the HBCs in these mice, I utilized the 
antibody Ki67 which should label cells in the G1, S, and G2 phase of the cell cycle but 
not in quiescent cells in the G0 phase (Scholzen and Gerdes, 2000). Staining the OE of 
iHBC-Gli2ΔN and control mice after 10 days of dox with Ki67 and p63 revealed that, 
compared to controls, in which Ki67 is excluded from p63+ HBCs, iHBC-Gli2ΔN mice 
display an overall increase in Ki67+ cells which are also p63+ (Fig. 3-5D-E). Typically, 
HBCs do not express Ki67+ due to their quiescence, but in iHBC-Gli2ΔN mice, 
approximately 40% of p63+ HBCs express Ki67. Together, these data suggest that 
constitutively active GLI2 induces HBC proliferation leading to a morphological and 
quantitative change. These findings further suggest that: 1) active HH signaling promotes 
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HBC proliferation of HBCs, and 2) p63 downregulation is required for subsequent HBC 
differentiation.     
GLI2 localizes to tips of proliferative HBC primary cilia. 
The Gli2ΔN transgene contains a MYC tag, allowing for its detection and the 
localization of GLI2 protein (Grachtchouk et al., 2011). As detailed in Chapter II, HBCs 
possess primary cilia (Joiner and Green, et. al., submitted) and GLI2 protein localizes to 
the tips of primary cilia in many HH-responsive tissues (Haycraft et al., 2005; Liu et al., 
2005). In order to investigate when and where GLI2ΔN protein was expressed, I 
immunolabled the OE of iHBC-Gli2ΔN and control mice with MYC and ARL13B, a small 
Ras GTPase that regulates ciliogenesis and cilia function and labels HBC cilia (Joiner et 
al., 2015). After 24 hours of dox treatment, although I did not see a change in HBCs (Fig. 
3-5AII, B), MYC is present in approximately 70% of HBCs in iHBC-Gli2ΔN mice but not 
in control mice (Fig. 3-6A-B). By 7 days of dox, nearly 90% of HBCs in iHBC-Gli2ΔN mice 
express MYC but not in control mice (Fig. 3-6A-B). Interestingly, MYC is present in only 
5% of HBC primary cilia in iHBC-Gli2ΔN mice after 24 hours of dox, while MYC is present 
in nearly 20% of HBC primary cilia in iHBC-Gli2ΔN mice following 7 days of dox (Fig. 3-
6C). These data suggest a correlation between the presence of GLI2 protein in primary 
cilia and subsequent HBC proliferation. Additionally, to determine if Gli2ΔN localized 
specifically to the tips of HBC primary cilia, I stained the OE with the basal body marker 
gamma (γ) tubulin in addition to ARL13B and MYC. This staining revealed that MYC was 
present in HBC primary cilia on opposite ends of the γ-tubulin+ basal bodies (Fig. 3-5D). 
These data demonstrate that Gli2ΔN does localize to the tips of primary cilia in HBCs.  
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Constitutively active Gli2 in HBCs results in SEC8 upregulation and loss of neuronal cells 
in the OE. 
 
To determine the status of other cells in the OE following an atypical proliferation 
of HBCs not triggered by an injury, I analyzed the neuronal GBC and OSN populations of 
HBC-Gli2ΔN mice. As previously mentioned, SEC8 labels a majority of the 
heterogeneous population of GBCs (Joiner and Green, et. al., submitted). Surprisingly, 
analysis of p63+ HBCs and GBCs immunolabeled with SEC8 revealed that although 
control mice contain a typical layer of SEC8+ GBCs above a monolayer of p63+ HBCs, 
iHBC-Gli2ΔN mice after 5 and 10 days of dox contain cells co-expressing SEC8 and p63 
(Fig. 3-7A). The overall number of SEC8+ cells increases in iHBC-Gli2ΔN mice after 5 
and 10 days of dox (Fig. 3-7B). The percentage of p63+ HBCs that express SEC8, which 
is 0% in control mice, increases to 60% and 90% of HBCs after 5 and 10 days of dox 
respectively (Fig. 3-7C). These data suggest that SEC8 is upregulated in the HBCs of 
iHBC-Gli2ΔN mice and that activation of GLI2 mediates this upregulation. 
 Although SEC8, labels a majority of GBCs, there are other markers for neuronal 
committed GBCs such, as MASH1 (Cau et al., 1997). The number of MASH1+ GBCs in 
the OE of iHBC-Gli2ΔN mice was dramatically decreased after 5 and 10 days of dox 
compared to control mice (Fig. 3-8A-B). Since all MASH1+ cells are also SEC8+ (Joiner 
and Green, et. al., submitted), any remaining MASH1+ cells in HBC-Gli2ΔN mice could 
be indicative of SEC8+ cells that do not co-express p63 (Fig. 3-7C). Additionally, GAP-
43+ immature OSNs and OMP+ mature OSNs are both reduced in iHBC-Gli2ΔN mice 
compared to control mice after 5 days of dox (Fig. 3-8C-D). Together, these data indicate 
that hyperproliferation of HBCs results in a loss of neuronal cells in the OE and suggest 
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the need for HBC quiescence to be tightly regulated, possibly mediated by Gli2 
expression in HBCs. 
Constitutively active Gli2 in HBCs results in improper regeneration of the olfactory 
epithelium following injury. 
 
HBCs are believed to be a quiescent population of cells unless activated by severe 
injury to participate in OE regeneration (Leung et al., 2007). Methimazole (MMI) is an 
olfactory toxicant whose metabolites induce cell death of OSNs, SUS cells, and GBCs 
but spares HBCs in the mouse OE (Brittebo, 1995; Packard et al., 2011b). MMI injury to 
the OE is used to study the response of HBCs during restoration of the OE. Due to the 
lethality of iHBC-Gli2ΔN mice after prolonged dox treatment, I induced the injury after 5 
days of dox, when a phenotype in HBCs was seen, and looked at early recovery time 
points (2 days, 5 days, and 9 days). Importantly, mice continued the dox diet during the 
recovery period. On the day of the injury, but after 5 days of dox (Day 0), iHBC-Gli2ΔN 
mice have an increased number of p63+/K5+ HBCs that are no longer restricted to a 
monolayer of cells as seen in control mice (Fig. 3-9A, E). Control mice contain an 
increased number of K5+/p63+ inactive HBCs and K5+/p63- active HBCs at 2 days 
following an injury, while iHBC-Gli2ΔN mice continue to have an even greater number of 
both active and inactive HBCs (Fig. 3-9B, E-F). By 5 days following injury, the appearance 
and number of HBCs of control mice have returned to normal while iHBC-Gli2ΔN mice 
still display an increased number of K5+/p63+ inactive and K5+/p63- active HBCs (Fig. 
3-9C, F-G). HBCs are no longer active at 9 days following injury in control mice, but the 
number of inactive and active HBCs is dramatically increased in iHBC-Gli2ΔN mice (Fig. 
3-9D, F-G). Overall, in control mice, the number of active HBCs appears to peak 2 days 
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after injury and then decreases over time in control mice, while the number of active and 
inactive HBCs continues to increase in iHBC-Gli2ΔN mice (Fig. 3-9F-G). These data 
suggest that HBCs in iHBC-Gli2ΔN mice are still able to become active to replenish HBC 
numbers, but that they remain in a fixed active state that cannot go on to differentiate into 
other cells of the OE.  
To determine whether other cells in the OE are replaced by the activation and 
differentiation of HBCs, I immunolabeled the OE of the same mice with the neuronal GBC 
marker, MASH1, immature OSN marker, GAP-43, and mature OSN marker, OMP. After 
5 days of dox, and at the time of injury (Day 0), iHBC-Gli2ΔN mice contain decreased 
numbers of MASH1+ GBCs (Fig. 3-10A, I), as well as GAP-43+ immature and OMP+ 
mature OSNs (Fig. 3-9B, J-K) compared to control mice. Following 2 days of recovery, 
both control and iHBC-Gli2ΔN mice exhibit a decrease in the number of MASH1+ GBCs 
(Fig. 3-10C, I) and immature and mature OSNs (Fig. 3-10D, J-K). By 5 days following 
injury, in control mice, MASH1+ GBCs return and are greater in number than prior to 
injury but are still nearly absent in iHBC-Gli2ΔN mice (Fig. 3-10E, I). Additionally, 
immature OSNs have returned with very few mature OSNs in control mice, while both 
populations of cells are absent in iHBC-Gli2ΔN mice (Fig. 3-10F, J-K). The number of 
MASH1+ GBCs returns to normal by 9 days of recovery in control mice, but are absent in 
iHBC-Gli2ΔN mice (Fig. 3-10G, I). Similarly, the number of immature OSNs increases in 
control mice by 9 days after injury with an additional return of mature OSNs, while iHBC-
Gli2ΔN mice continue to show no return of immature or mature OSNs (Fig. 3-10H, J-K). 
These data suggest that constitutive GLI2 activation in HBCs impairs their ability to 
contribute to regeneration of the OE.   
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Dominant negative repressive Gli2 in HBCs does not alter OE homeostasis.  
To investigate the repressive effects of GLI2 on HBCs, I utilized a dominant 
negative form of GLI2, Gli2ΔC4, in which the activation domain in the C-terminus is 
truncated (Sasaki et al., 1999). Similar to iHBC-Gli2ΔN mice, I used K5-rtTA;TetO-
Gli2ΔC4 mice which were generated in the laboratory of Dr. Andrzej Dlugosz at the 
University of Michigan (unpublished), which utilize the same dox-regulated model. 
However, in addition to the promoter specific dox-inducible strain (K5-rtTA) (Diamond et 
al., 2000), these mice carry the effector strain (tetO-Gli2ΔC4) which was generated in the 
laboratory of Dr. Dlugosz. The K5 promoter drives expression of the reverse tetracycline 
transactivator (rtTA) and binding of doxy to rtTA allows for binding to the tetracycline 
operator (tetO) and expression of Gli2ΔC4 specifically in HBCs in the OE.  
K5-rtTA;TetO-Gli2ΔC4 mice (referred to hereafter as iHBC-Gli2ΔC4 mice) and 
control littermates (referred to hereafter as control mice) survive longer than iHBC-Gli2ΔN 
mice; therefore, mice were treated with a dox diet for a longer period of time. Additionally, 
HBCs are typically quiescent and the constitutively active form of GLI2 promoted 
proliferation, so I hypothesized that dominant negative GLI2 would not acutely affect OE 
homeostasis. Therefore, iHBC-Gli2ΔC4 mice and control mice were treated with dox for 
36 days and tissue was immunolabeled with p63 and K5 to analyze HBCs, or MASH1 
and SEC8 to analyze GBCs. Strikingly, the appearance and number of HBCs (Fig. 3-11A, 
C) and GBCs (Fig. 3-11B, D) in iHBC-Gli2ΔC4 and control mice were not significantly 
different. Although, I was unable to detect the transgene in HBCs due to inadequate 
antibodies, I observed obvious skin and tail phenotypes in iHBC-Gli2ΔC mice, suggesting 
that the transgene is expressed in K5-expressing cells of the skin. These data indicate 
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that the repressive form of GLI2 does not affect OE homeostasis, which suggests that the 
HH pathway is either normally inactive or functions mainly as a repressor in the adult OE. 
Dominant negative Gli2 repressor expression in HBCs results in improper OE 
regeneration following injury. 
 
To explore whether GLI2 must be active in HBCs for basal cells to contribute to 
OE regeneration, I again utilized MMI injury to the OE of iHBC-Gli2ΔC4 mice. GLI2∆C4 
should be the dominant form of GLI2 expressed in the HBCs of these mice. Because 
these mice survive longer on dox (compared to GLI2∆N animals), I analyzed the OE 8 
weeks following injury when the OE should be nearly fully recovered (Genter et al., 1995; 
Bergman and Brittebo, 1999). I initially induced the Gli2ΔC4 transgene with a dox diet for 
7 days which continued throughout the recovery period. 
At Day 0 of injury and 8 weeks following injury, iHBC-Gli2ΔC4 and control mice 
have a similar number of p63+/K5+ HBCs (Fig. 3-12A, C). The number of SEC8+ GBCs 
at Day 0 is unchanged in iHBC-Gli2ΔC4 compared to control mice however at 8 weeks 
post injury, there is a decrease in the number of SEC8+ GBCs (Fig. 3-12B, D), suggesting 
a decrease in the differentiation of HBCs into GBCs. Furthermore, while there are no 
differences in the number of OSNs at Day 0 of injury, after 8 weeks of recovery, there is 
a decrease in the number of GAP-43+ immature OSNs and OMP+ mature OSNs (Fig. 3-
12E-G). Interestingly, there is not a complete loss of neurons and the OSNs that do return 
appear in a regionally variable manner. Together, these data suggest that dominant 
negative GLI2 repressor impairs HBC-driven OE regeneration and that HBCs require 
GLI2 activation to ensure normal OE regeneration. 
Gli2 regulation of SEC8 during the HBC to GBC transition in OE regeneration. 
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Many of the transcription factors expressed in GBCs, including Mash1 and Ngn, 
are necessary for OSN development (Cau et al., 1997; Cau et al., 2002). SEC8 is a 
secretory protein that is thought to be involved in exocytosis acting as a targeting protein 
for exocytosis or secretion of various proteins (Friedrich et al., 1997). Its loss results in 
incomplete gastrulation and embryonic lethality (Friedrich et al., 1997).  Interestingly, 
Sec8 null embryos like Mash1 null mice, display a loss of Notch1 (Friedrich et al., 1997; 
Cau et al., 2002), which is thought to play an important role in GBC differentiation 
(Manglapus et al., 2004).  
I showed that iHBC-Gli2ΔN mice exhibit an upregulation of SEC8 in HBCs while 
iHBC-Gli2ΔC4 mice have a normal expression profile of SEC8 seen only in GBCs. These 
observations suggest that the active form of GLI2 is necessary for the HBC to GBC 
transition of HBCs. To test this hypothesis, I analyzed the expression of p63, K5, and 
SEC8 in the OE of iHBC-Gli2ΔN mice that had been induced with an MMI injury to the 
OE. On Day 0 of the injury (5 days of dox), iHBC-Gli2ΔN mice contain increased numbers 
of p63+/K5+ HBCs and increased numbers of SEC8+ cells that have been upregulated 
in these HBCs (Fig. 3-13A, E). There is a further increase in SEC8+ cell numbers in iHBC-
Gli2ΔN mice 2 days following injury, while control mice show a slight decrease (Fig. 3-
13B, E). By 5 days following injury, control mice display increased numbers of SEC8+ 
cells, while there is a slight decrease in iHBC-Gli2ΔN mice (Fig. 3-13C, E). The number 
of SEC8+ cells remains normal at 9 days following injury in control mice, but are 
dramatically increased in iHBC-Gli2ΔN mice (Fig. 3-13D, E). Further analysis of SEC8 
expression in either inactive or active cells reveals that: 1) SEC8 is upregulated in a 
majority of inactive HBCs in the iHBC-Gli2ΔN mice regardless of injury, but only in a small 
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percentage in control mice soon after injury (Fig. 3-13F), 2) SEC8 is expressed in active 
HBCs of both control and iHBC-Gli2ΔN mice following injury (Fig. 3-13G), and 3) SEC8 
remains upregulated in the active HBCs in iHBC-Gli2ΔN mice, while in control mice, 
SEC8 is eventually downregulated (Fig. 3-13G). Together these data suggest that GLI2 
upregulates SEC8 in HBCs for them to become active but GLI2 must be downregulated 
to allow for HBCs to differentiate into SEC8+/p63- GBCs (Fig. 3-14).  
 
3.4 Discussion 
The HH pathway plays important roles in embryonic development and in adult 
tissue homeostasis and neurogenesis (reviewed in Petrova and Joyner, 2014). Here, I 
provide evidence that HH pathway components are expressed in distinct cell populations 
in the OE. Interestingly, the transcription factor, Gli1, which is a transcriptional readout of 
the HH pathway and often co-expressed with Ptch1 (Lee et al., 1997; Agren et al., 2004) 
is absent from the OE. Because Gli1 expression is dependent on Gli2 and Gli3 (Bai et al., 
2004) and Gli1-/- mice are viable (Park et al., 2000), GLI2 and GLI3 are believed to be the 
primary transcriptional effectors of HH signaling, while Gli1 is presumably secondarily 
activated at the transcriptional level (Sasaki et al., 1999). Therefore, it is possible that 
GLI1 does not function in the OE, especially if GLI2 and GLI3 act as repressors of the 
pathway in HBCs, which would preclude GLI1 expression in HBCs. However, different 
HH pathway components could be upregulated or downregulated in response to OE 
injury. Particularly, it would be interesting to visualize the expression of Gli2 transcript 
following an MMI injury to determine whether Gli2 downregulation correlates with the HBC 
to GBC transition. Analysis of lacZ reporter mice that are induced with an MMI injury could 
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verify this concept. Although Gli transcripts are present in various cell types of the OE, I 
do not have information about their corresponding protein levels due to inefficient 
antibodies. Furthermore, because GLI2 and GLI3 act as both transcriptional activators 
and repressors (Buttitta et al., 2003), it is important to understand how they are processed 
in both the normal OE and the injured OE. Future work to analyze GLI protein 
modifications and levels would help elucidate how these transcription factors function in 
HBCs.  
 My data indicate that HBC-specific expression of constitutively active GLI2 
promotes hyperproliferation and a subsequent loss of neuronal cells and impaired 
regeneration. Constitutively active GLI2 as well as full-length GLI2 can drive 
tumorigenesis, and when expressed in epidermal basal cells of mice, they form tumors 
characteristic of human basal cell carcinomas (Grachtchouk et al., 2000; Grachtchouk et 
al., 2011). Interestingly a subset of follicle stem cells are resistant to Gli2ΔN-mediated 
tumorigenesis, suggesting that there may be cell-specific protective mechanisms in place. 
In the OE, HBC proliferation is not uniform which could suggest a protective mechanism 
or could be due to timing of transgene induction. Interestingly, newly formed HBCs in 
iHBC-Gli2ΔN mice still possess primary cilia, which is not indicative of a proliferative cell 
(Plotnikova et al., 2009). However, my previous work indicates that the loss of HBC cilia 
does not stimulate proliferation (Joiner and Green, et. al., submitted), suggesting that 
these cells may not be as tightly regulated to the cell cycle as other cells. GLI2 trafficking 
to cilia is necessary for its processing (Haycraft et al., 2005; Humke et al., 2010; 
Tukachinsky et al., 2010). Additionally, GLI2 transcriptionally activates cyclin D1 and 
cyclin D1, which function in G1 phase of the cell cycle to promote cell cycle progression 
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(Mill et al., 2003). It is possible that there is a correlation between the presence of GLI2 
in the cilia of HBCs and their proliferative status. Understanding the correlation between 
proliferative HBCs and ciliated HBCs as well as the presence of GLI2 in primary cilia could 
provide more insight into the role of primary cilia in the cell cycle regulation of HBCs. 
What remains unknown is the fate of neuronal cells that are lost as a consequence 
of HBC proliferation. If the OE has an intrinsic maximum capacity for the number of cells 
it can withstand, it is possible that the neuronal cells die at the expense of newly formed 
HBCs. Analyzing apoptosis in the OE at various time points of dox treatment would 
confirm what happens to these cells. Additionally, after MMI-induced injury, I observed 
incomplete regeneration of the OE in iHBC-Gli2ΔN mice, apparently due to a lack of HBC 
differentiation, which instead appear fixed in an intermediate state. HBCs normally 
differentiate and replenish the GBC population following injury (Leung et al., 2007; Iwai 
et al., 2008). In iHBC-Gli2ΔN mice, SEC8 expression, which is regulated by GLI2 appears 
to be associated with the transition from HBCs to GBCs. However, Gli2 transcript is not 
present in SEC8+ GBCs (Fig. 3-4A), suggesting that the expression of SEC8 might only 
need transient Gli2 expression for it to be transcriptionally activated. In control mice, 
SEC8 is upregulated to a lesser extent earlier in the recovery period (Fig. 3-13B-C, F-G), 
in support of the idea that GLI2 is processed as an activator transiently during 
regeneration. Analyzing GLI2 transcript and protein following an MMI injury would 
determine what is seen in its upregulation or downregulation following injury. Although 
there are no studies that investigate the relationship between SEC8 and GLI2, there are 
reports on the relationship between GLI2 and the HBC marker and transcription factor, 
p63. In osteosarcoma cells, p63 induces Gli2 expression by binding to the Gli2 promoter, 
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suggesting that Gli2 is a direct transcriptional target of p63 (Ram Kumar et al., 2014). 
Normally, downregulation of p63 is associated with activation and differentiation of HBCs 
into other cells of the OE following an injury. Furthermore, p63 is thought to act as a 
promoter of HBC cell renewal and inhibit its differentiation (Fletcher et al., 2011). 
However, in iHBC-Gli2ΔN mice, despite downregulation of p63 leading to HBC activation, 
HBCs do not differentiate. Since Gli2 is a target of p63, when p63 is downregulated, Gli2 
should also be downregulated, but in iHBC-Gli2ΔN mice potentially this downregulation 
cannot occur leading HBCs to stay in a fixed intermediate HBC/GBC state. Future work 
investigating the role of SEC8 in this process and whether SEC8 is a direct transcriptional 
target of Gli2 would help elucidate the mechanisms controlling HBC differentiation. 
 As mentioned previously, GLI2 normally functions as an activator and GLI3 as a 
repressor of the HH pathway, but there are some instances where they can have reverse 
roles (Buttitta et al., 2003; Bai et al., 2004). Interestingly, expression of dominant negative 
GLI2 repressor (GLI2∆C4) did not alter HBC function in the OE of iHBC-Gli2ΔC4 mice 
during normal tissue homeostasis (Fig. 3-12). However, following an MMI-induced injury 
these mice exhibited a loss of neurogenesis and regeneration of the OE (Fig. 3-12). These 
data suggest that GLI2 is processed into a repressor in HBCs in order to maintain their 
quiescence and upon injury, must be differentially processed into an activator to initiate 
HBC-driven neurogenesis. Without GLI2 activator function, HBCs are stuck in a quiescent 
state and are therefore unable to contribute to regeneration of the OE. Because Gli3 is 
expressed in a subset of HBCs (Fig. 2-4B), it is also possible that Gli3 can act as a 
transcriptional activator. Following injury, GLI3 processing to an activator would initiate 
HBC activation. Analyzing Gli3 transcript and GLI3 protein levels following injury as well 
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as the proliferation of HBCs at early time points during recovery in iHBC-Gli2ΔC4 mice 
would be useful in further understanding the dynamics of GLI protein function in the OE. 
Additionally, analysis of a loss of Gli2 (Corrales et al., 2006) and/or Gli3 (Blaess et al., 
2008) in HBCs using conditional mouse models would elucidate the repressive or 
activator roles these transcription factors play in regulation of HBCs and neurogenesis 
and if any redundancies are present.  
 Finally, an important HH pathway component that is missing in the OE is HH ligand. 
There are three different HH ligands in the mammalian HH signaling pathway, DHH, IHH, 
and SHH (Echelard et al., 1993). I was unable to definitively determine which HH ligands 
are present in the OE and where they are expressed. Due to the proximity of SUS cells 
and GBCs to HBCs and their cilia, the ligand source could be present in these cells. SUS 
cells extend projections that terminate in endfeet that contact HBCs via HBC primary cilia 
(Joiner and Green, et. al., submitted). Importantly, there are examples of ligand-
independent HH signaling, specifically in cancer (Onishi et al., 2011; Lei et al., 2013). If 
HH ligand is not present in the OE, the regulation of HBCs could be occurring in a ligand-
independent manner. Future work to look at inhibition of the HH pathway via a SMO 
inhibitor (Low and de Sauvage, 2010) or complete loss of SMO using conditional mouse 
models (Long et al., 2001) could provide more insight on whether the regulation of HBCs 
is ligand-dependent or independent.  
In conclusion, the expression of HH pathway components in the OE, specifically in 
HBCs, and their importance in tissue homeostasis and neurogenesis reveals a potentially 
novel role for HH signaling in the OE, provides insight into a possible GLI-dependent and 
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repressive role for HH signaling during homeostasis, and defines a novel mechanism 
involved in the regulation of olfactory basal stem cells. 
 
3.5 Materials and Methods 
Mouse strains and Genotyping. All mice were maintained on a mixed genetic 
background. Transgenic K5-rtTA;TetO-Gli2ΔN (Grachtchouk et al., 2011) and K5-
rtTA;TetO-Gli2ΔC4 mice (unpublished) were provided by Dr. Andrzej Dlugosz (University 
of Michigan). All mice of either sex were housed and maintained according to the 
University of Michigan and University of Florida institutional guidelines. All protocols for 
mouse experimentation were approved by the University of Michigan Committee on the 
Use and Care of Animals. Genotyping was performed using primers and PCR parameters 
from previously published work referenced above.  
Doxycycline Transgene Induction and olfactory epithelium lesion. Mice were 
administered doxycycline water (200µg/ml doxycycline, 5% sucrose, Fisher) for the first 
3 days of treatment and fed doxycycline chow (1g/kg doxycycline, Bio-Serv) from the 
beginning of treatment after postnatal day 28 (P28) until the time of euthanasia. Based 
on an approximate daily food intake of 4 g/mouse and water intake of 6ml/mouse 
(Bachmanov et al., 2002), mice consumed approximately 2 mg doxycycline / day (0.8 mg 
in chow and 1.2 mg in water). Dox treated K5-rtTA;TetO-Gli2ΔN mice or K5-rtTA;TetO-
Gli2ΔC4 mice and their control littermates received an intraperitoneal injection of 
Methimazole (2-Mercapto-1-methylimidazole, Sigma) (75 mg/kg in sterilized 1xPBS) five 
days or 7 days after the start of dox diet respectively. K5-rtTA;TetO-Gli2ΔN mice were 
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euthanized 2, 5, or 9 days after MMI treatment while K5-rtTA;TetO-Gli2ΔC4 mice were 
euthanized 8 weeks after MMI treatment. 
Tissue Collection and Preparation. Mice were anesthetized with 30% Fluriso 
(Isoflurane, VetOne), transcardially perfused with 4% paraformaldehyde (PFA), 
decapitated, and their heads fixed in 4% PFA for 12-16 hours at 4°C. Tissue was then 
decalcified in 0.5M EDTA (Fisher)/1xPBS overnight at 4°C, cryoprotected in 10% (1hr), 
20% (1hr), and 30% sucrose/1xPBS overnight at 4°C, and frozen in OCT compound 
(Tissue Tek). 10-12μm of the olfactory epithelium and olfactory bulb were collected on a 
Leica CM1860 cryostat.  
X-Gal staining. Tissue sections were rinsed in 1xPBS to remove OCT and then 
incubated in X-gal solution for 6 hours at 37°C. Sections were rinsed in 1xPBS to remove 
X-gal solution, incubated in Nuclear Fast Red (Sigma) for 5min at RT, rinsed in water, 
and rinsed in 75% EtOH, 95% EtOH, 100% EtOH, and Xyelens for 5min each. After 
drying, sections were sealed with cover slips mounted with Permount (Fisher). 
Immunohistochemistry. For all immunofluorescence, antigen retrieval was used. 
For antigen retrieval, tissue sections were rinsed in 1xPBS to remove OCT then incubated 
in Citrate buffer (pH 6.0) for 30min at 90°C, cooled for 20min at RT, then washed with 
distilled water for 5min. Sections were blocked with 2% donkey or goat serum, 1% BSA 
in 1xPBS and incubated overnight in primary antibody. Antibodies were used at the 
following dilutions: mIgG2a anti-p63 (BioCare Medical, 1:200); mIgG2a anti-ARL13B 
(Neuromab, 1:500); rabbit anti-ARL13B (Proteintech, 1:500); mIgG1 anti-gamma tubulin 
(Sigma, 1:500); rabbit anti-K5 (Covance, 1:2500); mIgG1 anti-MASH1 (BD Pharmingen, 
1:100); mIgG2b anti-SEC8 (BD Transduction Laboratory, 1:500); goat anti-OMP (Wako 
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Chemicals, 1:1000); rabbit anti-GAP-43 (Millipore, 1:500); rabbit anti-Ki67 (Abcam, 
1:500); and rabbit anti-MYC (Abcam, 1:500). Sections were washed in 1xPBS three times 
for 5min each at room temperature and then incubated with Alexa Fluor-conjugated 
secondary antibodies (1:1000) for 1hr at room temperature. Tissue sections were then 
incubated with DAPI (Invitrogen, 5mg/ml) for 5 min, washed two times with 1xPBS, and 
then sealed with cover slips mounted with ProLong Gold (Invitrogen). 
For dual X-Gal and Immunofluorescence staining, tissue sections first underwent 
an X-Gal stain as described above, but instead of incubation in Nuclear Fast Re, sections 
were puddled with citrate buffer, and steamed for 10min in a glass jar in a hot water bath. 
Sections were then blocked and stained as described in the immunohistochemistry 
section above. 
Image processing and quantification. Images were captured using a Nikon A1R 
confocal microscope. ImageJ software was used to measure the length of the OE (in µm) 
in each image and to count specific cell types with the cell counter plugin. In order to 
quantify cell types, 10-15 images were taken from the dorsal medial, dorsal lateral, ventral 
medial, and ventral lateral regions, across 3-4 sections of the OE. Cell counts were 
averaged and converted to number of cells/mm of OE.  
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3-7 Figures 
 
Figure 3-1. GLI2 processing and corresponding genotypes. Schematic illustration of 
GLI2 constructs used in transgenic mouse models. A, GLI2 has a DNA-binding domain 
and C-terminal activation domain, causing it to be a weak activator of the HH pathway in 
the presence of HH ligand. B, In the Gli2ΔN construct, when the N-terminal repressor 
domain is removed, GLI2 can act as a constitutive activator of the HH pathway 
independent of HH ligand. C, When the C-terminal activator domain of GLI2 undergoes 
proteolytic cleavage, it like GLI3, acts as a repressor in the absence of HH ligand. D, In 
the Gli2ΔC4 construct, when the C-terminal activator domain is removed, GLI2 acts as a 
constitutive repressor of the HH pathway independent of HH ligand.   
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Figure 3-2. Components of the HH pathway are present in the CNS and olfactory 
turbinates. Whole heads of Control, Gli1lacZ/+, Gli2lacZ/+, Gli3lacZ/+, and Ptch1lacZ/+ mice 
were incubated with an X-Gal substrate that is cleaved by β-Galactosidase, producing a 
blue precipitate that indicates lacZ expression. (A-C’’’) Control mice show no color. (E) 
Gli1 is not expressed in the olfactory bulb (OB) but (F’-F’’’) in the stoma of olfactory 
turbinates. (H) Gli2 is expressed in the dorsal OB and (I’-I’’’) anterior/ventral parts of the 
olfactory turbinates. (J) Gli3 is not expressed in the OB but (L’-L’’’) similar to Gli2, is 
expressed in anterior/ventral parts of the olfactory turbinates at a lesser intensity. (N) 
Ptch1 is expressed in the entire OB and (O’-O’’’) in an opposing gradient to Gli2 and Gli3 
in posterior/dorsal parts of the olfactory turbinates. 
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Figure 3-3. Components of the HH pathway are present in specific cells of the OE. 
Tissue sections from Control, Gli1lacZ/+, Gli2lacZ/+, Gli3lacZ/+, and Ptch1lacZ/+ mice were 
incubated with an X-Gal substrate that is cleaved by β-Galactosidase, producing a blue 
precipitate that indicates lacZ expression. (A-D) Control mice show no color in the OE or 
lamina propria (LP). (E-H) Gli1 is not expressed in the OE, but in cells of the LP. (I-L) Gli2 
is uniformly expressed in basally located cells in the OE, a majority of cells in the LP, and 
a subset of SUS cells in the apical OE. (M-P) Gli3 is sparsely expressed in basally located 
cells of the OE and cells in the LP, and also a subset of SUS cells. (Q-T) Ptch1 is 
expressed with high intensity in a majority of more apically located cells, but not SUS 
cells, and with lower intensity in basally located cells. The expression pattern is “patchy.” 
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Figure 3-4. The HH transcription factors Gli2 and Gli3 are expressed specifically in 
HBCs of the OE, while Ptch1 is expressed in mature OSNs. Dual X-gal and 
immunofluorescence staining of coronal sections of the OE in lacZ reporter mice. (A) Gli2 
is expressed in all K5+ HBCs but not in SEC8+ GBCs. (B) Gli3 is expressed in fewer K5+ 
cells (arrow) but also excluded from SEC8+ GBCs. (C) Ptch1 is specifically expressed in 
a subset of mature OSNs.   
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Figure 3-5. Constitutively active Gli2 in HBCs results in hyperproliferation. (A) 
Immunofluorescence analysis of p63+/K5+ HBCs in the OE of (I) control mice and iHBC-
Gli2ΔN mice treated with dox for (II) 24 hours, (III) 3 days, (IV) 5 days, (V) 7 days, or (VI) 
10 days. (B) Quantified data show an increase in the number of HBCs in iHBC-Gli2ΔN 
mice treated with dox for at least 5 or more days compared to control mice. (C) Quantified 
data reveal that the thickness of the HBC layer subsequently increases in iHBC-Gli2ΔN 
mice compared to control mice. (D) While control mice possess p63+ HBCs devoid of 
Ki67, iHBC-Gli2ΔN mice treated with dox for 10 days, show an increase in the number of 
Ki67+ cells and Ki67 expression in p63+ HBCs. (E) Quantified data show an overall 
increase in the number of Ki67+ cells in the OE of iHBC-Gli2ΔN mice compared to control 
mice. (F) Quantified data show that in iHBC-Gli2ΔN mice, nearly 40% of p63+ HBCs are 
also Ki67+, while no HBCs express Ki67 in control mice. 
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Figure 3-6. GLI2 localizes to tips of HBC cilia. IF analysis of control and iHBC-Gli2ΔN 
mice reveals (A) expression of MYC in HBCs (indicative of ARL13B+ cells) of iHBC-
Gli2ΔN mice after 24 hours or 7 days of dox, which is absent in control mice. (B) 
Quantified data show that compared to controls, 60% of HBCs express MYC in iHBC-
Gli2ΔN mice treated with dox for 24 hours which increases to 90% of HBCs after 7 days. 
(C) Quantified data show that control mice do not have MYC expression in ARL13B+ HBC 
cilia, while iHBC-Gli2ΔN mice treated with dox for 24 hours exhibit MYC in ~10% of HBC 
cilia and those treated for 7 days exhibit MYC in ~25% of HBC cilia. (D) IF analysis shows 
MYC-labeled GLI2 localizes to tips of ARL13B+ cilia in opposition of γ-tubulin+ basal 
bodies in MYC-labeled HBCs of iHBC-Gli2ΔN mice treated with dox for 7 days. 
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Figure 3-7. Constitutively active Gli2 in HBCs results in the upregulation of SEC8. 
IF analysis of control and iHBC-Gli2ΔN mice reveals (A) an upregulation of SEC8 in HBCs 
of iHBC-Gli2ΔN mice represented by the co-expression of SEC8 in p63+ HBCs treated 
with dox for 5 or 10 days. (B) Quantified data show the total number of SEC8+ cells in the 
OE of iHBC-Gli2ΔN mice treated with dox for 5 or 10 days is increased compared to 
control mice. (C) Quantified data show that while the percentage of HBCs in control mice 
have no SEC8 expression, 60% of HBCs in iHBC-Gli2ΔN mice treated with dox for 5 days 
and 90% of HBCs in iHBC-Gli2ΔN mice treated with dox for 10 days have SEC8 
expression. 
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Figure 3-8. Constitutively active Gli2 in HBCs results in the loss of neuronal cells. 
(A) IF analysis of control and iHBC-Gli2ΔN mice and (B) quantified data reveal a dramatic 
reduction in the number of MASH1+ GBCs in iHBC-Gli2ΔN mice treated with dox for 5 or 
10 days compared to control mice. (C) IF analysis and (D) quantified data show a loss of 
GAP-43+ immature and OMP+ mature OSNs in iHBC-Gli2ΔN mice treated with dox for 5 
days compared to controls.  
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Figure 3-9. Constitutively active Gli2 in HBCs results in an increase in the number 
of active and inactive HBCs during the regeneration of the OE. Control and iHBC-
Gli2ΔN mice were treated with dox for 5 days and administered an I.P. injection of MMI 
to induce injury to the OE. IF analysis of p63+/K5+ inactive HBCs and p63-/K5+ active 
HBCs reveals that (A) at Day 0 of injury, there is an increase in the number of p63+/K5+ 
inactive HBCs of iHBC-Gli2ΔN mice, which (B) by 2 days following injury, increases in 
both control and iHBC-Gli2ΔN mice with additional p63-/K5+ active HBCs present. (C) 
After 5 days of recovery, HBCs of control mice appear to return to an inactive state while 
iHBC-Gli2ΔN mice continue to possess an increased number of p63+/K5+ inactive and 
p63-/K5+ active HBCs. (D) At 9 days following injury, HBCs of control mice are similar to 
Day 0, but the number of p63+/K5+ inactive and p63-/K5+ active HBCs continue to 
dramatically increase in number. Quantified data of (E) inactive HBCs and (F) active 
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HBCs reveal that HBCs of both control and iHBC-Gli2ΔN mice become active but while 
HBCs of control mice eventually become inactive, HBCs of iHBC-Gli2ΔN mice continue 
to be active. 
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Figure 3-10. Constitutively active Gli2 in HBCs results in the loss of neurogenesis 
during the regeneration of the OE. Control and iHBC-Gli2ΔN mice were treated with 
dox for 5 days and administered an I.P. injection of MMI to induce injury to the OE. IF 
analysis reveals that at Day 0 of injury, there is a reduction in the number of (A) MASH1+ 
GBCs and (B) GAP-43 immature and OMP+ OSNs in iHBC-Gli2ΔN mice compared to 
control mice. By 2 days following injury, there is a decrease in (C) MASH1+ GBCs and 
(D) GAP-43 immature and OMP+ OSNs in both control and iHBC-Gli2ΔN mice. Following 
5 days of recovery, (E) MASH1+ GBCs and (F) GAP-43 immature and OMP+ OSNs 
return in control mice, but are still absent in iHBC-Gli2ΔN mice. At 9 days following injury, 
(G) MASH1+ GBCs are still present in control mice but absent in iHBC-Gli2ΔN mice, while 
(H) there is a further return of GAP-43 immature and OMP+ OSNs in control mice but no 
OSNs present in iHBC-Gli2ΔN mice. Quantified data of (I) MASH1+ GBCs, (J) immature 
OSN, and (J) mature OSNs show a marked decrease in neuronal cells of control and 
iHBC-Gli2ΔN mice following MMI-induced injury that return in control mice but not in 
iHBC-Gli2ΔN mice.  
 
146 
 
 
Figure 3-11. Dominant negative repressive Gli2 in HBCs has no effect on 
homeostasis of the OE. Following 36 days of dox treatment, (A-B) IF analysis of control 
and iHBC-Gli2ΔC4 mice and (C-D) quantified data reveal no difference in the number of 
(A, C) p63+/K5+ HBCs or (B, D) MASH1+ and SEC8+ GBCs.  
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Figure 3-12. Dominant negative repressive Gli2 in HBCs results in the improper 
regeneration of the OE. Control and iHBC-Gli2ΔC4 mice were treated with dox for 7 
days and administered an I.P. injection of MMI to induce injury to the OE. (A) IF analysis 
and (C) quantified data reveal that the number of p63+/K5+ HBCs at Day 0 of injury and 
following 8 weeks is similar between control and iHBC-Gli2ΔC4 mice. (B) IF analysis and 
(D) quantified data show no difference in the number of SEC8+ GBCs at Day 0 between 
control and iHBC-Gli2ΔC4 mice but a decrease in GBCs of iHBC-Gli2ΔC4 mice 8 weeks 
following injury. The number of (E, F) GAP-43 immature and (E, G) OMP+ mature OSNs 
is unchanged in iHBC-Gli2ΔC4 mice compared to control mice at Day 0 of injury but 
following 8 weeks of recovery, there is a dramatic decrease in the number of OSNs in 
iHBC-Gli2ΔC4 mice compared to control mice.  
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Figure 3-13. Constitutively active Gli2 in HBCs impedes the differentiation of HBCs 
during regeneration of the OE. Control and iHBC-Gli2ΔN mice were treated with dox 
for 5 days and administered an I.P. injection of MMI to induce injury to the OE. (A) At Day 
0 of the injury, there is an upregulation of SEC8 in p63+/K5+ inactive HBCs of iHBC-
Gli2ΔN mice while control mice possess SEC8+ GBCs that are not co-expressed with K5 
or p63. (B) After 2 days of recovery, control mice exhibit some upregulation of SEC8 in 
p63+/K5+ inactive HBCs and p63-/K5+ active HBCs which is consistently seen in both 
groups of HBCs in iHBC-Gli2ΔN mice. (C) At 5 days following injury, control mice show a 
normal appearance of p63+/K5+ inactive HBCs and SEC8+ GBCs while iHBC-Gli2ΔN 
mice  continue to show an upregulation of SEC8 in p63+/K5+ inactive and p63-/K5+ active 
HBCs. (D) By 9 days of recovery, control mice exhibit normal HBC and GBC expression 
profiles, while iHBC-Gli2ΔN mice continue to show an increased number of p63+/K5+ 
inactive and p63-/K5+ active HBCs that co-express SEC8. Quantified data reveal that (E) 
the total number of SEC8+ cells is dramatically increased in iHBC-Gli2ΔN mice before 
and following injury compared to control mice, (F) the percentage of inactive HBCs that 
co-express SEC8 is largely in iHBC-Gli2ΔN mice regardless of injury and (G) a large 
percentage of active HBCs co-express SEC8 following injury in both control and iHBC-
Gli2ΔN mice but only in iHBC-Gli2ΔN mice do active HBCs still express SEC8 9 days 
following injury. 
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Figure 3-14. Model of GLI2- and SEC8-dependent transition of HBCs to GBCs 
during neurogenesis in the OE. Normally GLI2 acts as a repressor to maintain HBC 
quiescence (p63+/K5+). Upon injury, HBCs are activated and GLI2 acts as an activator 
which upregulates Sec8 (p63+/K5+/SEC8+). In order for HBCs to become multipotent 
(K5+/Sec8+) and contribute to differentiation and regeneration in the OE, p63 must be 
downregulated which should lead to downregulation of Gli2, and subsequent 
differentiation. However, because the constitutive form of Gli2 is driven by the K5 
promoter which I propose to be expressed in multipotent cells, HBCs are fixed in an active 
and multipotent state and unable to differentiate into neuronal cells to replenish the OE.   
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Chapter IV: 
Discussion and Future Directions 
4.1 A Novel Role for Primary Cilia in the Regulation of Olfactory Horizontal Basal 
Cells and Neurogenesis 
 
4.1.1 Summary of Key Findings 
 Data presented in Chapter II demonstrate a novel role for primary cilia in olfactory 
neurogenesis. I provide evidence that horizontal basal cells (HBCs) in the olfactory 
epithelium (OE) selectively possess primary cilia. My data support the paradigm that 
primary cilia are essential regulators of adult tissue homeostasis and neurogenesis (Han 
et al., 2008; Tummala et al., 2010; Amador-Arjona et al., 2011; Croyle et al., 2011; 
Kumamoto et al., 2012). Adult stem cells, like HBCs, often remain quiescent in adult 
tissues unless activated by an injury from which they generate multiple cell types (Veland 
et al., 2009). Primary cilia are often associated with the G0 stage or quiescent phase of 
the cell cycle (Plotnikova et al., 2009; Irigoin and Badano, 2011; Kim and Tsiokas, 2011). 
However, the adult stem cells that exist in a quiescent state make cell cycle 
considerations secondary to the need to respond to transient environment signals sensed 
through the cilia (Plotnikova et al., 2009). HBCs appear to work in this fashion – that is, 
primary cilia are not essential for control of the cell cycle (e.g. proliferation), but are 
important for sensing external signals that lead to their activation and differentiation. This 
observation is contrary to what is seen in other epithelia, such as the skin 
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(Croyle et al., 2011) but is similar to observations in neural stem cells (NSCs) of the SVZ 
where the loss of cilia also does not change the number of stem cells (Amador-Arjona et 
al., 2011). These data suggest a tissue-specific role for primary cilia in adult 
neurogenesis.  
I also show that a loss of HBC cilia in iHBC-IFT88 null mice results in reduced 
neurogenesis during development. It is believed that GBCs and not HBCs contribute to 
developmental neurogenesis (Guillemot et al., 1993; Cau et al., 1997; Cau et al., 2002). 
This notion is strongly supported by the fact that HBCs appear late embryonically 
(Packard et al., 2011b). However, a recent study suggested that HBCs do contribute to 
neurogenesis during postnatal development (Iwai et al., 2008). My data support this 
recent finding of HBC-driven neurogenesis during early postnatal development. 
Interestingly, there are regional differences in this neurogenesis that could be attributed 
to the temporal and spatial release of morphogens during development (Vedin et al., 
2009) or the regional differences of certain transcription factors expressed during 
development (Duggan et al., 2008).   
 Furthermore, I introduce SEC8 as a novel marker of GBCs. Several studies 
indicate that GBCs are neuronal precursors that exist as a heterogeneous population, 
compartmentalized by their expression of distinct transcription factors. In the GBC lineage 
cascade, Ascl1 (Mash1) expression lies upstream of Neurogenin1 (Ngn1) which lies 
upstream of, but also overlaps with, NeuroD1 expression (Cau et al., 1997; Manglapus et 
al., 2004; Packard et al., 2011a; Krolewski et al., 2013). NeuroD1 is eventually switched 
off prior to onset of post-mitotic differentiation, and low levels of NeuroD1 are sometimes 
found in immature OSNs (Packard et al., 2011a). Recently, the chromatin modifying 
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protein LSD1, was shown to localize with ASCL1 (MASH1) expressing cells, a subgroup 
of NGN1 and SOX2 expressing cells, as well as a subpopulation of immature OSNs, 
(Krolewski et al., 2013). I show that SEC8 overlaps with all LSD1-expressing cells and a 
surplus of cells that are not HBCs or immature OSNs, suggesting that SEC8 labels a 
larger population of GBCs that span the entire lineage of cells. Interestingly, Sec8 null 
embryos, similar to Mash1 mutant mice, show a loss of Notch1 (Friedrich et al., 1997; 
Cau et al., 2002), which is believed to be involved in GBC differentiation. These 
observations suggest that Sec8 plays important roles in signaling in GBCs, perhaps 
through Notch signaling, that is necessary for their neuronal differentiation. 
Due to their close association with other cell types in the OE and their expression 
of epidermal growth factor (EGF) receptor-like immunoreactivity, HBCs are primed to 
serve as a channel of communication to the GBCs about the status of the OE and other 
cell types (Carr and Farbman, 1992; Holbrook et al., 1995). My work supports the notion 
that HBCs and SUS cells make physical contact through HBC primary cilia that project 
into the interstitial space between SUS cell endfeet and HBCs (Joiner et al., 2015). These 
endfeet are proposed sites of communication (Jia and Hegg, 2010) and HBC primary cilia 
may act as a scaffold for this communication. 
Overall, my studies support the idea that HBCs contribute to olfactory regeneration 
and introduce a new role for primary cilia in that regeneration. I also provide evidence of 
a role for HBCs in OE development that was thought to be limited to GBCs (Doty, 2003; 
Treloar et al., 2010), and introduce a new marker for GBCs that may be important for their 
differentiation. What remains unexplored are: 1) the specific mechanisms that primary 
cilia utilize to regulate HBC proliferation and cell fate determination, 2) a more complete 
159 
 
profile of HBC primary cilia during development, homeostasis, and regeneration, and 3) 
the identification of potential therapeutic approaches that target HBC primary cilia. 
4.1.2 Future Directions 
Are Primary Cilia Sensors of Injury that Also Dictate Cell Fate?  
It is possible that HBC primary cilia are both detectors of injury and signaling 
scaffolds for differentiation and cell fate determination. If HBC cilia are detectors of the 
insult, observing what happens to primary cilia immediately following injury upon 
activation of HBCs would be informative. Primary cilia could be reabsorbed prior to 
proliferation and re-established prior to differentiation or maintained throughout HBC 
activation and differentiation. Ciliary resorption is triggered by the addition of a specific 
combination of growth factors including PDGFα and either insulin-like growth factor1 
(IGF-1), epidermal growth factor (EGF), or fibroblast growth factor (FGF) (reviewed in Kim 
and Tsiokas, 2011). These factors are positive regulators of neurogenesis in the OE and 
are most prominently expressed in HBCs and SUS cells (reviewed in Murdoch and 
Roskams, 2007). Analysis of these factors in the OE of iHBC-IFT88 null mice with and 
without an injury could provide insight to what possible signals HBCs detect following 
injury. 
Upon cell death, SUS cells may release a signal to HBCs that is transduced 
through primary cilia, triggering HBC activation. Using an additional lesion model in which 
SUS cells are ablated, one could determine if there is a direct connection between SUS 
cell death and HBC activation. Ablation of the OE with NiSO4 selectively causes SUS cell 
death with a subsequent increase in basal cell proliferation (Jia et al., 2010); however, 
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the population of basal cells was not defined. Analyzing the OE with specific HBC and 
GBC markers along with proliferative markers following a lesion with NiSO4 in control and 
iHBC-IFT88 null mice could test the theory that SUS cell death activates HBCs and 
whether cilia are important for the detection of injury. Additionally, a specific ablation of 
SUS cells would provide more direct information about the relationship and 
communication between SUS cells and HBCs. There exists a transgene, TetO-DTA which 
leads to expression of diphtheria toxin A under control of a tetracycline operator (Lee et 
al., 1998). SUS cells express K18 specifically in the OE (Holbrook et al., 2011) and if 
expression of the tetracycline transactivator, rtTA, can be driven under the K18 promoter 
(Ye et al., 2001), SUS cells could be specifically ablated to further analyze how HBCs 
respond. Ideally, this specific ablation of SUS cells should occur in iHBC-IFT88 null mice 
to determine if primary cilia are in fact necessary for detection of the insult but this 
breeding scheme would rely heavily on recombination and may not be possible.  
Furthermore, cell-fate mapping with the use of either K5-Cre-tdTomato mice in 
which K5 expressing cells and their progeny express tdTomato or inducible K5-CreERT2-
R26R mice in which K5 expressing cells and their progeny express lacZ. An inducible 
model would be ideal to investigate the lineage of HBCs following an injury in order to 
bypass any possible HBC-driven neurogenesis in development. Therefore Ift88fl/fl mice 
could be crossed with K5-CreERT2-R26R mice or the K5rtTA;TetOCre;Ift88fl/fl mice could 
be crossed with R26R-tdTomato mice to lineage trace HBCs in which cilia are ablated. 
The first cross would utilize a tamoxifen inducible system, while the second cross would 
utilize the doxycycline inducible system which I successfully utilized to remove cilia (see 
Chapter II). Both crosses would rely heavily on recombination and therefore, use of an 
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IFT88 null allele could alleviate some of this burden. Cell-fate mapping would ultimately 
elucidate what cells are derived from HBCs during regeneration of the OE and 
developmental neurogenesis. This technique would especially be important for 
circumventing the residual GBCs that remain after an MMI injury and incomplete loss of 
HBC cilia.  
Interestingly, I noticed an increase in respiratory epithelia in iHBC-IFT88 null mice 
8 weeks following MMI injury to the OE (Fig. 4-1). It is unknown whether this epithelia 
came from infiltration due to a loss of OSNs or from regeneration. Xie, et. al., showed 
through cell-fate mapping that respiratory regeneration comes from HBCs eight weeks 
following severe injury with the herbicide, dichlorobenzonitrile (DCBN) when there is a 
significant loss of GBCs (Xie et al., 2010). Most likely, multiple pathways and signaling 
factors work together to create the contribution of neurogenesis seen from HBCs. I 
speculate that during recovery, the first factor likely comes from the SUS cells alerting the 
HBCs to a severe lesion that requires the activation of both HBCs and GBCs. The second 
factor could come from GBCs, alerting the HBCs to take on a neuronal fate. Surprisingly, 
I saw no difference in cell death at 8 weeks post injury in iHBC-IFT88 null mice, but if 
there is more cell death in iHBC-IFT88 null mice earlier during recovery, this cell death 
might be necessary to trigger HBCs to regenerate tissue that, without a signal from GBCs, 
is fated to be respiratory. Analyzing the OE earlier during regeneration for apoptosis, 
respiratory markers, and using cell-fate mapping would elucidate whether the respiratory 
epithelia comes from HBCs or is a product of infiltration due to loss of OSNs. Additionally, 
SEC8 could be involved in communication with GBCs due to its role in exocytosis. 
Generating a conditional Sec8 allele, Sec8fl/fl, and using the mouse line that expresses 
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CreER under the GBC promoter, Ascl1 (Mash1),  (Ascl1CreER) (Kim et al., 2011) could 
provide insight into this theory, although MASH1 is only present in a subset of GBCs.  
How do HBC Primary Cilia Change with Age and in Ciliopathy Models? 
As mentioned before, defects in primary cilia lead to various human diseases, 
termed ciliopathies, in which mutations of various genes that are involved in the formation 
and maintenance of primary cilia affect a variety of tissues and organ systems (Singla 
and Reiter, 2006; Hildebrandt et al., 2011). Ciliary defects also affect the OE, resulting in 
anosmia, a loss of smell (Kulaga et al., 2004; Tadenev et al., 2011; McIntyre et al., 2012). 
My identification of primary cilia on HBCs and their importance in neurogenesis reveal 
new mechanisms for the etiology of olfactory dysfunction. There are numerous reported 
etiologies for olfactory disturbance including environmental toxins and head injuries. In 
addition, the normal decline in olfactory function due to aging afflicts approximately 25% 
of the population over 65 years old and this estimation is thought to be largely 
underrepresented (Murphy et al., 2002). Although the olfactory basal cells are responsible 
for the regeneration and restoration of cells in the OE, there is a net loss of neurons over 
time due to the fact that the capacity to match OSN death with regeneration is 
compromised as a function of age (Conley et al., 2003). This compromise can be 
attributed to the dramatic decrease in basal stem cell proliferation with age, with olfactory 
cell proliferation decreasing ~10 to 15 times after birth during the first 3 months of life 
(Legrier et al., 2001; Ducray et al., 2002). Similarly, there is an age-related decline in the 
neurogenesis of the SVZ and the hippocampus (reviewed in Riddle and Lichtenwalner, 
2007). Cilia may be associated with this loss of stem cell activation that seems to be a 
result of specific signals from the OE. If HBC cilia are depleted or become defective with 
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age, HBCs may become permanently inactive resulting in the inability to recover from an 
insult to the OE which would lead to a permanent loss of smell. Future work investigating 
age-related cilia loss or defects could define a mechanism for age-related anosmia. 
Additionally, analysis in the OE of ciliopathy mouse models in which the OE is ablated to 
determine if regeneration occurs normally could also translate to human ciliopathies in 
which HBC cilia may be affected (Kulaga et al., 2004; McIntyre et al., 2012).  
Potential Therapeutic Strategies for Olfactory Dysfunction. 
With their ability to generate multiple cell types, stem cells are potential therapeutic 
tools for tissue repair in various diseases including genetic and degenerative diseases as 
well as aggressive and recurrent cancers (Mimeault et al., 2007). However, stimulating 
their expansion and differentiation into functional progenitors remains a challenge due to 
the unknown drivers of differentiation. Olfactory basal stem cells can be cultured into 
neurospheres and transplanted back into mice in order to repopulate the OE (Jang et al., 
2008; Krolewski et al., 2011). Additionally, adenoviral delivery of Ift88 to mature OSNs in 
an Ift88 deficient mouse model that exhibited loss of OSN cilia and resulting anosmia, 
restored cilia and olfactory function to mice (McIntyre et al., 2012). My preliminary data 
indicate that combining ablation of the OE via MMI treatment with adenoviral infection 
results in ectopic gene expression in HBCs (Fig. 4-2). Together, these studies provide a 
possible therapeutic strategy for olfactory loss that focuses on cilia function and its 
regulation of olfactory stem cell function. Future work could include analysis of cultured 
HBCs to study what happens with a loss of ciliary genes via siRNA, subsequent viral 
infection to rescue defects, and transplantation back into the OE. Additionally, iHBC-
IFT88 null mice could be infected with adenovirus containing Ift88 (McIntyre et al., 2012) 
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to determine if there is a genetic rescue of cilia and phenotypic rescue of regeneration 
and olfaction. 
 
4.2 GLI-Dependent Role for Hedgehog Signaling in the Olfactory Epithelium 
4.2.1 Summary of Key Findings 
Data presented in Chapter III demonstrate a potential role for Hedgehog (HH) 
signaling in the olfactory epithelium (OE). Various HH components were found in specific 
cell types of the OE. Interestingly, their expression profiles differ from what is typical, 
specifically that Ptch1 and Gli1, both of which are direct HH transcriptional targets, display 
distinct expression patterns. The HH transcription factors Gli2 and Gli3 were expressed 
selectively in HBCs but also in a subset of SUS cells. Ptch1 appears to be present in a 
specific set of mature OSNs and at a lower levels in immature OSNS and some basal 
cells. I show that constitutive activation of Gli2 in HBCs of iHBC-Gli2ΔN mice results in 
their hyperproliferation with a resulting loss of neuronal cells. Although during normal 
homeostasis constitutive Gli2 has dramatic effects on the composition of the OE, 
expression of a dominant negative Gli2 repressor in iHBC-Gli2ΔC4 mice has no effect. 
These data suggest that GLI2 acts as a transcriptional repressor in the OE. Although GLI2 
is typically processed as an activator (Pan et al., 2006), studies have shown GLI2 can act 
as a repressor (Buttitta et al., 2003). Additionally, I demonstrate that both the activator 
and repressor forms of GLI2 lead to impaired regeneration following injury in the OE. 
These data suggest that GLI2 must be properly regulated in order for HBCs to contribute 
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to regeneration. Overall, these data implicate HH signaling, specifically Gli2, in the 
regulation of HBCs and their contribution to neurogenesis in the OE. 
Furthermore, I show an upregulation of the GBC marker, SEC8, in HBCs of iHBC-
Gli2ΔN mice, but this observation is not seen when HBCs express the repressive form of 
Gli2 in Gli2ΔC4 mice. The SEC8+ HBCs remain in the regenerating OE following injury 
and appear to be unable to transition to GBCs and eventually differentiate into OSNs. 
These data suggest that GLI2 and SEC8 are important for regulating HBC transition from 
dormancy to activation and ultimately differentiation into GBCs. Reports show that Gli2 is 
a direct transcriptional target of p63 (Ram Kumar et al., 2014) and that downregulation of 
p63 in response to injury and subsequent activation could downregulate Gli2, driving HBC 
differentiation. What remains unexplored is: 1) the role Gli3 plays in regulation of HBCs, 
2) whether there are any redundancies between Gli2 and Gli3, 3) a possible non-
canonical role for HH signaling in different aspects of olfactory tissue homeostasis, and 
4) the link between HBC primary cilia and HH signaling.  
4.2.2 Future Directions 
GLI Processing in the OE and Possible Redundant Roles 
I show that Gli2 and Gli3 transcripts are present in HBCs but what remains 
unknown is how the resulting proteins are processed. It is possible that GLI2 acts as a 
repressor in HBCs. Normally, HBCs are quiescent but when the constitutively active form 
of GLI2 is expressed, HBCs become proliferative. If GLI2 was normally processed as a 
weak activator (Sasaki et al., 1999), it would seem plausible for HBCs to be more 
proliferative and not quiescent. Because Gli2 transcript is present in HBCs, it is likely that 
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GLI2 protein is either targeted for degradation or processed into a repressor. 
Furthermore, preliminary data show that staining the OE of control mice, iHBC-Gli2ΔN 
mice, or HBC-Gli2ΔC4 mice with an antibody against GLI2 that detects the C terminus, 
but not the N terminus (Cho et al., 2008), is seen in HBCs of HBC-Gli2ΔN mice but not 
control or HBC-Gli2ΔC4 mice (Fig. 4-3). These data further suggest that GLI2 is 
processed into an N-terminal repressor since the antibody can only detect residues near 
the C terminus. Additional analysis to detect protein levels of full length GLI2 and GLI3, 
as well as repressor and active forms would help elucidate the roles of these transcription 
factors. In order to detect the protein levels specifically in HBCs, cell sorting for Beta-
Galactosidase in Gli2lacZ/+ and Gli3lacZ/+ mice could be utilized with Western blot analysis 
combined with qRT-PCR analysis to detect other HH components in HBCs. 
My preliminary data indicate that in mice containing an HBC-specific deletion of 
Gli2 (K5-rtTA;TetO-Cre;Gli2fl/fl), there is no change in OE cell composition during normal 
homeostasis and following an MMI-induced injury to the OE (Fig. 4-4). Unfortunately, 
because there are no commercially available antibodies to detect the active or repressor 
forms of GLI2 for immunohistochemistry, it is difficult to determine a loss of Gli2 in the 
HBCs of these mice. In order to ensure that proper recombination occurs, K5-rtTA;TetO-
Cre;Gli2fl/fl mice can be crossed with Gli2lacZ/+ mice so that cell sorting for Beta-
Galactosidase can be used to isolate HBCs and assess recombination efficiency via qRT-
PCR. Western blot analysis of the entire OE of K5-rtTA;TetO-Cre;Gli2fl/fl lysates can also 
be used to verify a loss of GLI2 protein. If recombination and subsequent loss of Gli2 
successfully occurs and there is still no phenotype seen with a loss of Gli2, Gli3 could 
play a redundant role in HH signaling since it is also expressed in HBCs.  
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In certain cases, including the development of the anterior neural tube (Motoyama 
et al., 2003), skeletal development (Mo et al., 1997), and development of the lung, 
trachea, and esophagus (Motoyama et al., 1998) Gli2 and Gli3 play redundant roles. 
However, this redundancy is unexplored in the adult. In order to elucidate the possible 
redundant role of Gli2 and Gli3 specifically in HBCs, a conditional knockout of Gli3 can 
be utilized. The laboratory of Dr. Alex Joyner has already generated a Gli3fl/fl mouse 
(Blaess et al., 2008). Successful breeding of K5-rtTA;tetO-Cre mice with Gli3fl/fl mice will 
produce an inducible HBC-specific Gli3 conditional null mouse (K5-rtTA;tetO-Cre;Gli3fl/fl). 
If no phenotype is seen in normal homeostasis or following an MMI-induced injury, mice 
with a conditional loss of both Gli2 and Gli3 (K5-rtTA;tet-OCre;Gli2fl/fl;Gli3fl/fl) could also 
be generated. Again, for analysis of loss of GLI2 and GLI3 proteins, lacZ can be 
introduced as one allele (for either Gli2 or Gli3) and subsequent cell sorting can be 
performed. Additionally, cell-fate mapping with a tdTomato reporter can be used to 
determine what cells, if any, stem from HBCs that lack Gli2, Gli3 or a combination of both 
following an injury and during normal tissue homeostasis. 
Non-Canonical Role of Hedgehog Signaling in the Olfactory Epithelium 
There are a few examples where a subset of the components of the canonical HH 
signaling pathway regulate various basic cellular processes seemingly independent of the 
full pathway. PTCH1 has been implicated in cell cycle regulation through interaction with 
cyclin B1 which acts at the G2/M checkpoint and is required for cell cycle progression 
(Barnes et al., 2001). Additionally, although not commonly described as non-canonical 
HH signaling, a role for the GLI transcription factors independent of the traditional HH 
ligand/SMO-signaling cascade has also been reported, particularly in cancer, where other 
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signaling pathways appear to directly regulate GLI proteins (reviewed in Stecca and Ruiz, 
2010). RAS, MAPK, and PI3/AKT signaling have all been implicated in the modulation of 
GLI proteins as well as receptor tyrosine kinase (RTK) signaling (Aberger et al., 2012). 
The growth factors, EGFR, TGFβ, and IGF2 were also shown to be implicated in SMO-
independent but GLI-dependent signaling (Aberger et al., 2012).   
 Although I have not examined the expression of Smo, it is believed to be expressed 
in the OE (Gong et al., 2009). Preliminary data from mice treated with the SMO 
antagonist, LDE-225 (Pan et al., 2010), a HH pathway inhibitor, showed no change in 
HBCs or the cell composition of the OE during natural turnover and in response to an 
MMI-induced lesion (Fig. 4-5), suggesting that the regulation of HBCs and OE 
regeneration is not HH ligand- or SMO-dependent. These findings were further supported 
by my data from mice containing an HBC-specific deletion of Smo (K5-rtTA;TetO-
Cre;Smofl/fl), in which there was no change in the cell composition of the OE during natural 
turnover (Fig. 4-6). Smo could still play a role upon injury to the OE, therefore, an MMI-
induced injury in K5-rtTA;TetO-Cre;Smofl/fl mice would be important to verify this idea. 
Furthermore, analyzing mice that express the constitutively active form of Smo, Smo-A1, 
(Hallahan et al., 2004) to determine if there is a similar phenotype to iHBC-Gli2ΔN mice 
could also confirm the role of Smo in HBC regulation and olfactory regeneration. 
Together, these data suggest a SMO-independent and possible GLI-dependent role for 
HH in regulation of HBCs and olfactory neurogenesis. Additional mice need to be 
analyzed to confirm these preliminary findings.  
An important component of the pathway that needs further investigation is the HH 
ligand and its source. SHH is the only member of the HH family that continues to be 
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expressed in the adult brain (Traiffort et al., 2010). Under normal conditions, neurons 
appear to be the main SHH-secreting cell type (as opposed to SHH-responding cells, 
which are primarily of glial nature), however, following injury, SHH expression has been 
reported in reactive astrocytes  (reviewed in Petrova and Joyner, 2014). Along with other 
neuronal populations, it is possible that anterograde movement of SHH protein along 
axons allows the delivery of the protein to both the SVZ and striatum (reviewed in Petrova 
and Joyner, 2014). My preliminary data show that through in situ hybridization, SHH 
ligand might be present in SUS cells (Fig. 4-7A), however, in Shh-Cre;Rosa26R-
TdTomato mice, in which Shh expressing cells and their progeny express TdTomato, 
clusters of cells including SUS cells, OSNs, and GBCs are positive for TdTomato (Fig. 4-
7B-C). If SUS cells express Shh, it would coincide with the possible communication 
between SUS cells and HBC cilia. However, due to studies demonstrating secretion of 
SHH in neurons and that SHH protein can move along axons along with the detection of 
Shh in the OB (Gong et al., 2009), it is possible that the source can come from the bulb 
or OSNs. Analyzing the OE of Shh-Cre;Rosa26R-TdTomato mice or using in situ 
hybridization for the detection of Shh transcript following an injury could also elucidate the 
source of ligand in the OE.  
What remains unknown is if the regulation of HBCs occurs in a true HH ligand-
independent manner. The use of conditional Ptch1fl/fl (Ellis et al., 2003; Uhmann et al., 
2007)mice could be used to specifically delete Ptch1 from HBCs to support the theory 
that regulation of HBCs occurs in a HH-independent manner. Inhibition of SHH ligand 
with the antibody 5E1, can be administered to mice via an I.P. injection (O'Toole et al., 
2011) to determine if normal OE homeostasis and regeneration following an injury is 
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disrupted. Additionally, HBCs can be cultured and treated with either 5E1 or SHH ligand 
to see if differentiation is inhibited or initiated respectively via immunofluorescence or 
qRT-PCR. In these cultured cells, other growth factors that have been implicated in GLI-
dependent signaling can also be utilized to inhibit or drive differentiation. Furthermore, 
the GLI small-molecule inhibitor, GANT61 (Mazumdar et al., 2011), can be used in vivo 
or in cultured cells to specifically inhibit GLI activity to further elucidate the possible GLI-
dependence of HBC regulation and regeneration in the OE.  
Canonical Role for Hedgehog Signaling in the Olfactory Epithelium 
Interestingly, in mice treated with LDE-225, there was a reduction in attractive odor 
behaviors with no effect on aversive behaviors, specifically the fear-inducing compound 
from fox feces, TMT (Fendt and Endres, 2008) (Fig. 4-8). Various studies suggest that 
HH signaling is important for axon branching and targeting of OSNs to the OB and as 
before-mentioned, mature OSNs express Ptch1. It is possible that inhibiting the HH 
pathway affects the targeting of OE to affect specifically attractive odor behaviors. OSNs 
that express specific odorants target specific areas of the OB. The olfactory epithelium 
can be divided into two non-overlapping areas: a dorsal zone and a ventral one which 
can map to corresponding dorsal and ventral areas of the OB (Kobayakawa et al., 2007). 
Different odors were shown to map to different areas of the OB, for example, TMT 
activated glomeruli in the ventral domain of the OB (Kobayakawa et al., 2007). When 
OSNs from a specific domain were genetically deleted, mice became attracted to smells 
that were usually aversive, including TMT and certain attractive odors such as urine and 
peanut butter became aversive (Kobayakawa et al., 2007).  
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Because Ptch1 is expressed in OSNs with regional variability, it is most likely that 
LDE-225 treatment affected only those neurons that express Ptch1 which could coincide 
with OSNs that express specific odorant receptors responsible for detection of attractive 
odorants as opposed to aversive ones. Further analysis of additional odorants and 
specific domain markers of the OB to determine if there is still activity (TH expression) in 
mice treated with LDE-225 would help further elucidate the role of HH signaling in 
olfactory behavior. Additionally, analyzing a loss of Ptch1 expression following LDE-225 
via treatment in Ptch1lacZ/+ mice would be important to ensure that treatment is effectively 
inhibiting the HH pathway in OSNs since Ptch1 is a known readout of the pathway. 
Furthermore, cell-specific knockouts of other HH components in mature OSNs via the 
OMP-Cre allele and SUS cells via K18-Cre allele could provide additional information 
about the role of the HH signaling pathway in the OE. 
Together, these experiments could elucidate a GLI-dependent role for the HH 
pathway plays in regulation of HBCs and olfactory neurogenesis and the HH ligand-
dependent role in olfactory transduction and behavior. 
What Happens to Hedgehog Pathway Components in Mice that Lack HBC Cilia? 
The HH pathway is tightly linked to primary cilia (Haycraft et al., 2005). Because 
HBCs possess cilia and the transcription factor GLI2, which localizes to tips of cilia, it 
would be important to investigate what happens to GLI2 and other HH components in 
iHBC-IFT88 null and iHBC-ARL13B null mice. Loss of Arl13b and Ift88 have been shown 
to affect the HH pathway (Haycraft et al., 2007; Larkins et al., 2011). These null mice can 
be crossed with lacZ reporter mice that express specific HH components to determine 
what happens to the components after a loss of Arl13b or Ift88. It would be interesting to 
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see what happens in iHBC-IFT88 null and iHBC-ARL13B null mice that are crossed with 
iHBC-Gli2ΔN mice and administered an injury to the OE. Without cilia, the constitutively 
active form of GLI2 could drive activation of HBCs regardless of the inability to detect the 
injury. Additionally, because Sec8 is upregulated following injury to the OE, conditional 
deletion of Sec8 or overexpression of Sec8 in HBCs of control mice or cilia deficient mice 
could also elucidate its role and sufficiency in mediating the HBC to GBC transition 
following an injury to the OE. Without Sec8, HBCs may not be able to differentiate and 
regenerate the OE but its overexpression in iHBC-IFT88 null and iHBC-ARL13B null mice 
could bypass the loss of HBC cilia, allowing for proper differentiation. Furthermore, Notch 
and Wnt signaling pathways have been implicated in olfactory neurogenesis so analyzing 
these pathways along with HH in vivo or in cultured cells that either possess cilia or lack 
cilia can further elucidate what drives certain cell fates in the OE. 
Overall, data presented in this dissertation demonstrate that HBCs, the presumed 
stem cell population of the OE, possess primary cilia and HH components that are 
important for HBC regulation and contribution to neurogenesis in the OE. My results 
provide novel insight on the mechanisms involved in regeneration of the OE by the 
introduction of a new role for cilia and the HH pathway in the olfactory periphery and the 
proposal of a GLI-dependent regulation of HBC activation and differentiation. There is 
most likely interplay between cilia and the HH pathway in regulating HBCs. Therefore, if 
olfactory dysfunction arises due to the loss of basal stem cell activity from loss of cilia due 
to a diseased state like a ciliopathy or aging or from a disruption in GLIs, restoration of 
cilia function or HH signaling components could be an important therapeutic tool. 
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Ultimately, these results establish a platform for future investigation of olfactory stem cell 
regulation. 
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4.3 Figures 
 
Figure 4-1. Loss of HBC cilia results in respiratory infiltration. Whole sections of the 
OE of control and iHBC-IFT88 null mice show respiratory infiltration (arrows) in iHBC-
IFT88 null mice where Acet-tub labeled cilia are present in areas that lack OMP-labeled 
mature OSNs. 
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Figure 4-2. HBCs are amenable to adenoviral infection. Two days post MMI-induced 
injury to the OE, K5+ HBCs are infected with adenovirus (AV) containing GFP, AV:GFP 
(see arrows). 
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Figure 4-3. GLI2 antibody detects Gli2ΔN in cilia of HBCs but not endogenous GLI2 
or Gli2ΔC4. Immunofluorescence analysis reveals (A) GLI2 antibody is co-expressed 
with K5+ HBCs of iHBC-Gli2ΔN mice treated with dox for 10 days but not control or iHBC-
Gli2ΔC4 mice treated with dox for 36 days and (B) GLI2 antibody localizes to cilia of K5+ 
HBCs (see arrows) in iHBC-Gli2ΔN mice treated with dox for 10 days but not control mice. 
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Figure 4-4. Conditional loss of Gli2 in HBCs has no effect on homeostasis or 
regeneration of the OE. (A) Immunofluorescence analysis and (B) quantified data reveal 
that iHBC-Gli2 null mice treated with dox for 17 or 36 days show now difference in the 
number of p63+/K5+ HBCs and SEC8+ GBCs compared to control mice. In iHBC-Gli2 
null and control mice treated with dox for 17 days and then administered an MMI-induced 
injury to the OE, (C, E) the number of p63+/K5+ HBCs and SEC8+ GBCs is similar as 
well as (D, F) the number of GAP-43+ immature and OMP+ mature OSNs.  
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Figure 4-5. The selective SMO inhibitor, LDE-225, has no effect on homeostasis or 
regeneration of the OE. Mice treated with LDE-225 for 27 days exhibit (A-B) no 
difference in the number of Sec8+ GBCs or OMP+ mature OSNs compared to vehicle 
treated mice. Mice treated with LDE-225 for 12 days, administered an MMI-induced injury 
to the OE, and then allowed to recover for 21 days, exhibit (C-D) no difference in the 
number of p63+ HBCs, K18+ SUS cells, and OMP+ mature OSNs compared to vehicle 
treated mice.  
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Figure 4-6. Conditional loss of Smo in HBCs has no effect on homeostasis of the 
OE. In iHBC-SMO null mice treated with dox for 19 days there is (A,C) no difference in 
the number of K5+ HBCs and (B, C-D) no difference in the number of SEC8+ GBCs, 
K18+ SUS cells, and OMP+ mature OSNs compared to control mice.  
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Figure 4-7. Shh might be present in SUS cells of the OE. (A) In situ hybridization of 
control tissue with RNA probe against Shh shows expression of the transcript in the tooth 
bud (internal control) and SUS cells of the OE. In ShhCreER;Roas26RFP mice, (B) RFP 
signal is seen in basal cells and SUS cells while (C) GFP is expressed specifically in SUS 
cells, suggesting they are the source of SHH, and RFP is expressed in SUS cells, OSNs, 
BG cells, and basal cells, suggesting they are the progeny.  
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Figure 4-8. The selective SMO inhibitor, LDE-225, reduces attractive behaviors in 
mice during homeostasis and following injury. (A) Mice treated with LDE-225 for 27 
days show a reduction in the investigation time for the attractive odors, urine and peanut 
butter, but (B) show no difference in avoidance of the component of fox feces, TMT, 
compared to vehicle treated mice. (C) Mice treated with LDE-225 for 12 days, 
administered an MMI-induced injury to the OE, and then allowed to recover for 21 days, 
exhibit a reduction in the investigation time for the attractive odors, peanut butter and 
vanilla compared to vehicle treated mice.  
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